Function of the Myc-binding protein Miz1 in the mouse mammary gland by Sanz Moreno, Adrian & Elsässer, Hans-Peter (Prof. Dr.)
Aus dem Institut für Klinische Zytobiologie und Zytopathologie 
Direktor: Prof. Dr. Roland Lill 
des Fachbereichs Medizin der Philipps-Universität Marburg 
 
 
 
Function of the Myc-binding protein Miz1  
in the mouse mammary gland 
 
Inaugural-Dissertation 
zur Erlangung des Doktorgrades der Naturwissenschaften 
(Dr. rer. nat.) 
 
dem Fachbereich Medizin der Philipps-Universität Marburg 
vorgelegt von 
 
Adrián Sanz Moreno 
aus Gijón (Asturias, Spanien) 
Marburg, 2014 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Aus dem Institut für Klinische Zytobiologie und Zytopathologie 
Direktor: Prof. Dr. Roland Lill 
des Fachbereichs Medizin der Philipps-Universität Marburg 
 
 
 
Function of the Myc-binding protein Miz1  
in the mouse mammary gland 
 
Inaugural-Dissertation 
zur Erlangung des Doktorgrades der Naturwissenschaften 
(Dr. rer. nat.) 
 
dem Fachbereich Medizin der Philipps-Universität Marburg 
vorgelegt von 
 
Adrián Sanz Moreno 
aus Gijón (Asturias, Spanien) 
Marburg, 2014 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Angenommen vom Fachbereich Medizin der Philipps-Universität Marburg am: 
10 März 2014 
 
Gedruckt mit Genehmigung des Fachbereichs 
 
Dekan: Prof. Dr. Helmut Schäfer 
Referent: Prof. Dr. Hans-Peter Elsässer 
1. Korreferent: Prof. Dr. Thorsten Stiewe 
2. Korreferent: Prof. Dr. Alexander Brehm 
 
Table of Contents 
 
 
 I 
TABLE OF CONTENTS 
 
1. INTRODUCTION 
 
1.1. The murine mammary gland 
 
1.1.1. Mouse mammary gland: cellular architecture and comparison 
           to the human breast ……………………………………………………….. 1 
1.1.2. The development of the mouse mammary gland ………………………….. 2 
1.1.3. The undifferentiated state: the quest for mammary stem cells …………….. 5 
1.1.4. Hormonal control of alveologenesis and lactogenesis …………………….. 7 
   
1.2. Prolactin signalling and the Jak2/Stat5 pathway 
 
1.2.1. Stat5 as the master mammary regulator ……………………………………. 8 
1.2.2. The prolactin and ErbB4 receptors ……………………………………….... 10 
1.2.3. Negative regulators of the Jak2/Stat5 pathway ……………………………. 11 
 
1.3. Function of the transcription factors Miz1 and Myc 
 
1.3.1. Miz1 ………………………………………………………………………… 13 
 
  1.3.1.1. Discovery and structure ………………………………………….. 13 
  1.3.1.2. Miz1 as a critical regulator of cell cycle arrest ………………….. 14 
  1.3.1.3. Miz1 and apoptosis ………………………………………………. 16 
1.3.1.4. Miz1 and stress induced by DNA damage ………………………. 17 
  1.3.1.5. Miz1 POZ domain deletion phenotypes in vivo …………………. 18 
  
1.3.2. Myc ………………………………………………………………………… 20 
 
1.4. Aim of the work …………………………………………………………………….. 24          
 
 
2. MATERIALS AND METHODS 
 
2.1. Materials 
 
2.1.1. Equipment ………………………………………………………………….. 25 
2.1.2. Plastic and glassware ………………………………………………………. 26 
2.1.3. Solutions and buffers ………………………………………………………. 28 
2.1.4. Kits, reagents and special materials ………………………………………... 30 
2.1.5. Primer sequences …………………………………………………………… 31 
2.1.6. Informatic resources ………………………………………………………… 32 
Table of Contents 
 
 
 II 
2.2. Methods 
 
2.2.1. Mice  
 
  2.2.1.1. Mouse lines ………………………………………………………. 33 
  2.2.1.2. Pup weights and pregnancy/lactation analysis …………………… 34 
  2.2.1.3. Mammary gland dissection ………………………………………. 34 
 
2.2.2. Cell culture 
 
  2.2.2.1. HC11 cell culture and differentiation ……………………………. 35 
  2.2.2.2. Miz1 knockdown in HC11 cells …………………………………. 35 
  2.2.2.3. HC11 acinar morphogenesis 3D culture …………………………. 36 
  2.2.2.4. Mammosphere culture of primary mammary cells from  
    MMTV-Cre and MycVD/VD mouse lines …………………………. 36 
2.2.2.5. Mammosphere quantification and size determination …………… 38 
2.2.2.6. Cultrex 3D culture of primary cells from Myc+/+ and  
             MycVD/VD mice …………………………………………………… 38 
2.2.2.7. Sudan Black staining of primary cells from Myc+/+ and  
             MycVD/VD mice ……………………………………………………. 39 
 
2.2.3. Molecular Biology 
 
  2.2.3.1. Transformation of competent bacteria …………………………… 39 
  2.2.3.2. Plasmid DNA purification (Maxiprep) …………………………… 39 
  2.2.3.3. Mouse genotyping ……………………………………………….. 40 
  2.2.3.4. RNA harvesting and isolation from cells and tissue ……………… 41 
  2.2.3.5. Determination of DNA and RNA concentrations ……………….. 42 
  2.2.3.6. First strand cDNA synthesis ……………………………………… 42 
  2.2.3.7. Semiquantitative RT-PCR ……………………………………….. 43 
  2.2.3.8. Agarose gel electrophoresis ………………………………………. 44 
  2.2.3.9. Quantitative reverse transcription PCR (qPCR) …………………. 45 
  2.2.3.10. Analysis of qPCR reference gene stability in mammary cells …. 46 
  2.2.3.11. Microarray analysis and bioinformatics …………………………. 47 
   
2.2.4. Protein Biochemistry 
 
  2.2.4.1. Protein extraction from HC11 cells and mammary tissue ………..  49 
  2.2.4.2. Determination of protein concentration: BCA assay …………….. 49 
  2.2.4.3. SDS-PAGE ………………………………………………………. 50 
  2.2.4.4. Western blotting …………………………………………………. 52 
 
2.2.5. Histology 
 
  2.2.5.1. Whole-mount carmine alum staining …………………………….. 54 
  2.2.5.2. Fixation and paraffin embedding of mammary tissues …………… 54 
  2.2.5.3. Paraffin block sectioning …………………………………………. 55 
Table of Contents 
 
 
 III 
  2.2.5.4. Hematoxylin and eosin (H&E) staining …………………………. 55 
  2.2.5.5. Immunohistochemistry …………………………………………… 55 
    
2.2.5.5.1. Immunoperoxidase staining ……………………………. 56 
2.2.5.5.2. Immunofluorescence …………………………………… 58 
 
2.2.5.6. TUNEL assay …………………………………………………… 58 
2.2.5.7. Sudan III lipid staining …………………………………………… 59 
 
2.2.6. Ultrastructural analysis ……………………………………………………... 59 
 
2.2.7. Morphometric analysis in lactating mammary glands ……………………… 60 
 
  2.2.7.1. Adipocyte percentage determination …………………………….. 60 
  2.2.7.2. TUNEL assay quantification …………………………………….. 60 
  2.2.7.3. Percentage of Ki67 positive cells ………………………………… 60 
 
2.2.8. Statistics ……………………………………………………………………. 60 
 
3. RESULTS 
 
3.1. Miz1/Myc expression in mammary gland development and HC11 mammary cells 
 
3.1.1. Miz1 expression during mammary gland development ……………………. 61 
3.1.2. Myc expression during mammary gland development …………………….. 62 
3.1.3. Miz1 expression during HC11 cell mammary differentiation ……………… 64 
3.1.4. Myc expression during HC11 cell mammary differentiation ……………… 65 
 
3.2. MMTV-Cre mediated deletion of the Miz1 POZ domain in the virgin mammary gland 
and its effect on ductal morphogenesis and mammary stem/progenitor cells 
 
3.2.1. Conditional knockout of the Miz1 POZ domain in the virgin mam. gland….  67 
3.2.2. Mammary ductal morphogenesis in Ctr and Miz1∆POZ animals after 
           MMTV-Cre mediated deletion …………………………………………….. 69 
3.2.3. MMTV-Cre Miz1∆POZ animals accumulate mammary stem/prog. cells …. 72 
 
3.3. Role of the interaction of Miz1 and Myc in mammary stem/progenitor cell biology and 
adipocyte differentiation .................................................................................................... 74 
 
3.4. Wap-Cre mediated deletion of the Miz1 POZ domain in the pregnant mammary gland 
causes a lactation defect by attenuated Stat5 expression and phosphorylation 
 
3.4.1. Conditional knockout of the Miz1 POZ domain in the pregnant and  
           lactating mammary gland ………………………………………………….. 79 
3.4.2. Miz1∆POZ females feature a lactation defect ……………………………… 82 
3.4.3. Apoptosis during lactation in Ctr and Miz1∆POZ mammary glands ……… 86 
Table of Contents 
 
 
 IV 
3.4.4. Reduced proliferation during lactation in Miz1∆POZ mammary glands ….. 87 
3.4.5. Morphogenetic 3D culture of HC11 cells and consequences after Miz1 
           knockdown: unaltered apoptosis, reduced proliferation and delayed  
           acinar lumen formation ……………………………………………………. 89 
3.4.6. Reduced differentiation during lactation in Miz1∆POZ mammary glands … 91 
3.4.7. Reduced differentiation in HC11 cells with low levels of Miz1 …………… 92 
3.4.8. Deficient Stat5 signalling in Miz1∆POZ mammary glands ……………….. 93 
3.4.9. Deficient Stat5 signalling in shMiz1 HC11 mammary cells ……………….. 95 
3.4.10. Gene expression analysis of Stat5 pathway regulators …………………… 96 
3.4.11. Lipid aggregation in Miz1∆POZ lactating mammary glands …………….. 97 
3.4.12. Confirmation and extension of the qPCR expression data by microarray  
             analysis …………………………………………………………………… 100 
3.4.13. Miz1 regulates vesicular transport gene expression ……………………… 103 
3.4.14. Decreased Prolactin receptor and ErbB4 expression in Miz1∆POZ lactating 
            glands ……………………………………………………………………… 106 
 
4. DISCUSSION 
  
4.1. Expression of Miz1 and Myc during postnatal mammary development ………… 108 
 
4.2. Impact of Miz1 in the virgin gland and mammary stem cells ……………………. 111 
 
4.3. Miz1 in the lactating mammary gland …………………………………………….. 117 
 
References ………………………………………………………………………………… 125 
 
5. APPENDICES 
 
5.1. Summary 
 
5.1.1. Zusammenfassung ………………………………………………………….. 151 
5.1.2. Summary …………………………………………………………………… 152 
 
5.2. List of abbreviations ………………………………………………………………… 155 
 
5.3. University teachers …………………………………………………………………. 157 
 
5.4. Acknowledgements …………………………………………………………………. 158 
 
Introduction 
 
 
 1 
1. INTRODUCTION 
 
1.1. The murine mammary gland 
 
1.1.1. Mouse mammary gland: cellular architecture and comparison to the 
human breast  
 
The mammary gland is believed to have evolved from apocrine sweat glands associated with hair 
follicles more than 310 millions of years ago (Oftedal, 2002). It represents an evolutionary 
achievement of mammals due to the ability of the gland to secrete milk, allowing the availability 
of its nutrients and antimicrobial agents for the growth and proper development of the suckling 
newborns (Peaker, 2002). The mouse mammary gland is a suitable organ for developmental 
studies due to the cyclical rounds of proliferation, differentiation and apoptosis that occur in each 
pregnancy and the presence of mammary stem cells in the pubertal gland and in the adult. In 
addition, relevant mouse models for the study of the origin and progression of human breast 
cancer have been successfully developed and are extensively used in laboratories worldwide 
(Allred and Medina, 2008). Although the murine gland is a valuable research model and 
resembles the human organ, there are noticeable differences between the mouse and human 
mammary gland. The ductal network ends in clustered structures called terminal ductal lobular 
units (TDLUs) in the human breast while alveolar buds formed in each estrous cycle are 
characteristic of the mouse mammary gland. In addition, the elongation of the ductal tree in the 
mouse is possible due to the existence of club-shaped structures called terminal end buds (TEBs) 
which migrate through the gland during puberty and these are not as prominent in human glands 
(Sarkar, 2009). Finally, the murine gland has less fibrous connective tissue and more adipocytes 
in the fat pad than the human breast (Visvader, 2009). 
Two main compartments constitute the mouse mammary gland: the epithelium and the 
surrounding stroma or fat pad which is mainly formed by adipocytes but also consists of 
fibroblasts, vasculature, macrophages and eosinophils (Gouon-Evans et al., 2000; Hennighausen 
and Robinson, 2005). The epithelium is comprised of two main cell types: basal and luminal 
(Macias and Hinck, 2012). The main basal cell type are myoepithelial cells which are contractile 
and responsible for the ejection of milk during lactation as a response to pup suckling and 
oxytocine release from the pituitary gland (Moumen et al., 2011).  A population of mammary 
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stem cells is also regarded to reside in the basal compartment of the mouse mammary gland 
(Joshi et al., 2010) probably corresponding with small light cells (SLC) visualized in a frequency 
of around 3% within the epithelium using electron microscopy (Chepko and Smith, 1997). The 
luminal compartment is composed of ductal and alveolar epithelium. In virgin mice, the ductal 
tree has lateral buds that partially differentiate in each estrous cycle and these undergo complete 
differentiation during pregnancy and lactation when the cleavage of small alveolar buds results in 
the formation of mature alveoli, capable of milk synthesis and secretion (Robinson et al., 1995).  
 
1.1.2. The development of the mouse mammary gland 
 
The development of the murine mammary gland starts at embryonic day 10 (E10) with the 
formation of stripes of ectoderm called milk lines on the ventral side of the embryo (Robinson et 
al., 1999). 5 pairs of symmetrically localized placodes become visible asynchronously at 
determined areas of the mammary line by E11.5 (Hens and Wysolmerski, 2005). Then, a ball-
shaped cell aggregate from the placode invaginates into the mesenchyme to form mammary buds 
at around E12.5 (Watson and Khaled, 2008). The differentiation of this mesenchyme correlates 
with androgen receptor expression and fetal androgens provoke the destruction of the mammary 
anlage in male embryos (Neville and Daniel, 1987). The buds remain quiescent in female 
embryos until the final stages of embryonic development by E16. Then epithelial cells proliferate 
and sprout into the fat pad precursor mesenchyme where they start branching by cellular division 
at the terminal end bud. Epidermal cells from the bud differentiate into the nipple and at birth, a 
primary rudimentary ductal tree, which consists of 15-20 branches, is already formed (Hens and 
Wysolmerski, 2005; Macias and Hinck, 2012). In humans, this basic ductal system is able to 
synthesize milk, popularly known as witch´s milk, upon exposure of the baby to hormones from 
maternal origin (Yap et al., 1980). With the onset of puberty at around 20-30 days of age (Otto et 
al., 2007), the murine ductal tree migrates through the fat pad guided by terminal end bud (TEB) 
bifurcation at the tips of the ducts (Hinck and Silberstein, 2005). These bulbous shaped structures 
are formed by two types of cells: cap and body cells (Fig. 1.1). The cap cells are organized as an 
outer layer and are considered to be the progenitors of the basal myoepithelial cells in the adult 
duct. The body cells form 6-10 inner layers in the TEB and finally constitute the luminal 
epithelial compartment in the mature gland. High proliferation at the TEBs drives the pubertal 
morphogenesis of the ductal tree through the stroma. The development of the adolescent 
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mammary gland is disrupted in animals lacking growth hormone (Gh), insulin-like growth factor 
1 (Igf1) or estrogen receptor alpha (Esr1) (Macias and Hinck, 2012). In addition, a number of 
proteins which are also important for ductal morphogenesis have been described and the 
phenotypes observed after overexpression or knockout in mice were also reviewed (Howlin et al., 
2006). Contrary to this, development of the gland during puberty is normal in animals in which 
prolactin (Prl) or progesterone receptor (Pgr) were depleted, pointing to the importance of these 
proteins for alveologenesis and mammary differentiation (Macias and Hinck, 2012).  
 
 
 
Fig. 1.1: Development of the pubertal mammary gland. The ductal tree (blue) migrates through the fat 
pad (pink) in a virgin 5-week-old gland (up) while side branches are formed (left) and club-shaped 
terminal end buds (TEBs; right) actively divide subsequently forming the two compartments of the adult 
mammary epithelium: luminal and basal (figure reprinted from Wiseman and Werb, 2002). 
 
The central cells of the TEB will suffer apoptosis for the establishment of the hollow ductal 
system of the adult gland only after branching morphogenesis has occurred (Affolter et al., 2003). 
An in vitro three-dimensional (3D) model has been developed trying to recapitulate some features 
of mammary morphogenesis in vivo using a gel-like mixture of different basement membrane 
proteins (Hebner et al., 2008). The central cells of these 3D acini suffer apoptosis (Debnath et al., 
2002) and autophagy (Debnath, 2008), forming a lumen after culture in the appropriate 
conditions (Debnath et al., 2003). This method is useful for the elucidation of the pathways which 
regulate lumen formation (Mailleux et al., 2008) and mammary ductal morphogenesis.  
Introduction 
 
 
 4 
As can be seen in Fig. 1.2, which illustrates mouse mammary gland development by whole-
mount preparations at different time points, only a rudimentary tree is visible close to the nipple 
at day 10 postpartum (Fig. 1.2A). The TEBs reach the lymph node after around one month of 
growth (Fig. 1.2B), keep proliferating and migrating through the stroma (Fig. 1.2C) and finally 
disappear once the ductal tree fills the whole fat pad after around 9-12 weeks postpartum (Fig. 
1.2D). Under hormonal stimulation, mainly by progesterone during the estrous cycle, ductal side 
branches form and disappear in the virgin gland (Atwood et al., 2000). Further differentiation of 
these mammary buds will only occur at pregnancy (Robinson et al., 1995). Three key processes 
coordinate the transformation of the virgin ductal tree into a milk-producing secretory organ 
during pregnancy and lactation: proliferation, differentiation and survival of the alveolar 
epithelium (Hennighausen and Robinson, 2005). An extensive increase in secondary and tertiary 
branching (Fig. 1.2E) precedes the formation of alveolar buds which cleave and differentiate into 
alveoli (Fig. 1.2F-G) in the second half of pregnancy (Macias and Hinck, 2012). The pituitary 
gland secretes the peptide hormone prolactin during pregnancy and lactation which acts directly 
by binding to the prolactin receptor, triggering the Jak2/Stat5 pathway, and indirectly by 
sustaining ovarian progesterone secretion (Oakes et al., 2008).  
 
 
 
Fig. 1.2: Mouse mammary gland development. Whole-mount preparations of virgin (A-D), pregnant 
(E-G), lactating (H) and involuting (I) inguinal mouse mammary glands photographed under a 
stereomicroscope after carmine alum staining (See Materials and Methods for experimental details). 
Individual pictures were submitted to the Grayscale mode in Adobe Photoshop CS5. 
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Prolactin is synthesized mainly by lactotrophs in the anterior pituitary gland under the control of 
the hypothalamus, but it is also produced in other organs including the mammary gland itself 
(Naylor et al., 2003). As alveolar cells expand and differentiate for milk protein production, 
adipocytes are depleted from the stroma and this process is more efficient in the presence of 
epithelium than in a cleared fat pad (Hovey and Aimo, 2010). Lipid cell depletion also depends 
on the number of pups and the duration of lactation (Elias et al., 1973). The exact milk 
composition produced by the lactating mammary gland (Fig. 1.2H) varies between species. 
Mouse milk contains around 12% proteins (including caseins, whey acidic protein, lactoferrin or 
lactalbumin), a very high concentration of lipids (around 30%) and 5% lactose (Anderson et al., 
2007). Once pups are fully weaned, milk accumulates in the gland and the process of involution 
is initiated. The regressing mammary gland (Fig. 1.2I) suffers massive apoptosis and alveolar 
cells are cleared leading to a virgin-like architecture of the gland. Of note, parity induces a 
distinct gene expression program than in the virgin gland (D’Cruz et al., 2002) and a new 
population of parity-induced mammary epithelial cells (PI-MECs) with stem cell properties 
originate after the first pregnancy (Wagner et al., 2002). Autophagy has also been linked to 
mammary involution although evidence is preliminary (Zarzynska and Motyl, 2008; Sobolewska 
et al., 2011). Two distinct phases of involution have been described. The first phase lasts around 
48 hours, is reversible and involves apoptosis of alveolar cells and their accumulation in the 
lumina of the alveoli. In a second irreversible phase, matrix metalloproteinases (MMPs) remodel 
the stroma, macrophages are recruited for clearing dead cells and adipocytes refill the gland 
(Watson and Kreuzaler, 2011a).   
 
1.1.3. The undifferentiated state: the quest for mammary stem cells 
 
Stem cells are able to self-renew and to differentiate into specific cellular lineages maintaining 
the homeostasis of the tissues in which they reside. Stem cell-related therapies hold great promise 
for regenerative medicine or cancer treatment (Blanpain et al., 2012). This is especially true after 
the development of the induced pluripotent stem cell (iPSC) technology which allows the 
reprogramming of  adult somatic cells into pluripotent progenitors (Takahashi and Yamanaka, 
2006) and the formulation of the cancer stem cell hypothesis (a recent update on current views on 
the topic can be found in Nguyen et al., 2012).  
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Great efforts have been made to elucidate the pathways which regulate mammary stem cell 
function (Fridriksdottir et al., 2011) and their relationship with breast cancer heterogeneity (Pece 
et al., 2010). The experiments which first hinted to the existence of mammary stem cells were 
performed by DeOme and coworkers and consisted on the serial transplantation of mammary 
gland tissue or hyperplastic alveolar nodules into the cleared mammary fat pad of syngeneic mice 
(Deome et al., 1959). Unlike transformed cells, transplanted normal mammary gland cells 
become senescent after 5-8 serial transplant generations (Daniel, 1975), while the host age and 
reproductive history of the animal does not impact the mammary stem cell frequency (Young et 
al., 1971). More recently, a whole mammary gland could be generated after transplantation of a 
single mammary stem cell with the Lin-CD29hiCD24+ signature (Shackleton et al., 2006). The 
quest for the identification and isolation of mammary stem cells has been intense during the last 
years. A type of small light cells (SLCs) with stem cell properties was identified by electron 
microscopy (Chepko and Smith, 1997) and several groups reported findings describing potential 
markers characteristic of mammary stem cells (Shackleton et al., 2006; Stingl et al., 2006; Santos 
et al., 2013). Moreover, new mouse models confirmed the presence of these rare dividing cells at 
the tips of the TEBs of the pubertal gland and at the alveolar buds during pregnancy (Bai and 
Rohrschneider, 2010). 
The hierarchical organization of the different stem/progenitor cells that give rise to the 
functionally differentiated luminal (ductal and alveolar) and myoepithelial cells of the adult gland 
is still not clear. At least two distinct models exist: one considers the existence of multipotent 
stem cells which could potentially differentiate into myoepithelial and luminal cell types and the 
second model suggests the presence of lineage-restricted stem cells which can form either 
myoepithelial cells or luminal cells but not both (Visvader and Smith, 2011). Recent evidence 
speaks in favor of both the former (van Amerongen et al., 2012) and the latter hypotheses (Van 
Keymeulen et al., 2011a), but more experimental data would be required for the completion of a 
functional model. Also, a population of parity-induced mammary epithelial cells (PI-MECs) has 
been described (Wagner et al., 2002; Matulka et al., 2007). These cells are pluripotent, self-
renewing and able to maintain their alveolar-restricted function upon transplantation (Visvader 
and Smith, 2011). Their origin is still controversial as PI-MECs have been described to arise 
from luminal cells which do not undergo apoptosis during involution (Wagner et al., 2002). 
Alternatively, others argue that these cells are already present in the virgin gland (Booth et al., 
2007). The Notch and Hedgehog pathways have been reported to control mammary stem cell 
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function (Liu, 2006; Bouras et al., 2008). As will be addressed in more depth later, Miz1 has 
recently been shown to positively regulate the Hedgehog pathway by binding to Smo and Gli2 
(Lu et al., 2013b, 1). Also, the increase on progesterone concentration during the estrous cycle 
has been reported to expand the mammary stem cell pool (Joshi et al., 2010). In addition, new 
methods for the study of stem cells in vitro were developed (Dontu et al., 2003; Dontu and 
Wicha, 2005a). The mammosphere assay, a mammary stem/progenitor cell culture technique, 
allows the maintenance in suspension of undifferentiated mammary stem/progenitor cells which 
can be subjected to passage for several generations until cells differentiate or undergo senescence 
(Dey et al., 2009a).   
 
1.1.4. Hormonal control of alveologenesis and lactogenesis 
 
The beginning of pregnancy is characterized by high proliferation, side branching and formation 
of alveolar buds. Alveoli extend throughout the whole ductal tree at around pregnancy day 16.5. 
These hollow alveolar cavities are dilated or enlarged by the secretions produced by luminal 
mammary cells at the end of pregnancy. Alveologenesis, final phase of mammary morphogenesis 
and essential for the formation of alveoli, is tightly linked to the functional differentiation of 
mammary cells within the alveoli for milk production and secretion, a process called lactogenesis 
(Brisken and Rajaram, 2006). Two separate phases have been described during lactogenesis 
(Neville et al., 2002). The first one starts at mid-pregnancy when milk protein gene expression is 
initiated and lipid droplets are visible in the cytoplasms of mammary cells. The second stage 
begins at around parturition and is characterized by a boost in milk protein gene expression, tight 
junction closure and the occurrence of lipid droplets and milk proteins in the alveolar lumina. 
This first post-partum secretion product from the mammary gland is called colostrum and 
contains immunoglobulins and protective proteins like the iron-binding protein lactoferrin 
(Neville et al., 2002). Several hormones control the precise sequence of events which take place 
during alveologenesis and lactogenesis (Brisken and Rajaram, 2006). Prolactin has been reported 
to be the main regulator of these processes. Heterozygous knockout females for the prolactin 
receptor allele have a lactation defect in their first pregnancy and homozygous knockout animals 
are sterile (Ormandy et al., 1997). When mammary epithelium from prolactin receptor knockout 
glands is transplanted into wildtype mammary fat pads, normal side branching and formation of 
alveolar buds occurs but no lobuloalveolar development is observed (Brisken et al., 1999). The 
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genetic depletion of downstream components of prolactin signalling (e.g. Jak2 and Stat5a/b) or 
negative regulators of the pathway (e.g. SOCS proteins) clearly affects alveolar formation and 
mammary differentiation (Brisken and Rajaram, 2006). Another hormone which is required for 
alveolar expansion is progesterone. There are two distinct isoforms of the progesterone receptor 
(A and B) encoded by the same gene (Hennighausen and Robinson, 2005). Deletion of both 
isoforms results in impaired lobuloalveolar development  (Lydon et al., 1995), but only isoform 
B (PR-B) is essential (Mulac-Jericevic et al., 2003). Progesterone receptor deficient epithelium 
transplanted into wildtype fat pads showed that this hormone acts by a paracrine mechanism 
(Brisken et al., 1998) with receptor activator of nuclear factor kB ligand (RANKL) as a paracrine 
mediator of progesterone-dependent alveolar formation (Mulac-Jericevic et al., 2003). 
 
1.2. Prolactin signalling and the Jak2/Stat5 pathway 
 
1.2.1. Stat5 as the master mammary regulator 
 
Signal Transducer and Activator of Transcription 5 (Stat5), originally termed Mammary Gland 
Factor (Wakao et al., 1994), is the central transcriptional switch for proper mammary gland cell 
proliferation, differentiation and survival (Hennighausen and Robinson, 2005). Stat5 comprises 
two closely related isoforms, Stat5a and Stat5b, which are 96% identical at the protein level. Both 
are encoded by a gene which localizes on chromosome 11 in mouse and in chromosome 17 in 
humans and this region contains also the Stat3 gene (Hennighausen and Robinson, 2008). Stat5a 
is the main actor in normal mammary gland development representing 70% of total Stat5 levels 
(Yamaji et al., 2012), while both isoforms are important for mammary tumorigenesis (Furth et 
al., 2011). Stat proteins are normally activated by phosphorylation at tyrosine residues after 
binding of ligands to cytokine receptors. Once phosphorylated, Stat proteins dimerize and 
translocate into the cell nucleus where they bind to γ-interferon-activated (GAS) DNA sequences 
(Hennighausen and Robinson, 2008) and stimulate mammary cell proliferation and 
differentiation (see Fig. 1.3). Stat5a/b constitutive knockout embryos are perinatal lethal due to 
severe anemia and conditional Stat5a/b ablation in late pregnancy results in an increase in 
mammary cell apoptosis (Cui et al., 2004). Stat5a deletion causes a lactation defect by the 
occurrence of a severely reduced alveologenesis in mutant glands during pregnancy and lactation, 
although ductal development is normal (Liu et al., 1997). Stat5b knockout males are smaller, but 
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no severe lactation defect is observed in female mutant glands (Udy et al., 1997; Teglund et al., 
1998). In the absence of Stat5a, the Stat5b isoform can compensate after several pregnancies, 
partially rescuing the lactation defect observed in Stat5a knockout mice (Liu et al., 1998). 
Stat5a/b loss does not affect stem cell population frequencies, but luminal progenitor mammary 
cells are greatly reduced, suggesting that Stat5a is necessary and sufficient for the formation and 
maintenance of luminal progenitor cells (Yamaji et al., 2009). Around 70% of the mRNAs found 
in the lactating mammary gland encode for milk proteins and most of the genes with the highest 
expression during lactation are bound by Stat5a/b within promoter proximal regions (Yamaji et 
al., 2012). The protein abundance of Stat5a and Stat5b determines the correct functioning of 
genetic programs which grant a proper mammary proliferation and milk synthesis during 
pregnancy and lactation (Yamaji et al., 2012).   
 
 
 
Fig. 1.3: Stat5 signalling regulates mammary cell proliferation and differentiation. Schematic 
representation of the activation of Stat5 by phosphorylation through either Jak2 via Prolactin Receptor 
(Prlr) or by direct interaction with a short version of ErbB4 which translocates pStat5 into the nucleus. 
Once there, Stat5 dimers bind to GAS sequences and activate the expression of genes which are pivotal 
for proper mammary proliferation and differentation (modified according to Hennighausen and Robinson, 
2008; Williams et al., 2004). 
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1.2.2. The prolactin and ErbB4 receptors 
 
Stat5 is regulated by a number of pathways during mammary pubertal development, lactation and 
tumorigenesis. Prolactin, ErbB4 or other factors like EGF, estrogen, GH and IGF can affect the 
phosphorylation of Stat5 (reviewed in Furth et al., 2011). During pregnancy and lactation, two of 
the main upstream regulators of Stat5 activation via phosphorylation are the prolactin and ErbB4 
receptors (Hennighausen and Robinson, 2008).  
Prolactin, a 23 kD peptide, is synthesized by lactotrophic cells of the anterior pituitary, but it can 
additionally be produced in several extrapituitary sites, like the mammary gland itself (Lkhider et 
al., 1997). Prolactin is the main ligand binding to the prolactin receptor and placental lactogens 
can also associate with it. The prolactin receptor is a transmembrane protein from the cytokine 
receptor superfamily and is expressed in long and short forms which are originated from a single 
Prlr gene by alternative splicing (Ormandy et al., 1997). Only the long form is able to participate 
in the activation of Stat5 (Gouilleux et al., 1994), although the receptor lacks intrinsic kinase 
function (Shillingford et al., 2002). Binding of prolactin to the long form of its receptor results in 
the tyrosine phosphorylation of Jak2 (Janus kinase 2), which is permanently associated with the 
receptor, independently of prolactin ligand levels (Campbell et al., 1994). Subsequently, activated 
Jak2 proteins phosphorylate each other and specific residues of the cytoplasmic domain of the 
receptor, which are docking sites for the binding of Stat5 (Sutherland et al., 2007). Upon 
association with these sites of the prolactin receptor, Stat5 is phosphorylated at tyrosine residues 
and this event leads to the dissociation of Stat5 from the receptor, the formation of Stat5 dimers 
and their translocation into the nucleus for transcriptional regulation (reviewed in Wagner and 
Rui, 2008). Homozygous prolactin receptor knockout females are sterile and heterozygous dams 
display a lactation defect in their first pregnancy (Ormandy et al., 1997). Accordingly, Jak2 null 
epithelium transplanted into wildtype hosts fills the fat pad but alveologenesis is impaired and 
mutant dams also suffer a lactation defect (Shillingford et al., 2002). Taken together, prolactin 
binding to its receptor is the signal for the activation of Stat5 via Jak2 and this network is 
essential for proper mammary gland cell proliferation and differentiation during pregnancy and 
lactation. Another important regulator of Stat5 phosphorylation is ErbB4 which belongs to the 
ErbB family of receptor tyrosine kinases comprising EGF receptor, ErbB2/HER2/Neu, ErbB3 
and ErbB4. From these, ErbB4 is unique with respect to two aspects: it is required for the 
differentiation of mammary gland cells, while the others stimulate proliferation (Muraoka-Cook 
Introduction 
 
 
 11 
et al., 2008) and its short intracellular form harbors three nuclear localization and three putative 
nuclear export sequences (Carpenter, 2003). ErbB4 expression is low during proliferative phases 
of development like puberty or early pregnancy and high when the mammary differentiation 
program is activated during late pregnancy and lactation (Schroeder and Lee, 1998). ErbB4 
knockout dams feature a lactation defect by defective differentiation due to impaired 
lobuloalveolar development (Jones et al., 1999; Long et al., 2003). In addition, ErbB4 depleted 
mammary cells fail to activate Stat5a, even in the presence of an intact prolactin/prolactin 
receptor/Jak2/Stat5a signalling pathway (Muraoka-Cook et al., 2008). This observation led to the 
notion that ErbB4 could be a direct mediator of Stat5 phosphorylation. Further, it was shown that 
subsequent to binding of EGF-like ligands (e.g. neuregulins, betacellulin or HG-EGF), ErbB4 is 
cleaved by TACE and presenilin-dependent γ-secretase resulting in an 80 kDa intracellular form 
named 4ICD or s80HER4. This short version of ErbB4 displays kinase activity essential for Stat5a 
activation and is able to act as a molecular chaperone, which translocates Stat5a into the cell 
nucleus due to its nuclear localization and export sequences (Williams et al., 2004; Muraoka-
Cook et al., 2006). In conclusion, the sustained activation of Stat5 via phosphorylation and its 
correct nuclear transport depend on the appropriate expression of the prolactin receptor and 
ErbB4 at the cell membrane of mammary cells during pregnancy and lactation (see Fig. 1.3).  
 
1.2.3. Negative regulators of the Jak2/Stat5 pathway 
 
A balanced functioning of the Jak2/Stat5 pathway is essential for a tightly regulated cell 
proliferation and differentiation at the distinct stages of mammary gland development. 
Suppressor of Cytokine Signalling (SOCS) proteins and Caveolin-1 have been described as part 
of a negative feedback loop, which attenuates the phosphorylation of Stat5 upon activation, 
keeping the Jak2/Stat5 pathway under strict regulatory control (Jasmin et al., 2006). 
The SOCS protein family comprises eight members, which are induced by cytokines: SOCS 1-7 
and Cytokine-Inducible Sh2-containing protein (CIS). The most well-known members of the 
family are SOCS1, SOCS2, SOCS3 and CIS (Jasmin et al., 2006). All contain a SOCS-box 
domain, functionally related to protein degradation by targeting through ubiquitination 
(Hennighausen and Robinson, 2008). CIS does not play a big role in mammary gland 
development as knockout animals and their progeny are phenotypically normal, although its 
expression increases during lactation (Marine et al., 1999; Sutherland et al., 2007). 
Overexpression of SOCS1-3 and CIS diminishes ß-casein synthesis (Lindeman et al., 2001) in 
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SCp2 mammary epithelial cells (Desprez et al., 1998). In addition, Socs1 deletion (accompanied 
of IFNγ knockout to rescue from neonatal lethality) leads to an accelerated alveolar formation 
during pregnancy due to a premature upregulation of the levels of pStat5, which leads to a 
precocious lactogenesis. Further, the lactation defect observed in prolactin receptor-heterozygous 
females (Ormandy et al., 1997) can be rescued by the deletion of just one allele of Socs1 
(Lindeman et al., 2001). SOCS1 has been shown to bind Jak2 and inhibit its kinase activity, while 
the N-terminus and SH2 domains of SOCS1 are essential in this process (Nicholson et al., 1999). 
In contrast to SOCS1, SOCS2 does not directly interact with Jak2 and its mechanism of action 
remains poorly understood (Sutherland et al., 2007; Hennighausen and Robinson, 2008). SOCS2 
was found not to be essential for lactogenesis, although the deletion of both alleles of Socs2 can 
rescue the lactation defect of prolactin receptor-heterozygous females (Harris, 2006). Finally, 
SOCS3 is a critical repressor of Stat3-mediated apoptosis during involution. Wap-Cre mediated 
deletion of Socs3 in the mammary gland results in accelerated remodeling and apoptosis due to 
high levels of pStat3 and Myc during an established lactation (Sutherland et al., 2006). When 
Socs3 is knocked out with MMTV-Cre (line D) (Wagner et al., 2001) and BLG-Cre (Selbert et 
al., 1998) no lactation defect is observed (Harris et al., 2006), but MMTV-Cre (line A) deletion 
results in impaired proliferation of mammary epithelium and reduced alveologenesis (Robinson 
et al., 2007). Collectively, SOCS1 and SOCS2 function as critical repressors of prolactin 
signalling during mammary differentiation and SOCS3 is a negative regulator of apoptosis during 
the remodelling of the gland characteristic of the involution phase while its concrete role in 
lactation has not been elucidated.  
The Jak2/Stat5 pathway can also be attenuated by membrane-bound proteins called caveolins. 
These proteins are the main constituents of the caveolae, which are membrane invaginations 
playing a role in endocytosis and mammary tumorigenesis (Patani et al., 2012). The family 
comprises three members encoded by the genes Cav1, Cav2 and Cav3, respectively. Cav1 
expression is significantly downregulated during late pregnancy and lactation coinciding with 
prolactin secretion (Park et al., 2001). Further, Caveolin-1 depletion in the mammary gland leads 
to a premature alveolar development during pregnancy due to hyperactivation of Stat5, while 
Caveolin-2 is not required for alveologenesis (Park et al., 2002). In addition, Caveolin-1 could be 
co-immunoprecipitated with Jak2 (Park et al., 2002) and the current model suggests that 
Caveolin-1 prevents the access of Jak2 to the prolactin receptor, negatively affecting Stat5 
phosphorylation and proper mammary differentiation (Hennighausen and Robinson, 2008). 
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1.3. Function of the transcription factors Miz1 and Myc 
 
1.3.1. Miz1 
 
1.3.1.1. Discovery and structure 
 
Myc-interacting zinc finger protein 1 (Miz1) was identified in a yeast two-hybrid screen aimed at 
searching for Myc partners capable of joint transcriptional repression (Peukert et al., 1997). Miz1 
belongs to the POK family of transcription factors characterized by harboring an N-terminal 
POxvirus and Zink finger/ Broad complex, Tramtrack, Bric à brac (POZ/BTB) domain and a 
number of Krüppel-type zinc fingers at the C-terminus (Fig. 1.4A; Costoya, 2007). The human 
Miz1 protein is formed by 803 amino acids being 92% identical to the murine ortholog which 
contains 794 amino acids (Schulz et al., 1995; Peukert et al., 1997). The evolutionary-conserved 
POZ domain is constituted by approximately 100 amino acids and is involved in transcriptional 
repression, cytoskeleton function, dimerization, gating of ion channels and ubiquitination 
(Stogios et al., 2005; Kelly and Daniel, 2006). More than 40 POK proteins have been identified 
in humans and these play a pivotal role in development, stem cell biology or cancer (Stogios et 
al., 2005; Costoya, 2007). In particular, the Miz1 POZ domain serves for homo- or hetero-
oligomerization and recruitment of non-POZ partners, so that Miz1 is in dynamic tetramer/dimer 
equilibrium in solution. The Miz1 tetramer results from the interaction of dimers through two 
five-stranded β-sheet interfaces (Fig. 1.4B; Stead et al., 2007). The POZ domain is essential for 
Miz1 function as a transcription factor and mutants lacking this domain are unable to stably 
associate with chromatin (Fig. 1.5A; Wanzel et al., 2008; Kosan et al., 2010; Möröy et al., 2011). 
Miz1 binding to DNA occurs in a long non-palindromic sequence located mainly in regions close 
to the transcriptional start site of its target genes (Wolf et al., 2013). In addition to the N-terminal 
POZ domain, the C-terminus of Miz1 contains 13 consensus Cys2His2 zinc finger domains. 
Twelve of these are consecutive and the thirteenth is separated from the others by a region 
involved in the interaction with Myc (Peukert et al., 1997). Cys2His2 zinc fingers are one of the 
main ways in which transcription factors bind DNA (Wolfe et al., 2000). These zinc fingers are 
formed by around 30 amino acids adopting a ββα conformation secured by two cysteines and 
two histidines, which are responsible of the coordination of a Zn++ ion. The structures of the zinc 
fingers 5-10 of Miz1 have been recently resolved by solution-state NMR (Fig. 1.4C; Bédard et 
al., 2012; Bernard et al., 2013).  
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Fig. 1.4: Miz1 protein structure. (A) Schematic representation of the Miz1 protein. Miz1 contains a 
POZ/BTB domain at the N-terminus, a transactivation domain (TAD) and 13 Krüppel-type zinc fingers 
for binding to DNA. Miz1 interacts with Myc in a region between zinc fingers 12 and 13. (B) X-ray 
crystal structure of a tetramer of POZ/BTB domains which results from the formation of two five-stranded 
beta-sheet interaction interfaces (reprinted from Stead et al., 2007). (C) The crystal structures of the zinc 
fingers 5-10 of Miz1 have been recently determined (reprinted from Bédard et al., 2012; Bernard et al., 
2013). 
 
1.3.1.2. Miz1 as a critical regulator of cell cycle arrest 
 
Miz1 can either activate or repress transcription depending on the identity of its binding partners 
(Fig. 1.5B; Herkert and Eilers, 2010; Möröy et al., 2011). Miz1 has been shown to transactivate 
in association with the histone acetyltransferase p300 (Staller et al., 2001) and nucleophosmin 
(Wanzel et al., 2008). Miz1 can repress transcription by forming a number of distinct complexes 
with other proteins like Bcl-6, Gfi1 or Zbtb4. In addition, Myc restrains Miz1-dependent 
activation of gene expression by interfering in the association of Miz1 with its coactivators (e.g. 
p300 and Myc have overlapping binding sites in the Miz1 protein as reported in Staller et al., 
2001). Myc binds Miz1 through its helix-loop-helix (HLH) domain, forming a ternary complex 
which comprises Miz1, Myc and Max (Herkert and Eilers, 2010). This dual role of Miz1 in 
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activation and repression of transcription has been extensively studied in regard to the cyclin-
dependent kinase inhibitors Cdkn2b (encoding p15Ink4b) and Cdkn1a (encoding p21Cip1), which 
negatively affect cellular proliferation by inducing cell cycle arrest and are of crucial relevance in 
cancer (Krimpenfort et al., 2007; Abbas and Dutta, 2009).  
Miz1 was shown to activate the expression of p15Ink4b by interacting with the cysteine/histidine 
rich region 3 of p300 and to repress it via ternary complex formation with the Myc/Max 
heterodimer (Staller et al., 2001). As Miz1 seems to lack a functional nuclear localization signal, 
it was suggested that the protein might access the cell nucleus by association with other 
interacting partners like p300 or Myc (Peukert et al., 1997; Staller et al., 2001). In addition to the 
transcriptional regulation exerted in the nucleus, Miz1 is located also in the cytoplasm where it 
stably associates to microtubules (Ziegelbauer et al., 2001; Ziegelbauer et al., 2004). In 
conjunction to the cell cycle, a two-input model was proposed in which in the absence of TGFβ, 
Myc represses p15Ink4b expression by association with Miz1 at the initiator region of Cdkn2b. 
Upon TGFβ activation, Myc is downregulated allowing the formation of a Smad activator 
complex upstream of the Cdkn2b promoter, including Smad3 and Smad4, which may contact 
both Miz1 and Sp1 for p15Ink4b transcriptional activation (Seoane et al., 2001). The Miz1/Myc 
complex has shown to be important in the repression of Cdkn2b and cell adhesion genes also in 
vivo (Gebhardt, 2006; Riggelen et al., 2010a). In a similar way and short after these reports, Miz1 
was demonstrated to positively regulate p21Cip1 by binding to the proximal promoter of Cdkn1a, 
while Myc recruitment represses the expression of p21Cip1 in HaCaT, Cos7 and HL-60 cells 
(Seoane et al., 2002; Wu et al., 2003b). In addition, Miz1 forms other repressive complexes 
independently of Myc. For instance, Bcl6 suppresses p21Cip1 by interaction with Miz1, allowing 
the proliferation of B-cells in germinal centers during the normal immune response and in B cell 
lymphomas (Fig. 1.5B; Phan et al., 2005). Also, SB transposase interacts with Miz1, participating 
in the repression of cyclin D1 in a Miz1-dependent manner (Walisko et al., 2006). Analogously 
to Myc, the SNAG domain repressor Gfi1 has been shown to suppress the expression of p15Ink4b 
and p21Cip1 in association with Miz1 (Fig. 1.5B; Basu et al., 2009; Liu et al., 2010). Finally, the 
POZ domain zinc finger protein Zbtb4 recruits the Sin3/histone deacetylase and forms a complex 
with Miz1 for repression of p21Cip1 (Weber et al., 2008). Taken together, Miz1 activates 
transcription by binding close to the transcriptional start sites of different cell cycle arrest genes 
and a number of proteins can negatively influence this activation by binding to Miz1 and forming 
repressor complexes.  
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Fig. 1.5: Regulation of gene expression by the transcription factor Miz1. (A) Miz1 binds to DNA as a 
multimer, most probably as a tetramer, and the POZ-BTB domain is required for multimerization and 
association of Miz1 with chromatin. The p15Ink4b locus is shown as an example of Miz1-transcriptional 
activation. (B) Miz1 can act as an activator (in association with p300 and nucleophosmin) or as a repressor 
(e.g. after binding of Bcl6, Gfi1 or Myc/Max complexes to Miz1). The regulation of p21Cip1 is shown as an 
example of this dual regulation (figure reprinted from Möröy et al., 2011). 
 
1.3.1.3. Miz1 and apoptosis 
 
As seen in many biological contexts, Myc sensitizes cells to apoptosis when overexpressed 
(Hoffman and Liebermann, 2008) and the binding to Miz1 was reported as essential for this 
function of Myc (Patel and McMahon, 2006). Later, Miz1 was shown to activate the anti-
apoptotic gene B cell leukemia/lymphoma 2 (Bcl2). By interacting with Miz1, Myc represses 
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Bcl2 and apoptosis follows (Patel and McMahon, 2007). The authors conclude that Miz1 is 
critical for cellular survival by preventing Myc-mediated apoptosis. In addition to Myc, Bcl6 
restrains the expression of Bcl2 by binding to Miz1 and this process is relevant in 
lymphomagenesis (Saito et al., 2009). Another report describes how Miz1 associates with the 
tumor suppressors p53 and p19ARF, which compete for Miz1 binding (Miao et al., 2009). Miz1 
interacts with the DNA-binding domain (DBD) of p53, abrogating the active transcription of 
apoptotic genes by p53. When levels of murine p19ARF increase, this protein binds Miz1 and p53 
is relieved from the complex with Miz1 leading to p53-mediated transcriptional activation of 
apoptotic genes like Bax. Finally, the binding of Myc to Miz1 has been shown to switch the 
cellular response to human p14ARF from cell cycle arrest to apoptosis (Herkert et al., 2010). 
 
1.3.1.4. Miz1 and stress induced by DNA damage 
 
UV irradiation stimulates the release of an inhibitory complex formed by the topoisomerase II 
binding protein (TopBP1) and Miz1, allowing the latter to bind and activate the p21Cip1 promoter 
(Herold et al., 2002). TopBP1 expression in human keratinocytes declines 2 hours after UV 
irradiation and levels keep low till at least 10 hours after exposure. Thus, Miz1 is important for 
DNA damage-induced cell cycle arrest. In addition, Myc represses the expression of p21Cip1 by 
direct binding to Miz1 as a point mutant of Myc (MycV394D; hereafter referred to as MycVD), 
which is unable to bind to Miz1 but is still proficient for Max interaction, lacks the ability to 
repress p21Cip1 in response to UV irradiation (Herold et al., 2002). Furthermore, knockdown of 
Miz1 increases apoptosis and impairs the ability of cells to arrest in G1 by a diminished p21Cip1 
induction after exposure to UV-induced DNA damage (Wanzel et al., 2004). In the same 
publication, a new Myc-independent repressive function of Miz1 is described. Akt 
phosphorylates Miz1 at Ser428 and this post-translational modification is required for the 
association of Miz1 with the 14-3-3η protein, which in turn inhibits Miz1 function by direct 
interaction with its 1st and 5th zinc fingers (Wanzel et al., 2004). 
Finally, Myc was shown to be ubiquitinated by the E3-ligase HectH9 (also known as Mule, ARF-
BP1 and HUWE1) and Miz1 inhibits this ubiquitination (Adhikary et al., 2005). Also, Miz1 is 
required for the binding of TopBP1 to chromatin and to prevent HectH9-mediated proteasomal 
degradation of TopBP1 (Herold et al., 2008). 
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1.3.1.5. Miz1 POZ domain deletion phenotypes in vivo 
 
The constitutive deletion of the three first coding exons of Miz1 in the mouse by homologous 
recombination, comprising the POZ domain and a transactivation region with a neomycin 
resistance cassette, results in embryonic lethality at around E7.5. At this time point, massive 
apoptosis and reduced proliferation are observed in knockout embryos which seem to express 
mesodermal markers but fail to undergo a complete gastrulation (Adhikary et al., 2003). In order 
to study Miz1 function in vivo and due to the lethality associated with its constitutive deletion, a 
conditional knockout mouse model was developed in which the exons coding for the POZ 
domain (E3 and E4) are flanked by LoxP sites and depleted by the expression of a tissue-specific 
Cre recombinase (Gebhardt et al., 2007; Kosan et al., 2010). As described before, the POZ 
domain is essential for oligomerization and association of Miz1 with chromatin (Möröy et al., 
2011). The first report of Miz1 POZ domain deletion in vivo describes a complex phenotype after 
K14-Cre mediated POZ recombination in the keratinocytes of the interfollicular epidermis, the 
hair follicle and sebaceous glands. Mutant animals display an irregular arrangement of hair 
follicles, a catagen delay in the hair cycle, development of hair cysts, loss of zig-zag hairs and 
pigment incontinence (Gebhardt et al., 2007). In addition, K14-Cre Miz1∆POZ animals exhibit a 
decreased formation of chemically-induced skin papillomas (DMBA/TPA treatment), due to high 
levels of p21Cip1 in their skin accompanied by a reduced proliferation and increased 
differentiation (Hönnemann et al., 2012). In this context, Miz1 binds to the Cdkn1a promoter and 
the phenotype can be rescued in a p21Cip1 null background stressing that Miz1 is a critical 
repressor of p21Cip1 during skin tumorigenesis (Hönnemann et al., 2012). These observations 
were recently confirmed by the analysis of papilloma formation in Mule (also known as HectH9, 
ARF-BP1 and HUWE1) null mice, which exhibit an increase of Miz1/Myc complexes. This leads 
to a sustained repression of cell cycle arrest genes (Cdkn1a and Cdkn2b), subsequently resulting 
in a boosted tumorigenesis in mutant animals. Mule ubiquitinates Myc, and to a lesser extent 
Miz1, providing a rational explanation for the accumulation of Miz1/Myc complexes in Mule 
knockout mice (Inoue et al., 2013). Mule had previously been shown to ubiquitinate Miz1, 
targeting it for proteosomal degradation, especially in the context of TNFα-induced JNK 
activation (Yang et al., 2010; Liu et al., 2012). In this scenario of active TNF signalling, POZ 
domain deletion in the lung, by intratracheal administration of adenoviruses encoding Cre 
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recombinase, results in hyperinflammation and increased mortality of mutant animals after 
lipopolysaccharide (LPS) treatment (Do-Umehara et al., 2013).  
Finally, deletion of the Miz1 POZ domain in the hematopoietic system under the Vav-Cre 
promoter leads to a largely reduced population of mature B cells in knockout mice, due to a block 
at the Pre-Pro-B to Pro-B cellular differentiation transition (Kosan et al., 2010). Mutant animals 
display a decreased Stat5 phosphorylation and very high levels of SOCS1 mRNA. The data show 
that Miz1 binds to the Socs1 promoter and the authors suggest that Miz1 is a SOCS1 repressor in 
this system. In addition, SOCS1 downregulation only partially rescues the phenotype and the re-
expression of Bcl2 and Ebf1 is required to completely restore the differentiation of B cells from 
Vav-Cre Miz1∆POZ animals (Kosan et al., 2010). Using the same mouse model (Vav-Cre), T cell 
cellularity was also found greatly reduced in the thymus of Miz1∆POZ mice. Mutant T cells 
suffer a block at the transition from CD4-CD8- to CD4+CD8+ cells and inhibition of SOCS1 or 
Bcl2 overexpression rescue the number of T cells and their differentiation capabilities (Saba et 
al., 2011). Both of these phenotypes during early lymphocyte development seem to be largely 
Myc-independent, as MycVD/VD knock-in animals, in which the interaction between Miz1 and 
Myc is not possible, have normal numbers of B and T cells (Möröy et al., 2011; Saba et al., 
2011). Deletion of the POZ domain of Miz1 in the central nervous system (CNS) under the 
Nestin-Cre promoter leads to progressive cerebellar neurodegeneration associated with loss of 
Purkinje cells (Wolf et al., 2013). In this recent publication, 261 Miz1-binding sites in the whole 
genome are revealed by ChIP-Sequencing performed with chromatin from neural progenitor cells 
cultivated as neurospheres. The majority of these regions are located close to the transcriptional 
start site and a long non-palindromic Miz1-binding sequence is present in approximately 70% of 
them. There is a fair overlap of Miz1-bound genes in the nervous system and in MDA-MB231 
human breast cancer cells although the absolute number of binding sites differs, most probably 
due to the use of distinct antibodies for ChIP-Seq. Despite the fact that Miz1 seems to have a 
pleiotropic function, not showing Miz1-bound sites a clear functional gene enrichment by 
bioinformatic analysis, many of its target genes are related to vesicular transport, endocytosis and 
lysosomal biogenesis. In line with these data, Miz1∆POZ cerebella accumulate ubiquitinated 
proteins and p62, which facilitates the elimination of ubiquitinated protein aggregates by 
autophagy (Pankiv et al., 2007). This leads to the observation of an impaired autophagic flux 
(Komatsu et al., 2006), as proteasomal activity is unchanged, which progressively causes the late-
onset neurodegeneration observed in Nestin-Cre Miz1∆POZ animals (Wolf et al., 2013).  
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1.3.2. Myc 
 
The Myc proto-oncogene family comprises the evolutionary conserved c-Myc (Sheiness et al., 
1978), N-Myc (Schwab et al., 1983) and L-Myc (Nau et al., 1985) proteins. c-Myc, usually 
referred to as Myc, has been extensively studied since its discovery and is associated with a 
plethora of cellular functions like proliferation, differentiation, apoptosis, cellular growth 
(ribosome biogenesis, protein synthesis and metabolism) and inhibition of cell cycle arrest (Eilers 
and Eisenman, 2008; Hoffman and Liebermann, 2008; van Riggelen et al., 2010). Myc is 
commonly deregulated in a wide variety of cancers by either insertional mutagenesis, 
chromosomal translocation or amplification (Meyer and Penn, 2008).  
The 439 amino acid human Myc protein harbors a transactivation domain (TAD) and the Myc 
homology boxes I and II at the N-terminus (Fig. 1.6A). The homology box I (aa 44-63) is 
important for the phosphorylation of Myc at Thr58 and Ser62 and the homology box II (aa 128-
143) serves for the interaction with the transactivation/transformation-associated protein 
(TRRAP; McMahon et al., 1998). These two Myc homology boxes are required for 
transformation, the first in conjunction with Ras and the second with TRRAP (Meyer and Penn, 
2008). The Myc homology boxes IIIa, IIIb and IV are located in the middle part of the protein, 
together with a nuclear localization signal (NLS; aa 320-328; Dang and Lee, 1988). At the C-
terminus, Myc has a Basic Region (BR; aa 355-369) for the binding to canonical and non-
canonical E-boxes and a basic helix-loop-helix-leucine zipper domain (HLH-LZ; aa 370-439) for 
dimerization and interaction with the small protein Max, also called “myc-associated factor X” 
(Fig. 1.6; Blackwell et al., 1990; Blackwood and Eisenman, 1991). Myc/Max heterodimers bind 
mainly to the E-box sequence CACGTG, while the formation of the complex typically results in 
transactivation. Further, Myc requires association with Max through its HLH-LZ for exerting its 
oncogenic activity (Dang et al., 1989; Amati et al., 1993). 
The Mxd family of proteins also interact with Max competing with Myc/Max complexes for 
binding to DNA and resulting in the repression of bound genes (Grinberg et al., 2004). In 
addition to its role in positively regulating transcription, Myc can also repress gene expression 
through interaction of its HLH domain with Miz1 which, in turn, directly binds to the repressed 
genes (Peukert et al., 1997; Herkert and Eilers, 2010). Max has been shown to be essential in 
Myc-dependent repression (Mao et al., 2003), although functions of Myc which are Max-
independent have been described as well (Gallant and Steiger). 
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Fig. 1.6: The Myc/Max heterodimer. (A) Schematic representation of the structure of human Myc and 
Max proteins. Myc harbors 4 homology boxes (I-IV) and a transactivation domain (TAD). Myc and Max-
share a Basic Region (BR) for DNA binding and the helix-loop-helix-leucine zipper (HLH-LZ) domain 
required for their interaction (modified according to Meyer and Penn, 2008). (B) X-ray crystal structure of 
the Myc/Max heterodimer recognizing DNA. Myc is represented in red and Max in blue (reprinted from 
Wikipedia; originally published by Nair and Burley, 2003).  
 
The Myc protein has a relatively short half-life of around 25 minutes (Hann and Eisenman, 
1984), is regulated by various post-translational mechanisms (Vervoorts et al., 2006; Wang et al., 
2011) and it also represses its own transcription (Penn et al., 1990). The constitutive knockout of 
Myc is lethal before 10.5 days of gestation (Davis et al., 1993) and decreasing its expression in 
vivo reveals that Myc controls cell number and not cell size in mice (Trumpp et al., 2001). 
Although Myc is generally considered to block differentiation in many biological contexts, it can 
also promote differentiation in the epidermis by driving stem cells into the transit amplifying 
compartment (Gandarillas and Watt, 1997; Watt et al., 2008; Eilers and Eisenman, 2008). Myc 
transcriptional targets seem to be context-dependent, as little overlap can be found after 
comparing microarray expression data in different systems. Also, genome-wide binding 
experiments have shown that tens of thousands of Myc-binding sites exist and that the levels of 
Myc determine the relative occupancy of these DNA regions (Lüscher and Vervoorts, 2012). 
Myc has been recently proposed to be a “universal amplifier” of the expression of active genes in 
a particular cellular context by promoting transcriptional elongation, however, this model cannot 
explain Myc´s role as a transcriptional repressor (Lin et al., 2012; Nie et al., 2012; Rahl et al., 
2010). Myc has been reported to regulate Hox genes in collaboration with Miz1 after analyzing 
genome-wide binding of Miz1 and Myc in human embryonic stem cells by ChIP-on-chip analysis 
(Varlakhanova et al., 2011). In addition, Myc is critical in the establishment and maintenance of 
pluripotency (Chappell and Dalton, 2013) and to enhance the efficiency of the reprogramming of 
somatic cells into induced pluripotent stem (iPS) cells, although Myc can be substituted by other 
Introduction 
 
 
 22 
factors (Takahashi and Yamanaka, 2006; Nakagawa et al., 2008; Nakagawa et al., 2010). Myc 
seems to regulate a different set of genes (the so-called “Myc module”) than other pluripotency 
factors such as Nanog, Oct4 or Sox2, which share a great amount of transcriptional targets (Chen 
and Daley, 2008; Kim et al., 2008; Kim et al., 2010). In line with these reports, deletion of Myc 
in the basal compartment of the mammary gland using K5-Cre leads to a decreased population of 
mammary stem cells as assessed by limiting dilution and serial transplantation experiments 
(Moumen et al., 2012). Finally, Myc has been shown to increase self-renewal in neural progenitor 
cells and its association with Miz1 is important in this process (Kerosuo et al., 2008).  
Myc is often deregulated in human breast cancer (Hynes and Stoelzle, 2009) and its 
overexpression in the mouse mammary gland leads to tumorigenesis (Stewart et al., 1984; 
Schoenenberger et al., 1988a). Myc is highly expressed in the beginning of pregnancy (Blakely, 
2005), most probably contributing to alveolar expansion by boosting mammary proliferation, 
while its synthesis is sensitive to estrogen and progesterone levels (Hynes and Stoelzle, 2009). 
Furthermore, overexpression of Myc between days 12.5 and 15.5 of gestation in the mouse 
mammary epithelium leads to a precocious lactation due to downregulation of Caveolin-1 which 
leads to hyperactivation of Stat5 and premature involution (Blakely, 2005). A link between a 
positive regulation of mammary gland differentiation and Myc expression had already been 
described (Schoenenberger et al., 1988a). Also, Myc overexpression in mammary cells has been 
shown to induce epithelial to mesenchymal transition (EMT) in vitro (Cho et al., 2010). Wap-
Cre-mediated Myc conditional deletion in mouse mammary alveolar cells during mid-pregnancy 
causes a delayed proliferative response, reduced milk production, decreased translational 
efficiency and impaired repopulation ability upon transplantation in NOD-SCID mice (Stoelzle et 
al., 2009).  
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1.4. Aim of the work 
 
Miz1 (Myc-interacting zinc finger protein 1) is a transcription factor which can both activate and 
repress gene expression depending on the identity of its binding partners. It can activate 
transcription in association with p300 or nucleophosmin and repress gene expression by 
recruitment of proteins like the Myc/Max heterodimer, Gfi1 or Bcl-6. Miz1 harbors 13 zinc 
fingers and an evolutionary-conserved BTB/POZ domain at the amino terminus. The latter 
domain is essential for multimerization and for the association of Miz1 with chromatin. Miz1 
function as a transcription factor is abrogated after deletion of the BTB/POZ domain. As 
constitutive ablation of Miz1 is embryonic lethal at E7.5, a conditional knockout mouse model 
was developed. In this model, the exons which code for the BTB/POZ domain are flanked by 
LoxP sites for Cre-mediated recombination. Using this in vivo tool, the function of the 
transcription factor Miz1 in the skin, hematopoetic system or cerebellum was described. Miz1 
was shown to be important for hair follicle structure and hair morphogenesis, proper 
differentiation of B and T cells of the hematopoetic system and for the regulation by direct 
binding of several vesicular transport and autophagy genes in the cerebellum. The repression 
exerted by the Myc/Max heterodimer on cell cycle arrest genes is also crucial for tumor 
formation after induction of skin papilloma or in lymphomagenesis.  
Miz1 expression is elevated in epithelial tissues and the mammary gland, as a skin appendage, 
represented a promising target organ for further research. Also, Myc is often deregulated in breast 
cancer and the function of the Miz1/Myc complex in the mammary gland is still poorly 
understood. The murine mammary gland constitutes an invaluable tool for developmental studies, 
due to the consecutive rounds of proliferation, differentiation and apoptosis which occur after 
each pregnancy. Miz1 expression could be analysed in virgin, pregnant, lactating and involuting 
mammary glands in vivo. Also, deletion of the POZ domain of Miz1 was accomplished by using 
two different mouse strains: MMTV- and Wap-Cre. MMTV-Cre is already active in the embryo 
and is suitable for the study of virgin gland development and stem cell research. Interestingly, 
stem cell function and frequency can be analysed by cultivation of mammospheres, cell 
aggregates enriched in stem and progenitor mammary cells. The role of the interaction between 
Miz1 and Myc on mammary stem cells was investigated using a mutant Myc unable to bind Miz1 
in vivo (MycVD/VD).  
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Wap-Cre allows a highly-specific gene recombination in luminal mammary alveolar cells starting 
during mid-pregnancy and allowed the study of the role of Miz1 on mammary differentiation and 
alveologenesis. Miz1 was investigated in vitro using HC11 mammary cells, able to synthesize 
milk proteins upon addition of a lactogenic hormone cocktail. In conclusion, we aimed to focus 
on the function of the Miz1/Myc complex in the regulation of the distinct mammary gland 
developmental stages concentrating on its possible influence on mammary cellular proliferation, 
differentiation and adult mammary stem cell regulation.  
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2. MATERIALS AND METHODS 
 
2.1. Materials 
 
2.1.1. Equipment 
 
Autoclaves  Tuttnauer 5075 EL   Tuttnauer (Netherlands) 
   Tuttnauer 5075 ELV   Tuttnauer (Netherlands) 
   Heraeus ST5042   Heraeus (Hanau, Germany) 
 
Balances  Sartorius Type 1474   Sartorius (Göttingen, Germany) 
   Sartorius Analytic AC2105  Sartorius (Göttingen, Germany) 
 
Blotters  Perfect Blue Semi-dry  Peqlab (Erlangen, Germany)   
 
Cameras  MicroPublisher 3.3 RTV  Q-Imaging (Canada) 
   F-view     Olympus (Japan) 
   Canon EOS 450D   Canon (Japan) 
   Lumenera Infinity 1   Lumenera (Canada) 
 
Cell Counter  Cellometer Auto T4   Nexcelom (USA) 
 
Centrifuges  Refrigerated centrifuge 3K30  Sigma (Osterode am Harz, Germany) 
   Refrigerated centrifuge 5810R Eppendorf (Hamburg, Germany)  
Refrigerated centrifuge J2-21  Beckman (USA) 
   Bench centrifuge Biofuge pico Hereaus (Düsseldorf, Germany) 
 
Freezers (-80°C) Sanyo MDF-594   Sanyo (Japan) 
   Colora UF85-360T   Colora (Lorch, Germany) 
 
Heating block  Techne Dri-Block DB2A  Techne (UK) 
 
Heating oven   Binder ED240    Binder (Tuttlingen, Germany) 
 
Homogenizer Ultra-Turrax T25   Janke & Kunkel (Staufen, Germany) 
 
Incubators  Nuaire DH Autoflow   Integra (Fernwald, Germany) 
   Heidolph Unimax 1010  Heidolph (Schwabach, Germany) 
   
Laminar Flow Hood Faster BHA 48   Faster (Italy) 
 
Magnetic Stirrer Heidolph MR2000   Heidolph (Schwabach, Germany) 
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Microplate Reader Infinite 200    Tecan (Crailsheim, Germany) 
 
Microplate Sealer Alps 50V Heat Sealer   Thermo Scientific (USA) 
 
Microscopes  Leitz Diaplan MPS 46/52   Leitz (Wetzlar, Germany) 
   Olympus BX61   Olympus (Japan)   
   Zeiss IM35     Zeiss (Jena, Germany) 
   Leica TCS SP2 AOBS  Leica (Wetzlar, Germany) 
   Olympus SZ61   Olympus (Japan) 
 
Mixer   Eppendorf Mixer 5432  Eppendorf (Hamburg, Germany) 
 
pH meter  Wtw pH 521    Wtw (Weilheim, Germany) 
 
Power supplies Biometra Power Pack P25  Biometra (Göttingen, Germany) 
   Lkb 2301 Macrodrive 1  Lkb Bromma (Sweden) 
 
qPCR System  Stratagene Mx3005P   Agilent (USA) 
 
Sonicator  Bioruptor Standard   Diagenode (Belgium)   
 
Spectrophotometer Hitachi U-2000   Hitachi (Japan) 
 
Thermocyclers Personal Cycler UNO   Biometra (Göttingen, Germany) 
   Peqstar 96 Universal   Peqlab (Erlangen, Germany)  
    
UV Transilluminator IBI UVT 400-M   Ibi Scientific (USA) 
 
Vortexer  Vortex Genie 2   Bender & Hobein (Switzerland) 
 
Waterbath  GFL Typ 1004   GFL (Burgwedel, Germany) 
 
Water purification Elix 5 UV    Millipore (USA)  
 
2.1.2. Plastic and glassware 
 
Cell counting  Fuchs Rosenthal Chamber  Schreck (Hofheim, Germany) 
 
Cell culture plates 100 x 20 mm, plastic   Sarstedt (Nümbrecht, Germany) 
   24-well plates, plastic   Greiner (Frickenhausen, Germany) 
   24-well ultra low attachment  Corning (USA) 
 
Cell scrapers   25 cm     Sarstedt (Nümbrecht, Germany) 
  
Cell strainers  70 µm     BD Biosciences (USA) 
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Containers  Sterile, 50 ml    Labcor (USA) 
 
Cover slips  Glass     Menzel-Gläser (Braunschweig, 
        Germany) 
 
Cryo container Nalgene “Mr. Frosty”   Thermo Scientific (USA) 
 
Cryotubes  1.8 ml     Nunc, Thermo (USA) 
 
Dispenser  Multipette    Eppendorf (Hamburg, Germany) 
 
Glass pipettes  1, 2, 5 and 10 ml   Hirschmann Laborgeräte (Eberstadt, 
        Germany) 
 
Labteks  8-well Labtek II Chamber Slide Nunc, Thermo (USA) 
 
Microtiter plates 96-well Microplates, PS, F-bottom Greiner bio-one (Frickenhausen, 
        Germany) 
   96-well PCR plate   Thermo Scientific (USA) 
   
Needles  BD Microlance 3 (20G)  BD Biosciences (USA) 
   TSK (18G)    Tsk (Japan) 
   Fine-ject (26 G)   Henke Sass Wolf (Tuttlingen, 
        Germany)  
 
Pasteur pipettes 230 mm    Roth (Karlsruhe, Germany) 
 
PCR tubes  0.2 ml     Greiner bio-one (Frickenhausen, 
        Germany) 
 
Plastic pipettes 10 ml     Greiner bio-one (Frickenhausen, 
        Germany) 
   50 ml     Sarstedt (Nümbrecht, Germany) 
   
RNase free tips Biosphere fil. tip   Sarstedt (Nümbrecht, Germany) 
 
Slides   Glass, 76 x 26 mm   Thermo Scientific (USA) 
   
Sterile filter  Filtropur 0.2    Sarstedt (Nümbrecht, Germany) 
 
Syringes  1 ml plastic    Terumo (USA) 
   50 ml perfusor, plastic  Braun (Melsungen, Germany) 
 
 
Tubes   1.5 and 2 ml, safe-lock  Eppendorf (Hamburg, Germany) 
   15 and 50 ml    Sarstedt (Nümbrecht, Germany) 
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2.1.3. Solutions and buffers 
 
CaCl2 Solution (2M)   14.7 g CaCl2; Merck (Darmstadt, Germany)  
     Fill volume to 50 ml with H20dd and mix 
     Sterile filter  
 
Carmine Alum stain   1 g Carmine; Merck (Darmstadt, Germany)  
2.5 g KAl(SO4)2; Merck (Darmstadt, Germany) 
Add 450 ml of H20dd and boil mix for 20 minutes 
     Fill volume to 500 ml with H20dd 
     Cool solution and filter  
 
Carnoy´s solution   60% Ethanol; Roth (Karlsruhe, Germany) 
     30% Chloroform; Roth (Karlsruhe, Germany) 
     10% Acetic acid; Roth (Karlsruhe, Germany)  
 
EDTA (0.5 M)   18.61 g EDTA; Roth (Karlsruhe, Germany) 
     Add 80 ml H20dd  
Adjust pH to 8 with 5 M NaOH; Applichem (Darmstadt, 
Germany) 
     Fill volume to 100 ml with H20dd 
 
2x HBS buffer   5.96 g HEPES; Roth (Karlsruhe, Germany)  
     0.106 g Na2HPO4; Roth (Karlsruhe, Germany) 
     8.18 g NaCl; Roth (Karlsruhe, Germany) 
     Add 450 ml of H20dd 
Adjust pH to 7.05 with 5 M NaOH 
Fill volume to 500 ml with H20dd 
Sterile filter volume desired 
 
10x Laemmli buffer    30 g Tris; Roth (Karlsruhe, Germany) 
     144 g Glycine; Roth (Karlsruhe, Germany) 
     10 g SDS; Roth (Karlsruhe, Germany) 
Fill volume to 1 liter with H20dd 
 
LB (Lysogeny broth) media   10 g Tryptone; Fluka (Switzerland) 
     5 g Yeast extract; Sigma (USA) 
     10 g NaCl; Roth (Karlsruhe, Germany) 
     Adjust pH to 7 with NaOH 
Fill volume to 1 liter with H20dd 
 
PBS (Phosphate buffered saline)  0.138 M NaCl   
     0.0027 M KCl 
     pH=7.4 
     Sigma (USA); P-3813  
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Red blood cell lysis solution  4.5 g NH4Cl; Merck (Darmstadt, Germany) 
     0.5 g KHCO3; Sigma (USA) 
     20 µl 0.5 M EDTA  
     Fill volume to 500 ml with H20dd 
 
RIPA buffer    50 mM Tris (pH=8) 
     150 mM NaCl; Roth (Karlsruhe, Germany) 
     1% Triton X-100; Sigma (USA) 
     0.5% Sodium deoxycholate; Merck (Darmstadt, Germany) 
     0.1% SDS; Roth (Karlsruhe, Germany) 
 
4x SDS-PAGE loading buffer 8% SDS; Roth (Karlsruhe, Germany) 
     20% ß-mercaptoethanol; Merck (Darmstadt, Germany) 
     40% Glycerol; Fisher Scientific (USA) 
     0.1% Bromophenol Blue; Sigma (USA) 
     0.250 M Tris-HCl 
 
Sudan III solution   0.3 g Sudan III; Merck (Darmstadt, Germany) 
     100 ml hot 70% ethanol 
     Mix well and 60°C o/n incubation 
     Let cool down and filter 
 
Sudan Black B solution  0.1 g Sudan Black B; Merck (Darmstadt, Germany)  
     Add 100 ml 70% ethanol and boil 
     Let cool down and filter 
 
5x TBE (Tris/Borate/EDTA)  54 g Tris; Roth (Karlsruhe, Germany) 
     27.5 g Boric acid; Roth (Karlsruhe, Germany) 
     20 ml 0.5M EDTA (pH=8)  
     Fill volume to 1 liter with H20dd 
 
10x TBS (Tris buffered saline) 80 g NaCl; Roth (Karlsruhe, Germany) 
     2 g KCl; Roth (Karlsruhe, Germany) 
     30 g Tris; Roth (Karlsruhe, Germany) 
     Add H20dd and adjust pH to 7.4 with HCl; Merck 
     (Darmstadt, Germany) 
     Fill volume to 1 liter with H20dd 
 
TE (Tris/EDTA) pH=8  10 mM Tris; Roth (Karlsruhe, Germany)  
     1 mM EDTA; Roth (Karlsruhe, Germany) 
      
Tissue fixation (Histology)   3.7% PFA (Roth) in PBS; Sigma (USA) 
 
10x Transfer buffer   48 mM Tris; Roth (Karlsruhe, Germany) 
     39 mM Glycine; Roth (Karlsruhe, Germany) 
     0.04% SDS; Roth (Karlsruhe, Germany) 
     20% Methanol; Roth (Karlsruhe, Germany) 
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2.1.4. Kits, reagents and special materials 
 
Kits 
 
Absolute qPCR SYBR Green Mix (AB1167; Thermo Scientific, USA) 
AEC (red) Substrate Kit (00-2007; Invitrogen, USA) 
DeadEnd Fluorometric TUNEL System (G3250; Promega, USA) 
Mouse on Mouse (MOM) Basic Kit (BMK-2202; Vector Laboratories, USA) 
NucleoBond Xtra plasmid purification system (#740416.50; Macherey-Nagel, Düren, Germany) 
NucleoSpin RNA clean-up Kit (740948; Macherey-Nagel, Düren, Germany) 
rDNase Set (740963; Macherey-Nagel, Düren, Germany) 
REDExtract-N-Amp Tissue PCR Kit (XNATR; Sigma, USA) 
RevertAid First Strand cDNA Synthesis Kit (#K1622; Thermo Scientific, USA) 
 
Reagents and special materials 
 
BCA Protein Assay (B9643; Sigma, USA) 
Benzonase Nuclease (70664-3; Novagen; Darmstadt, Germany) 
Collagenase/Hyaluronidase 10x (#07912; Stem Cell Technologies, Canada) 
Cultrex BME Growth Factor Reduced Pathclear (#3433-005-02; Trevigen, USA) 
Hoechst 33342 (14533; Sigma, USA) 
Lumi-Light and Lumi-LightPLUS Western Blotting Substrates (Roche, Switzerland) 
Methyl Cellulose (M0512; Sigma, USA) 
Nitrocellulose transfer membranes 0.45 µm (10401196; Whatman, UK) 
PageRuler Plus Prestained Protein Ladder (26619; Thermo Scientific, USA) 
Phalloidin-TRITC (P1951; Sigma, USA) 
Phosphatase Inhibitor Cocktail (P5726; Sigma, USA) 
Protease Inhibitor Cocktail (P8340; Sigma, USA) 
PVDF transfer membranes 0.20 µm (741260; Macherey-Nagel, Düren, Germany) 
Restore Western Blot Stripping Buffer (#21059; Thermo Scientific, USA) 
RNA later (R0901; Sigma, USA) 
Supersignal West Dura Substrate (#34075; Thermo Scientific, USA) 
TriDye 2-Log DNA Ladder (N3270S; New England BioLabs, UK) 
TRI Reagent (T9424; Sigma, USA) 
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2.1.5. Primer sequences (qPCR, semiq-PCR and genotyping) 
 
 
QUANTITATIVE PCR PRIMERS 
 
Gene Sequence  Amplicon (bp) 
Ambra1 fw: GAGCACCCAATTTACCCAGA 
rv:  GATCATCCTCTGGGCGTAGTA 
66 
Ano4 fw: CGCTTATGACTGGGATCTGATT 
rv:  GCTTCAAACTGGGGTCGTAT 
66 
Camk2b fw: AATGCAAGGAGGAAGCTCAA 
rv:  TCCATCTGCTTTCTTGTTGAGTAA 
96 
α casein (s1) fw: GACATCTCTCAGGAACTCCACA rv:  TCCATAGAATGAATAGAGAGACATGAG 92 
β casein fw: GGTGAATCTCATGGGACAGC rv:  TGACTGGATGCTGGAGTGAA 70 
Cav1 fw: CCAGGGAAACCTCCTCAGA 
rv:  CCGGATGGGAACAGTGTAGA 
100 
Cdkn1a fw: TCCACAGCGATATCCAGACA 
rv:  GGCACACTTTGCTCCTGTG 
90 
Clca1 fw: CATCTACAAGTGGCAGCGTCT 
rv:  TGCCCCTGCTCTGACATC 
72 
Clca2 fw: CCAACAGGCTACTGGTGGA 
rv:  TGCTCTGGTCACTGGAGGTA 
80 
Erbb4 fw: AATGCTGATGGTGGCAAGA rv:  CATCACTTTGATGTGTGAATTTCC 82 
Exoc2 fw: GGGAGAACCTGGGTACTGGT 
rv:  CCGTGAGGAGGCAATTATGT 
72 
Lrp12 fw: CAGGCTGGCGTATTTTTCA 
rv:  ATTTCCACAGCGGAACTGAT 
70 
Miz1 fw: AGGCACACTGTCTGAGAAGAGA 
rv:  TGGTTCAGCTGCTCCAAGA 
96 
Mki67 fw: GCTGTCCTCAAGACAATCATCA 
rv:  GGCGTTATCCCAGGAGACT 
71 
Myc fw: CCTAGTGCTGCATGAGGAGA 
rv:  TCCACAGACACCACATCAATTT 
93 
Pikfyve fw:  GGCCGACTGATCTGGATTC 
rv:   CCAGCAAATGACCATCAAATAC 
60 
Prlr fw: GCAGTGGCTTTGAAGGGTTA 
rv:  CAGACTTGCCCTTCTCTAGCA 
106 
Socs1 fw: GTGGTTGTGGAGGGTGAGAT 
rv:  CCTGAGAGGTGGGATGAGG 
61 
Socs2 fw: CGCGAGCTCAGTCAAACAG 
rv:  AGTTCCTTCTGGAGCCTCTTTT 
87 
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Table 2.1: List of primers. Sequences in 5´ to 3´ direction. Amplicon length is indicated in base pairs. 
 
2.1.6. Informatic Resources 
    
Figure design   Adobe Illustrator/Photoshop CS5 Adobe Systems (USA)  
 
Image acquisition  Cell^F     Olympus (Japan) 
    QCapture Pro 5   QImaging (Canada) 
    Leica LAS AF Lite   Leica (Wetzlar, Germany)                    
    Infinity Capture 5.0.0   Lumenera (Canada) 
Image quantifications  ImageJ 1.43u    NIH (USA) 
Gene Sequence (5´ to 3´ direction) Amplicon (bp) 
Socs3 fw: ATTTCGCTTCGGGACTAGC 
rv:  AACTTGCTGTGGGTGACCAT 
126 
Spast fw: CAGCCCTGGGTCCTATCC 
rv:  TTCTCATCTCACTGGCAGACAT 
69 
Stat5a fw: AAGATCAAGCTGGGGCACTA 
rv:  CATGGGACAGCGGTCATAC 
60 
Stat5b fw: CGAGCTGGTCTTTCAAGTCA 
rv:  CTGGCTGCCGTGAACAAT 
64 
Vamp4 fw: TGCAAGAGAATATTACAAAGGTAATTG 
rv:  GAAAGCGGTGGCATTATCC 
95 
Vps13d fw: CTGACTAACCTAGAGCACCAGATCTAT 
rv:  TGTGGTTCCGAAGAGCAAA 
94 
Vps28 fw: AGCTTCTGTCGCCATCTCC 
rv:  CCCAGGCAGCTATACAGCAC 
65 
WAP fw: TGACATGTACACCCCCAGTG rv:  CTGGTCACTCCCGACAGG 81 
 
SEMI-QUANTITATIVE PCR PRIMERS 
 
β actin fw: CTAAGGCCAACCGTGAAAAG rv:  ACCAGAGGCATACAGGGACA 104 
β casein fw: ACTGTATCCTCTGAGACTG rv:  TCTAGGTACTGCAGAAGGTC 578 
 
GENOTYPING PRIMERS 
 
Cre fw: GAACGCACTGATTTCGACCA 
rv:  AACCAGCGTTTTCGTTCTGC 
200 
Miz1 
Primer 1: GTATTCTGCTGTGGGGCTATC 
Primer 2: GGCTGTGCTGGGGGAAATC 
Primer 3: GGCAGTTACAGGCTCAGGTG 
floxed: 311 
wildtype: 276 
recombinant: 180 
MycVD fw: TGTCCATTCAAGCAGACGAG 
rv:  AATTCCAGCGCATCAGTTCT   
Myc wildtype: 200 
VD knock-in: 300 
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Microarray analysis  David Bioinformatics 6.7  NIH (USA) 
 
Primer design   Universal Probe Library Assay Roche (Switzerland) 
 
Quantitative PCR  Stratagene Mx Pro 4.10d  Agilent (USA) 
    GenEx 5    MultiD Analyses (Sweden)  
 
References    Zotero 4.0.11    GMU (USA) 
 
Sequence alignment  Clustal Omega   EMBL-EBI (UK) 
    BLAST    NCBI (USA) 
 
Statistics    GraphPad Prism 5.03   GraphPad Software (USA)   
 
Translate tool   ExPASy    SIB (Switzerland)  
 
Whole-mount edition  Autostitch v2.2 Demo   UBC (Canada) 
 
2.2. Methods 
 
2.2.1. Mice 
 
2.2.1.1. Mouse lines 
 
MMTV-Cre Line A and Wap-Cre animals (Wagner et al., 1997; Wagner et al., 2001) were 
crossed with Miz1lox/lox mice (Gebhardt et al., 2007) in order to conditionally knockout the POZ 
domain of Miz1 in the mammary gland. MMTV-Cre and Wap-Cre lines were kindly provided by 
Prof. Lothar Hennighausen (NIDDK, Bethesda, USA). Miz1lox/lox mice were generated in the 
laboratory of Prof. Tarik Möröy (IRCM, Montreal, Canada). Wap-Cre and Miz1lox/lox lines were 
backcrossed for six generations, and MMTV-Cre for four generations, to a 129S2/SvHsd 
background. In the present Thesis, Cre + Miz1+/+ animals are referred to as control (Ctr) and Cre 
+ Mizlox/lox as Miz1∆POZ. MycVD/VD knock-in animals were generated in the laboratory of Prof. 
Tarik Möröy (IRCM, Montreal, Canada) and generously provided by Prof. Martin Eilers 
(Biocenter, Würzburg, Germany). Experiments with mice followed the German Animal 
Protection Law (Tierschutzgesetz) and were approved by the experimental animal local 
authorities (Regierungspraesidium Giessen; Geschäftszeichen V54-19c20/15cMR 20/10 Nr. A 
1/2010). 
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2.2.1.2. Pup weights and pregnancy/lactation analysis 
 
Pup weights (Fig. 3.16) were measured every 3 days using a Kern EMB balance (Kern & Sohn; 
Balingen, Germany). The number of the progeny was standardized to 6 pups after birth and for 
each genotype pups from 6 mothers were monitored. Wap-Cre females were mated at 65 dpp for 
1st pregnancy and lactation analysis and 2 weeks after completion of the 1st lactation for the study 
of the 2nd pregnancy and lactation. For pregnancy samples, mating plugs were checked every day 
and mammary dissection was performed at the indicated time points. 
 
2.2.1.3. Mammary gland dissection  
 
Thoracic mammary glands (3rd and 8th gland pair) were dissected for obtaining RNA and protein 
samples. Inguinal mammary glands (4th and 9th gland pair) were collected for whole-mount 
staining and histology. A schematic representation of the systematization of mammary gland 
sample collection is shown in Fig. 2.1. 
 
 
Fig. 2.1. Schematic representation of mammary gland sample collection. The solutions used for the 
different samples after mammary gland dissection are shown in brackets (modified according to Ip and 
Asch, 2000). 
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2.2.2. Cell culture 
 
2.2.2.1. HC11 cell culture and differentiation 
 
HC11 mammary epithelial cells (Ball et al., 1988) were routinely cultured in complete growth 
medium consisting of RPMI 1640, 10% FBS, 60 µg/ml gentamicin, 2 mM glutamine (all from 
PAA, Austria), 20 µg/ml insulin from bovine pancreas (I6634; Sigma, USA) and 10 ng/ml of 
EGF (E4127; Sigma, USA). To induce competence to differentiate, 2-day confluent HC11 cells 
were incubated for 48 hours in medium without EGF and with low serum (2%). To induce 
differentiation, competent cells were incubated with DIP medium based on RPMI 1640 and 
supplemented with 2% FBS, 60 µg/ml gentamicin, 2 mM glutamine (all from PAA, Austria), 10 
µg/ml insulin (I6634; Sigma, USA), 1 µM dexamethasone (D4902; Sigma, USA) and 5 µg/ml of 
prolactin from sheep pituitary gland (L6520; Sigma, USA). A scheme of the protocol followed 
for HC11 differentiation is shown in Fig 2.2. 
 
2.2.2.2. Miz1 knockdown in HC11 cells 
 
Phoenix packaging cells (Orbigen, USA) were transfected by the calcium phosphate method with 
shscr or shMiz1 expression vectors (Herkert et al., 2010) using standard protocols. Briefly, 30 µg 
of each plasmid were mixed with 63 µl of 2M CaCl2 filling the volume to 500 µl with sterile 
H20dd. This mix was applied drop by drop into 15 ml Falcon tubes (Sarstedt; Nümbrecht, 
Germany) containing 500 µl of 2x HBS buffer in agitation. Recipes for preparation of the 
solutions required for transfection can be found in Section 2.1.3. After incubation for 5 minutes at 
room temperature, the solution obtained in the last step was added to Phoenix cells and carefully 
mixed. Cells were then incubated at 37°C and medium was replaced after 15 hours post-
transfection with 7 ml of fresh medium. Retroviral supernatants were obtained in two harvests 
(48 and 66 hours after transfection) and stored at -80°C. 
Half a million HC11 cells per 10 cm dish were plated 24 hours before infection. Then, cells were 
incubated with 3 ml of retroviral supernatant (shscr or shMiz1), 4 µg/ml of polybrene and 2 ml of 
growth medium. Next, 5 ml of medium were added to the cells 15 hours post-infection. When 
cells reached confluency, they were split 1:3 and selected with 2 µg/ml of puromycin (P8833; 
Sigma, USA). Histone H2B-GFP infected HC11 cells were used to estimate the efficiency of 
infection and to determine the end of the antibiotic selection. 
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2.2.2.3. HC11 acinar morphogenesis 3D culture  
 
Three-dimensional acini forming culture of HC11 cells was performed as described elsewhere 
(Debnath et al., 2003; Xian, 2005; Hebner et al., 2008). Briefly, 24-well plates (662160; Greiner 
bio-one, Frickenhausen, Germany) coated with 40 µl sterile Cultrex basement membrane extract 
(BME) Growth Factor Reduced (#3433-005-02; Trevigen, USA) per well on sterilized 13 mm 
coverslips (Menzel-Gläser, Braunschweig, Germany) were used. Coated coverslips were allowed 
to solidify for at least 30 minutes at 37° C. HC11 cells were seeded at a concentration of 25.000 
cells per ml in 3D medium: RPMI 1640 supplemented with 2% FBS, 60 µg/ml gentamicin, 2 mM 
glutamine (all from PAA, Austria), 10 µg/ml insulin (I6634; Sigma, USA), 5 ng/ml of EGF 
(E4127; Sigma, USA), 2 µg/ml of puromycin (P8833; Sigma, USA) for selection and 2% 
Cultrex. 3D medium was replaced every 4 days using a total volume of 1 ml per well. Acini were 
fixed in 4% PFA for 20 minutes, washed twice in PBS and stored at 4° C until staining. Next, 
three 15-minute incubations with 1 ml/well of 100 mM Glycin/PBS (Roth, Karlsruhe, Germany) 
followed. Acini were permeabilized for 60 minutes in 1 ml of 0.5% TritonX100/PBS (Sigma, 
USA), blocked for 2 hours in IF-buffer (0.1% BSA, 7.7 mM NaN3, 0.2% TritonX100, 0.05% 
Tween20 in PBS) with 1% milk powder. This buffer was used for dilution of primary and 
secondary antibodies. 300 µl/well of primary antibody were incubated overnight at 4° C and the 
next morning at RT. After three 15-minute washes with 1 ml IF buffer, 500 µl of secondary 
antibody were incubated overnight at 4° C and for 2 hours of the next morning at RT. Actin 
filaments in acini were stained with 10 µg/ml Phalloidin-TRITC (P1951; Sigma) incubated for 40 
minutes. Images were captured using a TCS SP2 AOBS confocal microscope (Leica, Wetzlar, 
Germany) and analysed with LAS AF lite freeware (Leica Microsystems, Wetzlar, Germany). 
 
2.2.2.4. Mammosphere culture of primary mammary cells from MMTV-Cre and 
MycVD/VD mouse lines 
 
Primary cell mammosphere culture was largely performed according to the protocol provided 
with the collagenase/hyaluronidase mix (#07912) from Stem Cell Technologies (Canada) using 
MMTV-Cre and MycVD/VD mouse lines (Figures 3.10 and 3.11) and 4 technical replicates per 
mouse. Thoracic (3rd and 8th gland pair) and inguinal (4th and 9th gland pair) mammary glands 
(Fig. 2.1) were rendered into a paste in a Petri dish using sterilized scissors after adding 4.5 ml of 
digestion media containing DMEM (Lonza, Switzerland), 1 mM glutamine, 5% FBS and 60 
µg/ml gentamicin (all from PAA, Austria). Next, minced mammary fragments were transferred in 
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digestion media into a 15 ml Falcon (Sarstedt; Nümbrecht, Germany). This procedure was 
performed for the number of animals used in each experiment and then digestion was started in 
all gland fragments synchronously with 500 µl of 10x collagenase/hyaluronidase mix (#07912; 
Stem Cell Technologies, Canada) per animal. After mixing well, samples were incubated for 7 
hours at 37° C. Then, cells were centrifuged (350 g, 5 minutes, break on) and the supernatant 
discarded. Next, the pellet was resuspended in 5 ml of a mix containing 25% of Cold Hanks 
Balanced Salt Solution Modifed (Sigma, USA) with 2% FBS (hereinafter referred to as HF) and 
75% of Red blood cell lysis solution. See Section 2.1.3. for details on the preparation of this 
solution. After a 5 minute incubation for red blood cell lysis, cells were centrifuged (350 g, 5 
min, break on) and the supernatant discarded. The pellet was resuspended in 3 ml of pre-warmed 
trypsin-EDTA (0.05% trypsin and 0.02% EDTA in PBS; PAA, Austria) and incubated for around 
2 minutes while mixing well with a Pasteur pipette operated on an automatic pipettor (Automatic 
Sarpette; Sarstedt, Nümbrecht, Germany). Then, the reaction was stopped adding 10 ml of cold 
HF (see above) and samples were centrifuged (350 g, 5 minutes, break on).  
The supernatants were carefully removed and the pellet was resuspended in 2 ml of pre-warmed 5 
mg/ml dispase (17105-041; Gibco, Life Technologies, USA) previously diluted in Cold Hanks 
Balanced Salt Solution Modifed (Sigma, USA) and 200 µl of 1 mg/ml DNase I (buffer included 
in the kit; 740963; Macherey-Nagel, Düren, Germany) were added. After mixing well, samples 
were incubated for 10 minutes at 37° C. Next, the cell suspension was diluted with additional 10 
ml of cold HF and filtered through a 70 µm cell strainer (BD Falcon; BD Biosciences, USA) on a 
50 ml Falcon (Sarstedt; Nümbrecht, Germany). Then, cells were centrifuged (350 g, 5 minutes, 
break on) and the supernatant was carefully removed. The pellet was resuspended in 2 ml of 
complete liquid mammosphere medium consisting of MEBM (CC-3151; Lonza, Switzerland), 60 
µg/ml gentamicin (P11-004; PAA, Austria), 20 ng/ml EGF (E4127; Sigma, USA), 5 µg/ml 
insulin (I6634; Sigma, USA), 4 µg/ml heparin (H4784; Sigma, USA), 0.5 µg/ml hydrocortisone 
(H0888; Sigma, USA), 2% of 50x B27 without vitamin A (12587-010; Gibco, Life Technologies, 
USA) and 20 ng/ml bFGF (354060; BD Biosciences, USA). Next, cells were counted using a 
Fuchs Rosenthal Chamber (Schreck; Hofheim, Germany) and 100.000 cells per well were plated 
on 24-well ultra low attachment plates (3473; Corning, USA) already containing 2 ml of 
semisolid mammosphere medium (see above) with 1% methyl cellulose (M0512; Sigma, USA). 
Fresh liquid mammosphere medium was added every 5-6 days of culture. After 2 weeks of 
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culture, spheres were disaggregated, counted and 2000 cells per well were replated for the 
formation of secondary or tertiary mammospheres.  
 
2.2.2.5. Mammosphere quantification and size determination 
 
Mammospheres were harvested into a 15 ml Falcon tube (Sarstedt; Nümbrecht, Germany) using a 
total volume of 7 ml of liquid mammosphere medium. Next, they were centrifuged (350 g, 5 
minutes, break off) and the pellet was carefully resuspended in 200 µl mammosphere medium. 
Then, 50 µl of each of the 4 technical replicates per animal were transferred into different wells 
of a sterile 96-well plate previously marked with a cross in the bottom using a syringe needle 
under the stereomicroscope Olympus SZ61 (Olympus, Japan). Spheres in each of the 4 areas of 
the well were counted for each of the 4 technical replicates using a 5x magnification on a Zeiss 
IM35 microscope (Zeiss, Jena, Germany). For size determination, diameters of secondary or 
tertiary mammospheres were scored using ImageJ 1.43u software (NIH, USA). The number of 
spheres measured per animal is indicated in Figures 3.10 and 3.11. 
 
2.2.2.6. Cultrex 3D culture of primary cells from Myc+/+ and MycVD/VD mice 
 
Primary cells from mammary glands of Myc+/+ and MycVD/VD animals, which had undergone the 
treatments described in Section 2.2.2.4, were plated on 8-well Labtek II Chamber Slides (Nunc, 
Thermo, USA) coated with 50 µl of sterile and solidified Cultrex basement membrane extract 
(#3433-005-02; Trevigen, USA). Similarly, as already described for MCF-10A cells (Debnath et 
al., 2003), primary cells were counted and 25.000 cells per animal were resuspended in 500 µl of 
MEBM (CC-3151; Lonza, Switzerland) and mixed with another 500 µl of 2x 3D medium. Then, 
400 µl/well of this mix were plated on top of the solidified Cultrex-coated Labteks.  
3D medium consisted of MEBM (CC-3151; Lonza, Switzerland), 20 ng/ml EGF (E4127; Sigma, 
USA), 0.5 µg/ml hydrocortisone (H0888; Sigma, USA), 100 ng/ml cholera toxin (C-8052; 
Sigma, USA), 10 µg/ml insulin (I6634; Sigma, USA), 80 µg/ml gentamicin and 2% Cultrex 
basement membrane extract (#3433-005-02; Trevigen, USA). 
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2.2.2.7. Sudan Black staining of primary cells from Myc+/+ and MycVD/VD mice 
 
Primary cells, from mammary glands of Myc+/+ and MycVD/VD animals, growing on Cultrex-
coated (#3433-005-02; Trevigen, USA) Labteks (Nunc, Thermo, USA) were stained for lipids 25 
days after plating. After two PBS washes, cells were fixed with 4% PFA (Merck, Darmstadt, 
Germany) in PBS for 30 minutes at room temperature. Then, mammary cells were washed first in 
PBS, secondly in H2Odd and finally in 50% ethanol. Subsequently, cells were stained with Sudan 
Black B (Merck, Darmstadt, Germany; see Section 2.1.3 for preparation) for 20 minutes. After 
two H2Odd washes, cells were counterstained with Nuclear Fast Red (Kernechtrot with 
Aluminiumsulfat; Fluka, Switzerland) for 10 minutes at room temperature. Next, two H2Odd 
washes were performed and slides were mounted with Mowiol (Roth, Karlsruhe, Germany).  
 
2.2.3. Molecular Biology 
 
2.2.3.1. Transformation of competent bacteria 
 
In order to obtain plasmids to stably knockdown Miz1, three different vectors were inserted in 
competent Escherichia coli: a shscr (short hairpin scrambled control) and two different specific 
short hairpins to downregulate Miz1 (shMiz1#1 and shMiz1#2), all kindly provided by Prof. 
Martin Eilers´ lab (Biocenter, Würzburg, Germany). Briefly, 20 µl of E. coli (RapidTrans; Active 
Motif, USA) and 100 ng of each plasmid were incubated for 45 minutes on ice and then for 45 
seconds at 42° C in a waterbath. Next, 180 µl of LB medium (see Section 2.1.3 for preparation) 
were added to each tube and incubated for 45 minutes at 37° C. After this, 20 µl of bacteria 
(undiluted, 1:10 and 1:100) were plated into agar plates containing antibiotic (50 µg/ml of 
ampicillin) and incubated at 37° C overnight. Then, one isolated bacterial colony for each vector 
was allowed to multiply for 8 hours in the presence of 2 ml of LB medium in a shaker at 37° C. 
Finally, 500 µl of transformed bacteria were further cultivated in 200 ml LB media flasks 
containing 50 µg/ml of ampicillin at 37° C overnight. 
 
2.2.3.2. Plasmid DNA purification (Maxiprep) 
 
Transformed bacteria, carrying the shscr, shMiz1#1 and shMiz1#2 vectors, were centrifuged at 
5000 rpm for 10 minutes. Then, the NucleoBond Xtra system (#740416.50; Macherey-Nagel, 
Düren, Germany) was used to purify DNA plasmids. In brief, bacterial pellets were mixed with 
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resuspension buffer including RNaseA and then lysis buffer was added to the suspensions and 
incubated at room temperature for 5 minutes. Next, columns and filters were exposed to 
equilibration buffer. Neutralization buffer was added to the suspensions and the lysates were 
mixed by repeated inversion (10-15 times). The suspensions were carefully poured into the 
columns, washed and the filters discarded. After a new wash, the different plasmid DNAs were 
eluted and precipitated with room temperature isopropanol (Roth, Karlsruhe, Germany). Next, 
plasmids were centrifuged (9400 g, 30 minutes, 4° C) and 70% ethanol (Roth, Karlsruhe, 
Germany) was added to the pellets. After a new centrifugation (9400 g, 5 minutes, room 
temperature), ethanol was carefully removed and the pellets allowed to dry. DNA pellets were 
then dissolved in 400 µl of TE buffer (see Section 2.1.3 for preparation) and plasmid yield was 
determined by UV Spectrophotometry (U-2000; Hitachi, Japan) at 260 nm.    
 
2.2.3.3. Mouse genotyping 
 
Genotyping was performed according to existing protocols (Gebhardt et al., 2007; Hönnemann et 
al., 2012) using the REDExtract-N-Amp Tissue PCR Kit (XNATR; Sigma, USA). In short, DNA 
from ear punches was extracted using 50 µl of Extract Solution and 12.5 µl of Tissue Preparation 
Solution and incubated for 10 minutes at room temperature. Then, samples were digested at 95° 
C for 3 minutes in a heating block (Dri-Block DB2A; Techne, UK). Immediately after that, 50 µl 
of Neutralization Solution were added per sample. After agitation, neutralized tissue was stored at 
4° C till PCR amplification: 2 µl of DNA were mixed with 10 µl of a solution containing 4 µl of 
specific primers (See Section 2.1.5.) already in H2Odd (at a concentration of 100 µM per primer) 
and 6 µl of REDExtract-N-Amp PCR Reaction Mix included in the kit. The program of the PCR 
consisted of 30 cycles, after a 3 minute initial denaturation at 95° C, with the following steps: 
 
a) Denaturation: 95° C for 45 seconds. 
b) Annealing: 60° C for 45 seconds. 
c) Elongation: 72° C for 2 minutes. 
 
Before storage at 4° C, samples were submitted to 1 cycle at 72° C for 10 minutes. Finally, the 
different animal genotypes were unveiled by 2% agarose gel electrophoresis using TriDye 2-Log 
(N3270S; New England BioLabs, UK) as DNA marker.  
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2.2.3.4. RNA harvesting and isolation from cells and tissue 
 
 
For obtaining RNA from cells, 1 ml of TRI Reagent (T9424; Sigma, USA) was homogeneously 
distributed on 10 cm Petri dishes, cells were harvested using cell scrapers (Sarstedt; Nümbrecht, 
Germany) and samples were immediately stored at -80° C till RNA isolation. For obtaining RNA 
from murine tissue, thoracic mammary gland fragments (maximum 0.5 cm in all 
dimensions) were stored in RNA later (R0901; Sigma, USA) at 4° C till homogenization in 2 ml 
of TRI Reagent on ice using the Ultra-Turrax T25 homogenizer (Janke & Kunkel; Staufen, 
Germany) and submitting each sample to 5 cycles of 5 seconds at a speed set to 13500 rpm. As 
for cell culture, samples were immediately stored at -80° C after homogenization. RNase-free tips 
with filters (Biosphere, Sarstedt; Nümbrecht, Germany) were used when pipetting samples 
containing RNA while surfaces and dissection instruments were rinsed in RNase AWAY (7003; 
Molecular BioProducts, Thermo, USA).  
For RNA isolation from both cell culture and tissue, the protocol from the Tri Reagent bulletin 
was followed (T9424; Sigma, USA) (Chomczynski and Sacchi, 1987). In short, 200 µl of 
chloroform (Roth; Karlsruhe, Germany) were added per 1 ml Tri Reagent sample and, after 
vigorous shaking, probes were incubated for 5 minutes at room temperature. A centrifugation 
step followed (12000 rpm, 15 minutes, 4° C) and subsequently the upper transparent phase 
containing RNA was carefully transferred to a tube. Then, 500 µl of isopropanol (Roth, 
Karlsruhe, Germany) were added to the samples, mixed and incubated for 10 minutes at room 
temperature. Next, samples were again centrifuged (12000 rpm, 15 minutes, 4° C) and the RNA 
pellet dissolved in 90 µl of RNase-free water. A DNA digestion followed using 10 µl of the 
rDNase Set (740963; Macherey-Nagel, Düren, Germany) and incubation for 10 minutes at 37° C. 
Next, the NucleoSpin RNA clean-up Kit (740948; Macherey-Nagel, Düren, Germany) was used. 
Briefly, RNA binding conditions were adjusted, mixing samples with 600 µl of Buffer RA1-
ethanol premix. Then, each probe was loaded onto a NucleoSpin RNA Binding Column and 
RNA was bound to the silica membrane by centrifugation for 30 seconds at 10000 g. After 
replacing collection tubes, the membranes were washed with 700 µl of buffer RA3 and 
centrifuged again for 30 seconds at 10000 g. The flow-through was discarded, 350 µl of buffer 
RA3 were added and columns were centrifuged for 2 minutes at 10000 g. The columns were then 
transferred to fresh 1.5 ml tubes (provided with the kit) and RNA was eluted in 50 µl RNase-free 
water by centrifugation for 1 minute at 10000 g. Finally, RNA was stored at -80° C.  
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2.2.3.5. Determination of DNA and RNA concentrations  
 
DNA and RNA concentrations were determined by UV Spectrophotometry (U-2000; Hitachi, 
Japan) at 260 nm (OD260). The samples were diluted using TE buffer (See Section 2.1.3) which 
served as blank. The following formula was used to calculate DNA and RNA concentrations: 
OD260 * F * dilution. The F factor value depends on the type of nucleic acid and whether it is 
single or double-stranded. An OD of 1 corresponds approximately to 50 µg/ml of DNA for 
double-stranded DNA, 40 µg/ml for single-stranded DNA and RNA and 20 µg/ml for 
oligonuclotides (Sambrook et al., 1989). The dilution of 1:100 with TE buffer gave normally 
absorbance values between 0.1 and 1 and was used for most concentration determinations. 
 
2.2.3.6. First strand cDNA synthesis 
 
Methods for synthesis of first strand cDNA depend on the enzyme RNA-dependent DNA 
polymerase (reverse transcriptase) to catalyze the reaction (Sambrook et al., 1989). The 
RevertAid First Strand cDNA Synthesis Kit (#K1622; Thermo Scientific, USA) was used. This 
kit relies on a genetically engineered version of the Moloney Murine Leukemia Virus reverse 
transcriptase (RevertAid M-MuLV RT) with a low RNase activity. According to the kit, 
synthesis of full-length cDNAs can be achieved using long templates (up to 13 kb). Random 
hexamers primers were used in all cDNA synthesis reactions performed in this Thesis. These 
primers bind non-specifically along an RNA template and all RNAs (not only mRNAs) serve as 
templates for cDNA synthesis. In short, for one cDNA synthesis reaction, 1 µg of RNA, 1 µl of 
random hexamer primer (0.2 µg/µl) and DEPC-treated water to a final volume of 12 µl were 
pipetted into a 0.2 ml tube (Greiner bio-one; Frickenhausen, Germany). After gentle mixing, 
samples were incubated at 70° C for 5 minutes. In order to prepare a master mix for the amount 
of samples desired, the following components were added per reaction: 4 µl of 5x reaction buffer, 
1 µl of Ribolock Ribonuclease inhibitor (20 u/µl), 2 µl of 10 mM dNTP mix and 1 µl of 
RevertAid M-MuLV Reverse Transcriptase (200 u/µl). 8 µl from this master mix were added to 
the preheated sample as described above. Next, the samples were incubated first at 25° C for 10 
minutes, then at 42° C for 60 minutes and finally the reaction was stopped heating at 70° C for 10 
minutes. All these incubations at different temperatures were performed on a Personal Cycler 
(Biometra; Göttingen, Germany). Synthesized first strand cDNA was then stored at 4° C for 
short-term use.  
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2.2.3.7. Semiquantitative RT-PCR 
 
The polymerase chain reaction (PCR) allows the amplification of any fragment of DNA resulting 
in the formation of millions of copies which can be used in downstream applications like gene 
expression analysis, sequencing or genetic fingerprinting. It was developed by Kary Mullis and 
colleagues (Saiki et al., 1985; Mullis and Faloona, 1987) by improving pre-existing methods 
(Agarwal et al., 1970; Kleppe et al., 1971) and shortly after that successfully used in combination 
with a thermostable polymerase (Saiki et al., 1988). The different steps of the polymerase chain 
reaction (PCR) are the following: 
 
a) Initialization: The temperature rises to 94-98° C for those DNA polymerases which require 
heat for activation. 
b) Denaturation: DNA melts at 94-98° C resulting in single-stranded DNA. 
c) Annealing: Temperature is lowered to 50-60° C to allow the binding of specific 
oligonucleotides (primers) and the polymerase to template DNA.   
d) Elongation: The heat-stable DNA polymerase synthesizes a new strand complementary to the 
template in 5´ to 3´ direction at a temperature which varies with the enzyme used. Taq 
polymerase (from the thermophilic bacterium Thermus aquaticus) has an optimum temperature 
of 70-80° C and is normally used at 72° C. 
e) Final elongation: This step is performed to ensure that any remaining single-stranded template 
is extended (normally 10 minutes at 72° C).  
The mix for the semiquantitative RT-PCR reaction showed in Fig. 3.25 (expression of ß casein 
and actin in HC11 cells) consisted of: 
 
- 1 µl dNTPs 10 mM (R0191; Fermentas, Thermo, USA) 
- 0,5 µl cDNA from mammary tissue and 6 µl for HC11 cells samples 
- 5 µl 10x PCR master mix (P2192; Sigma, USA) 
- 10 µl primer mix (stock:10 picomol/ µl). Ordered from Metabion (Martinsried, Germany) 
- 2 µl REDTaq polymerase (D0688; Sigma, USA) 
- 5 µl MgCl2 (R0971; Fermentas, Thermo, USA) 
- till 50 µl with H20dd 
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Samples were then amplified using a thermocycler (Personal Cycler UNO; Biometra, Göttingen, 
Germany) and the following PCR program: 
 
- Initialization: 94° C for 3´ 
- Denaturation: 94° C for 30´´ / Annealing: 58° C for 30´´ / Elongation: 72° C  for 2´  (x35) 
- Final elongation: 72° C for 10´ 
 
Once the PCR was over, 2 µl of 6x DNA-loading buffer (0.4% xylene cyanol, 50% glycerin, 1 
mM EDTA pH 8 and 0.4% bromophenol blue) were added to 10 µl of the samples and 10 µl of 
this mix were run in an agarose gel (see next Section) using TriDye 2-Log (N3270S; New 
England BioLabs, UK) as DNA marker.  
 
2.2.3.8. Agarose gel electrophoresis 
 
When applying an electric field across an agarose gel, the negatively charged DNA and RNA, 
due to their phosphate backbone, move in the direction of the positively-charged anode 
(Sambrook et al., 1989). Nucleic acids can be separated by size due to their distinct migration 
through the gel and the fragment size can be determined by running the samples side by side with 
an appropriate marker. The higher the percentage of the agarose gel, the smaller the nucleic acids 
that can be resolved. A DNA or RNA intercalating agent like ethidium bromide is tipically used 
to visualize the bands under a UV lamp. For the casting of a 2% gel, 2.4 g of agarose (2267.3; 
Roth, Karlsruhe, Germany) were introduced into a 500 ml Erlenmeyer flask (Schott; Mainz, 
Germany). Then, 120 ml of TBE buffer (See Section 2.1.3 for preparation) were poured into the 
flask and microwaved until the mix was clear due to the complete melting of agarose. The 
evaporated volume was substituted with H2Odd. Subsequently, 2 µl of ethidium bromide were 
added (10 mg/ml stock; Sigma, USA) for visualization of the nucleic acids and the liquid agarose 
was poured into a cast accompanied by a comb to form the wells for sample loading. After 35-45 
minutes, the solidified agarose gel was placed in a TBE-filled running chamber and 10 µl of the 
samples were loaded using 6x DNA-loading buffer, reserving one lane for 7 µl of TriDye 2-Log 
(N3270S; New England BioLabs, UK) DNA ladder. The samples were run at a constant voltage 
of 100 V for approximately 45 minutes. Finally, bands on the gel were visualized using an IBI 
UV transilluminator (Ibi Scientific, USA) and photographed with a FinePix JZ300 camera 
(Fujifilm, Japan). 
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2.2.3.9. Quantitative Reverse Transcription PCR (qPCR) 
 
Quantitative Reverse Transcription PCR (qRT-PCR) or simply Quantitative PCR (qPCR) allows 
the simultaneous amplification of DNA by the polymerase chain reaction (PCR) and real time 
detection of newly synthesized nucleic acid by the use of a fluorescent reporter molecule. It 
provides the capability of precisely quantifying the amplified product, which is useful in e.g. 
gene expression analysis, diagnosis of diseases or microRNA quantification. The earliest reports 
of the use of qPCR were done by Higuchi and colleagues (Higuchi et al., 1992; Higuchi et al., 
1993). After each amplification cycle, the increase in fluorescence is proportional to the amount 
of newly synthesized DNA and the qPCR instrument collects data in real time. A threshold level 
of fluorescence is set above the background and the cycle at which an amplification plot reaches 
this fluorescence threshold is called Ct value or threshold cycle. If the initial amount of DNA 
template is high, then the Ct value will be low (it will reach the threshold in an earlier cycle) and 
vice versa. After an exponential phase of amplification a plateau is reached as the reaction 
components are consumed. In short, specific intron-spanning primers were designed using the 
Universal Probe Library Assay (Roche, Switzerland). SYBR Green-based real-time polymerase 
chain reactions (AB1167; Thermo Scientific) were run in triplicate using a Mx3005P qPCR 
System (Stratagene, Heidelberg, Germany) and 96-well non-skirted plates (AB-0600/W; Thermo 
Scientific, USA). A typical qPCR reaction would include: 
 
- 2.5 µl of cDNA diluted 1:10 with nuclease-free H2O 
- 10 µl of primer mix containing nuclease-free H2O (200 nM primer final concentration) 
- 12.5 µl of Absolute qPCR SYBR Green Mix (AB1167; Thermo Scientific, USA) 
 
After all components of the qPCR reaction were included, the plates were sealed using Clear Seal 
Diamond film (AB-0812; Thermo Scientific, USA) and an Alps 50V Heat Sealer (Thermo 
Scientific, USA). A quick centrifugation followed (400 g, 30 seconds, room temperature) and 
then the samples were submitted to the following PCR program: 
 
- Initialization: 95° C for 15´ 
- Denaturation: 95° C for 30´´ / Annealing: 60° C for 30´´ / Elongation: 72° C for 30´´ (x45) 
- Denaturation: 95° C for 1´ 
- Dissociation curve analysis: 60° C → 95° C  
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The ∆∆Ct method was used for relative quantification of gene expression (Livak and Schmittgen, 
2001). In short, for calculation of the ∆Ct between the gene of interest (GOI) and the 
housekeeping or reference gene (e.g. GAPDH) the following formula was used for each sample: 
 
∆Ct = CtGOI – CtGAPDH 
 
Then, the difference between the ∆Ct of the different samples and the ∆Ct of the group selected 
as control was calculated (∆∆Ct) with the formula: 
 
∆∆Ct = (CtGOI – CtGAPDH)sample - (CtGOI – CtGAPDH)control  
 
Finally, the normalized target amount in the sample is 2-∆∆Ct and gene expression levels can be 
compared between samples. The ∆∆Ct method was applied using Office Excel 2003 (Microsoft, 
USA) and statistical analysis was performed with GraphPad Prism 5.03 (GraphPad Software, 
USA). For in vivo experiments, gene expression in one of the control (Ctr) animals was 
arbitrarily set to 1 and the relative fold change expression was calculated for the rest of the mice. 
‘No template’ controls (NTC) were included in each run and product specificity was verified by 
dissociation curve analysis (Bustin et al., 2009). All primer sequences and amplicon sizes are 
available in Section 2.1.5. 
 
2.2.3.10. Analysis of qPCR reference gene stability in mammary cells 
 
An optimal reference or housekeeping gene should have a stable expression in the different 
experimental conditions used. In order to find the most reliable gene in proliferative, arrested and 
differentiating mammary cells with distinct levels of Miz1 and Myc, several cDNAs from HC11 
cells were used for qPCR (see time points surrounded by a square in Fig. 2.2):  
 
 
 
Fig. 2.2. HC11 cDNAs used for reference gene analysis with geNorm and Normfinder. 
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In samples from 0 and 72 hours of differentiation (see grey squares in Fig. 2.2), cDNAs from 
control or from HC11 cells overexpressing Miz1 or Myc were also used. The following reference 
genes were tested: GAPDH, 18s, Hprt, ß Actin, Hmbs, Sdha and Ubqln1. The expression of 18s, 
Hmbs and ß Actin in these experimental conditions was highly variable and the other four genes 
behaved more robustly when analyzed in GenEx 5 software (MultiD Analyses, Sweden). 
GAPDH has been described to be a suitable reference gene in pregnant and lactating mouse 
mammary glands in vivo (Han et al., 2010). Our own analysis on proliferative and differentiating 
HC11 cells confirms this notion. The M-value of this gene using geNorm (Vandesompele et al., 
2002) was 0.4669 and the SD with Normfinder (Andersen et al., 2004) was 0.3072. In 
consequence, GAPDH was selected as reference gene for qPCR analysis. 
 
 
Fig. 2.3. Housekeeping gene analysis. Normfinder (left) and Genorm (right) software were used for the 
analysis.   
 
2.2.3.11. Microarray analysis and bioinformatics 
 
Microarray analysis of gene expression using first pregnancy lactation day 6 mammary gland 
samples from Wap-Cre + Miz1+/+ (Ctr) and Wap-Cre + Miz1lox/lox (Miz1∆POZ) animals (n=4 per 
genotype) was performed. RNA integrity (RQI>9 in all samples with 10 as the highest score 
available) and concentration were assessed with the Experion automated electrophoresis station 
(Bio-Rad Laboratories, USA). 100 ng of total RNA were employed for cDNA synthesis. Next, 
the Quick-Amp Labeling Kit (Agilent, USA) was used and Cy3 and Cy5 marked probes were 
hybridized for 16 hours at 65° C with a mouse genome Agilent-028005 array. The resulting 
intensity values for the red and green channels were normalized using the lowest method within 
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the limma package in R/BioConductor (Gentleman et al., 2004; Smyth, 2004). Regulated probes 
were selected on the basis that the logarithmic (base 2) average intensity value (A-Value) was ≥ 
5. Microarrays were performed by Dr. Michael Krause in the Genomics Unit of the Institute of 
Molecular Biology and Tumor research (IMT, Marburg). Data were generated by Florian 
Finkernagel and Lukas Rycak (IMT, Marburg) and are available on ArrayExpress under the 
accession code E-MTAB-1718. Gene numbers from Venn diagrams of Fig. 3.31A were obtained 
by introducing the lists of regulated genes in Miz1∆POZ versus control animals (for fold changes 
equal or higher than 1.5 or 2) under the Official Gene Symbol identifier in the Functional 
Annotation tool of David Bioinformatics 6.7 (NIH, USA). In Fig. 3.31B, the 4 most significant 
Gene Ontology (GO) terms were obtained using also the Functional Annotation tool of David 
Bioinformatics v6.7 (Huang et al., 2008; Huang et al., 2009). Cell functions are represented by 
relative gene abundance between groups. 
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2.2.4. Protein Biochemistry 
 
2.2.4.1. Protein extraction from HC11 cells and mammary tissue 
 
For protein extraction, HC11 cells were washed with 10 ml of sterile PBS (P-3813; Sigma, USA) 
and then harvested using cell scrapers (Sarstedt; Nümbrecht, Germany) and 1 ml of ice cold 
RIPA buffer (See Section 2.1.3 for preparation). In addition, the buffer contained protease 
(P8340; Sigma, USA) and phosphatase (P5726; Sigma, USA) inhibitor cocktails and benzonase 
nuclease (70664-3; Novagen Darmstadt, Germany). Snap frozen thoracic mammary gland 
fragments were stored at -20° C, homogenized with the Ultra Turrax T25 Homogenizer (Ika, 
Staufen, Germany) and each sample was submitted to 5 cycles of 5 seconds at an idle (no load) 
speed of 13500 rpm using 2 ml of ice cold RIPA buffer for virgin, pregnant and involuting glands 
and 5 ml for lactation samples (due to the high protein concentration of these). After overnight 
incubation of the cell and tissue samples at 4°C for efficient benzonase nuclease action, lysates 
were centrifuged (12000 rpm, 15 minutes, 4°C) to remove cellular debris and supernatants were 
subsequently stored at -20°C. 
 
2.2.4.2. Determination of protein concentration: BCA assay  
 
The bicinchoninic acid (BCA) protein assay allows the quantitative determination of protein 
concentration and is compatible with the use of detergents and buffer salts (Smith et al., 1985). 
Under alkaline conditions, a Cu++-protein complex is formed and then the Cu++ is reduced to Cu+. 
Different aminoacids are able to reduce Cu++ to Cu+: cysteine, cystine, tryptophan and tyrosin 
(Wiechelman et al., 1988). Thus, the extent of the reduction is directly proportional to the protein 
concentration in the samples. BCA forms a purple complex with Cu+, allowing a quantification of 
the protein content of the samples by comparison with a bovine serum albumin (BSA) calibration 
curve. In brief, 30 µl of the BSA standards (11 standards from 0 till 5 µg of BSA) and 10 µl of 
our protein samples with 20 µl of H20dd were added to 96 well plates (655101; Greiner bio-one, 
Frickenhausen, Germany). Different dilutions with H20dd of our protein samples (for example 
1:10, 1:30 and 1:50) were normally used to correctly extrapolate the absorbance data from the 
standard curve to our sample results. Then, 200 µl of bicinchoninic acid (BCA) solution (B9643; 
Sigma, USA) with 2% CuSO4 were included in each well using a Transferpette-8 multipipette 
(Brand, Wertheim, Germany). The absorbance of the reactions was measured at 37°C and 562 
nm on three time points (0, 15  and 30 minutes after starting the measurement) using an Infinite 
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M200 microplate reader (Tecan, Männedorf, Germany). Finally, the protein concentration of our 
samples (µg/µl) was calculated using Office Excel 2003 (Microsoft, USA), averaging the 
absorbances obtained in the three different time points.  
 
2.2.4.3. SDS-PAGE (Sodium Dodecyl Sulfate PolyAcrylamide Gel Electrophoresis) 
 
SDS-PAGE allows the separation of a complex mixture of proteins by their molecular weight 
based on the differential migration of these through a matrix under an electric field (Shapiro et 
al., 1967). The first reports on its use (Pederson, 2008) were related to resolving viral proteins in 
a gel with SDS (Summers et al., 1965) and for studying immunoglobulin chain synthesis (Shapiro 
et al., 1966). SDS is an anionic detergent that, after boiling, denatures proteins and provides a 
negatively-charged coat around the protein and the negative charge is proportional to the mass of 
the protein. At saturation, 1.4 g of SDS binds to each 1.0 g of protein. A reducing agent (ß 
mercapto-ethanol or dithiothreitol) is used to break down disulphide bonds disrupting the tertiary 
and quaternary structure of the proteins so that they are linearized. SDS-coated proteins have the 
same charge to mass ratio so that differential migration depends entirely on mass but not on 
charge of the proteins. Negatively charged proteins will then migrate towards the cathode through 
a polyacrilamide gel matrix. The polyacrylamide chains are crosslinked by N,N-methylene 
bisacrylamide. The polymerization is initiated by ammonium persulfate (Hunkeler, 1991) and 
TEMED accelerates the formation of free radicals from persulfate and these catalyze the 
polymerization reaction. As the percentage of acrylamide increases, the pore size decreases, 
allowing the separation of differently sized proteins. Proteins with a higher molecular mass 
should be resolved with low acrylamide percentage and smaller proteins in higher percentage 
gels. Discontinuous buffer systems are characterized by distinct buffer ions in the gel compared 
to those in the electrode reservoirs (Ornstein, 1964; Davis, 1964), being the Laemmli SDS-
discontinuous system the most widely used  (Laemmli, 1970). The stacking gel (1 M Tris-HCl, 
pH=6.8) allows proteins to migrate in a tight band moving behind chloride ions while the 
resolving gel (1.5 M Tris-HCl, pH=8.8), once glycine has been deprotonated, permits the 
migration of proteins according to their size using differential pore sizes (6-15% acrylamide gels 
are normally used) for accurate protein band discrimination (modified from Mullins lab SDS-
PAGE protocol, UCSF, USA). 8% and 15% acrylamide gels were used in the present thesis. In 
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short, for the preparation of 20 ml of an 8% resolving gel (Sambrook et al., 1989), the following 
components were mixed adding APS and TEMED at the end to ensure proper polymerization: 
 
- 9.3 ml H2Odd 
- 5.3 ml of a 30% acrylamide/bisacrylamide 37.5:1 mix (3029.1; Roth, Karlsruhe, Germany) 
- 5.0 ml 1.5 M Tris-HCl (pH=8.8) 
- 200 µl 10% SDS (4360.2; Roth, Karlsruhe, Germany) 
- 200 µl 10% APS (17874; Thermo Scientific, USA) 
- 12 µl TEMED (161-0800; Bio-Rad Laboratories, USA) 
 
After pouring the acrylamide solution for the resolving gel into the space between glass plates, 
500 µl of isopropanol were added to ensure the formation of a flat gel. Next, the isopropanol was 
removed and H2Odd was used to wash the upper part of the resolving gel. Once the matrix had 
polymerized (about 30 minutes), the stacking gel was added on top of the resolving gel including 
a comb for well formation. For the preparation of 5 ml of stacking gel (Sambrook et al., 1989) the 
following components were combined: 
 
- 3.4 ml H2Odd 
- 830 µl of a 30% acrylamide/bisacrylamide 37.5:1 mix (3029.1; Roth, Karlsruhe, Germany) 
- 630 µl 1 M Tris-HCl (pH=6.8) 
- 50 µl 10% SDS (4360.2; Roth, Karlsruhe, Germany) 
- 50 µl 10% APS (17874; Thermo Scientific, USA) 
- 5 µl TEMED (161-0800; Bio-Rad Laboratories, USA) 
 
During the polymerization of the stacking gel, protein samples (20-60 µg) were prepared by 
mixing them with 4x SDS-PAGE loading buffer (see Section 2.1.3), and were incubated for 5 
minutes at 95° C on a heating block (Techne Dri-Block DB2A; Techne, UK) for protein 
denaturation. Once the polymerization of the stacking gel was complete (about 30 minutes), the 
gel was mounted in the electrophoresis apparatus and combs were removed. Samples were then 
loaded including 5 µl of PageRuler Plus Prestained Protein Ladder (26619; Thermo Scientific, 
USA) for proper estimation of the molecular weights of our proteins of interest. With the help of 
a power supply (see Section 2.1.1 for equipment details), 15 mA of constant current per gel were 
applied till the dye front migrated into the resolving gel. Then, current was increased to 30 mA 
until bromophenol blue reached the bottom of the resolving gel.  
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2.2.4.4. Western blotting 
 
Western blotting involves the transfer of proteins from the SDS-PAGE gel on nitrocellulose or 
polyvinylidene difluoride (PVDF) membranes and the detection of antigenic epitopes using 
specific antibodies (Towbin et al., 1979). This technique is very useful not only for the 
identification but also for the quantification of proteins and does not require radiolabelling 
(Sambrook et al., 1989). 
For semi-dry western blotting, 1 mm filter paper rectangles of 9 cm x 6 cm were cut. In addition, 
PVDF (741260; 0.20 µm; Macherey-Nagel, Düren, Germany) and nitrocellulose transfer 
membranes (10401196; 0.45 µm; Whatman, UK) were also cut slightly smaller than the filter 
paper (approximately 8.3 cm x 5.8 cm). PVDF membranes were then submerged into methanol 
for 1 minute for activation due to their high hydrophobicity. After this, filter papers, membranes 
and gels were incubated for 15 minutes in transfer buffer with methanol (see Section 2.1.3) at 
room temperature with gentle rotation. Then, the following components were arranged in order: 
anode/filter paper/SDS-PAGE gel/nitrocellulose or PVDF membrane/filter paper/cathode inside 
of a Perfect Blue Semi-dry blotting chamber (Peqlab, Erlangen, Germany). The transfer of the 
proteins of the gel into the membrane was performed using 2.5 mA per cm2 of membrane during 
45 minutes. After the transfer, membranes were blocked for 45 minutes using 5% milk (T145.2; 
Roth, Karlsruhe, Germany) or 2% albumin (T844.2; Roth, Karlsruhe, Germany) diluted in TBST 
(TBS with 0.1% of Tween; Merck, Darmstadt, Germany) at room temperature with gentle 
rotation. Next, membranes were incubated inside of sealed plastic bags overnight at 4° C with 
one of the diluted primary antibodies indicated in Table 2.2. Blocking substance (milk or 
albumin) was used for dilution of antibodies. All primary antibody incubations were performed at 
4°C overnight except for the rabbit anti-milk serum, which was done at room temperature for 1 
hour (Marte et al., 1995). 
After primary antibody incubation, membranes were washed 3 times (10 minutes each) with 
TBST inside of plastic containers or cassettes under agitation. Next, membranes were incubated 
with the appropriate HRP-conjugated secondary antibody (See Table 2.2) for one hour at room 
temperature with rotation. Membranes were then washed again 3 times (10 minutes each) with 
TBST and transferred to TBS for detection of the protein bands using either the Supersignal West 
Dura Extended Duration (#34075; Thermo Scientific, USA) or the Lumi-Light (Roche, 
Switzerland) chemiluminescent Western blotting substrates which were applied to the 
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membranes for 5 minutes at room temperature. After this, autoradiography films (SC-201696; 
Santa Cruz Biotechnology, USA) were exposed to the membranes. Finally, for visualization of 
the protein bands, films were submerged in paper developer solution Neutol Liquid (Agfa, 
Belgium), washed in H20dd to remove the excess of developer and protected using Sistan Image 
Silver Stabilizer (Agfa, Belgium). Dried films were scanned using a ScanJet 3400C scanner 
(Hewlett-Packard, USA) and images of blots were displayed in Grayscale mode using Photoshop 
CS5 (Adobe Systems, USA) for blot representation in figures. 
 
 
 
Primary antibodies 
 
Antigen Info Company/Provider Dilution 
Actin (A2103) rabbit polyclonal Sigma (USA) 1:1000 
Milk proteins rabbit polyclonal Prof. Nancy Hynes (Basel, Switzerland) 1:5000 
β-Casein  (S-15) goat polyclonal Santa Cruz (USA) 1:200 
Cytokeratin 18 (C-04) mouse monoclonal Abcam (UK) 1:1000 
Miz1 (10E2) mouse monoclonal Prof. Martin Eilers (Würzburg, Germany) 1:400 
Miz1 (B10) mouse monoclonal Santa Cruz (USA) 1:250 
Myc (N262) rabbit polyclonal Santa Cruz (USA) 1:400 
pStat5a/b (#05-495) mouse monoclonal Millipore (USA) 1:500 
Stat5a/b (C-17) rabbit polyclonal Santa Cruz (USA) 1:250 
α-Tubulin mouse monoclonal Thermo Scientific (USA) 1:5000 
 
Secondary antibodies 
 
Antibody Host Company Dilution 
Anti-Goat IgG Rabbit Bio-Rad (#172-1034) 1:7500 
Anti-Mouse IgG Goat Bio-Rad (#172-1011) 1:7500 
Anti-Rabbit IgG Goat Bio-Rad (#172-1019) 1:7500 
 
 
Table 2.2: List of primary and secondary antibodies used for Western Blotting. Dilution of antibodies 
was performed using blocking solution: either 5% milk (T145.2; Roth, Karlsruhe, Germany) or 2% 
albumin (T844.2; Roth, Karlsruhe, Germany) diluted in TBST (TBS with 0.1% of Tween; Merck, 
Darmstadt, Germany). Blocking of any of the milk protein or phosphoprotein blots was performed with 
2% albumin to avoid cross-reactions between the primary antibodies and the blocking solution.  
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2.2.5. Histology 
 
2.2.5.1. Whole-mount carmine alum staining 
 
For proper visualization of the ductal development of whole mouse mammary glands, a carmine 
alum staining was performed. The protocol followed for staining with this bright-red pigment 
was done according to the one described by Ip and Asch (Ip and Asch, 2000). In short, inguinal 
mammary glands (4th and 9th gland pair in Fig. 2.1) were spread on a glass slide, fixed in 
Carnoy’s solution (see Section 2.1.3) for 4 hours at room temperature, washed in 70%, 50% and 
25% ethanol for 15 minutes each, rinsed in tap water for 5 minutes and stained in carmine alum 
(see Section 2.1.3) overnight. Then, mammary glands were washed in 70%, 95% and 100% 
ethanol for 15 minutes each. Next, mammary glands were cleared in xylene (Roth, Karlsruhe, 
Germany) for 30 minutes and subsequently for 2 hours replacing with fresh xylene. Mammary 
glands inside of a glass Petri dish containing xylene were photographed using a stereomicroscope 
Olympus SZ61 (Olympus, Japan) equipped with a Lumenera Infinity 1 camera (Lumenera, 
Canada). Finally, 2-3 individual pictures spanning the whole gland were stitched together using 
Autostitch v2.2 Demo software (UBC, Canada). 
 
2.2.5.2. Fixation and paraffin embedding of mammary tissues 
 
Inguinal mammary glands (see Fig. 2.1) were dissected, cut in 0.5-1 cm long fragments and fixed 
overnight at 4°C using 50 ml per animal of freshly prepared 3.7% paraformaldehyde (Roth, 
Karlsruhe, Germany) in PBS. The edges of the glands were discarded and only “central” 
mammary gland fragments surrounding the lymph node were used for histological analysis. 
Then, samples were washed in tap water for 3 hours applying a constant flux and stored in 70% 
ethanol at 4°C. For paraffin embedding, samples were placed in embedding cassettes (Leica, 
Wetzlar, Germany) and dehydrated by two-hour baths in first 80% ethanol, then 96 % ethanol 
and finally 2 separate incubations in 100% isopropanol. Samples were then bathed in Paraffin I 
(melting temperature: 42-44° C) at 60° C overnight. Next morning, cassettes were transferred to 
Paraffin II (melting temperature: 51-53° C) and incubated for 8 hours at 60° C. Finally, an 
overnight incubation on Paraplast (melting temperature: 56-58° C) at 60°C followed. For 
embedding, molds were filled with paraffin wax and tissue was placed in the mold. After paraffin 
covered cassettes and molds completely, they were chilled in a cold plate and blocks were 
removed from the molds. 
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2.2.5.3. Paraffin block sectioning 
 
Paraffin blocks were cooled down on an ice tray and cut in 3-4 µm sections using a Microm HM 
400 sliding microtome (Microm, Thermo Scientific, USA). Paraffin ribbons were carefully 
stretched on a 40° C waterbath and sections were mounted onto Poly-L-Lysine (Biochrom, 
Merck-Millipore, Darmstadt, Germany) coated slides. Slides were then dried either at 40° C 
overnight or at 60° C for 30 minutes and stored at room temperature until use.  
 
2.2.5.4. Hematoxylin and eosin (H&E) staining  
 
H&E double staining was first employed in 1876 by Wissowzky (Gill, 2012) and remains the 
most commonly used staining technique in pathology laboratories until today. Hematoxylin stains 
nucleic acids in dark-blue or purple color (basophilic) and eosin binds to most proteins in the 
cytoplasm (eosinophilic or acidophilic) giving them a pink coloration (Fischer et al., 2008). In 
brief, slides were deparaffinized with two 5-minute baths in Roti-Histol (Roth, Karlsruhe, 
Germany). Then, samples were rehydrated incubating successively in 100% isopropanol and 
decreasing ethanol concentrations: 96%, 80% and 70% for 5 minutes each. After 5 minutes in 
H20dd, slides were bathed in Mayer´s hemalum solution (Merck, Darmstadt, Germany) for 3 
minutes at room temperature and immersed in running tap water for 5-10 minutes. Next, slides 
were incubated for 10-15 minutes with 0.1% eosin (Merck, Darmstadt, Germany) and dehydrated 
in baths of increasing ethanol concentrations: firstly 80% ethanol for 10 seconds, then 96% 
ethanol for further 10 seconds and lastly 100% isopropanol for 5 minutes. Finally, slides were 
cleared with two 5-minute incubations in xylene (Roth, Karlsruhe, Germany) and cover slipped 
with a drop of Enthelan mounting media (Merck, Darmstadt, Germany). Paraffin embedding, 
block sectioning and H&E stainings were routinarily performed by Waltraud Ackermann 
(Institute of Cellular Biology, Marburg, Germany). 
 
2.2.5.5. Immunohistochemistry 
 
Immunohistochemistry (IHC) allows the detection of antigens in tissue samples by the use of 
specific antibodies. This antibody-antigen interaction can be detected utilizing antibodies 
conjugated to enzymes which catalyse a colored reaction (e.g. immunoperoxidase staining) or by 
antibodies tagged to a fluorophore (immunofluorescence). The technique was developed and first 
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used in 1941 by Dr. Albert Coons and colleagues (Coons and Kaplan, 1950). The following 
general protocol was used for formalin-fixed and paraffin-embedded tissue sections. First, tissue 
slides were deparaffinized with two 5-minute baths in Roti-Histol (Roth, Karlsruhe, Germany) 
and rehydrated incubating in 100% isopropanol and decreasing ethanol concentrations: 96%, 
80% and 70% for 5 minutes each. Next, slides were transferred to a 5-minute bath in H20dd. In 
some cases, antigen retrieval was necessary and improved the quality of the stainings 
substantially (see Table 2.3A for details). Aldehyde-containing fixatives crosslink proteins in the 
sample and exposure of the slides to heat allows the unmasking of epitopes, which favors binding 
of the antibodies. Antigen retrieval was achieved with either 10mM Tris/1mM EDTA (pH 9) or 
10mM citrate buffer (pH 6) for 15-30 minutes in a steamer. 
For reduction of the background in immunofluorescence, samples were incubated with 10 mg/ml 
Glycine (Roth, Karlsruhe, Germany) in PBS for 10 minutes. Glycine binds free aldehyde groups 
that can potentially also bind primary or secondary antibodies resulting in high background. In 
immunoperoxidase stainings, slides were incubated for 10-15 minutes with 3% H2O2 diluted in 
PBS which suppresses endogenous peroxidase activity, leading also to a reduced background. 
After washing the slides twice in PBS for 5 minutes each, a PAP pen was used to draw 
hydrophobic circles around the tissue sections. Blocking was accomplished by incubating the 
samples with 10% goat serum (X0907; Dako, Denmark) in PBS for 45 minutes at room 
temperature. Serum was carefully removed from the slides which were not negative controls and 
mammary sections were incubated overnight at 4° C in a humidified chamber with distinct 
primary antibodies diluted in blocking solution (see Table 2.3A). Slides were then washed 3 
times in PBS (5 minutes each) and incubated with the secondary antibody. Next steps differ 
depending on the immunodetection method employed and are explained separately in the 
following sections. 
 
2.2.5.5.1. Immunoperoxidase staining 
 
Secondary antibody incubation was performed using biotinylated antibodies, diluted 1:500 in 
blocking solution, against the species in which the primary antibody was raised (see Table 2.3B 
for details). Sections were incubated with specific secondary antibodies for 45 minutes at room 
temperature inside of a humidified chamber and then 3 PBS washes (5 minutes each) followed. 
Horseradish peroxidase-labeled Streptavidin (KPL, USA), having a very high affinity for biotin, 
was added to the tissue sections at a concentration of 2 µg/ml and incubated for 30 minutes at 
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room temperature inside of the chamber. After 3 PBS washes of 5 minutes each, the 3-amino-9-
ethylcarbazole (AEC) Substrate Kit (00-2007; Invitrogen, USA) was utilized in all 
immunoperoxidase stainings. The AEC substrate was prepared, trying to avoid exposure to light, 
adding 1 drop of reactive A to 1 ml of H2Odd. Then, 1 drop of reactive B and 1 drop of reactive 
C were also included and mixed. Around 200 µl of the AEC substrate were used per slide and the 
progress of the reaction was observed in real-time under a light microscope. Once the staining 
strength was adequate, sections were transferred to H2Odd and counterstained in Mayer´s 
hemalum solution (Merck, Darmstadt, Germany) for 3 minutes at room temperature and 
subsequently immersed in running tap water for 5-10 minutes. Finally, slides were mounted with 
Mowiol and kept at room temperature till documentation utilizing a Leitz Diaplan MPS 46/52 
(Leitz, Wetzlar, Germany) microscope equipped with a MicroPublisher 3.3 RTV camera (Q-
Imaging, Canada). 
 
 
Primary antibodies 
 
Antigen Info Company/Provider Dilution Technique Antigen Retrieval 
Cleaved Caspase-3 
(5A1E) 
Rabbit 
Monoclonal Cell Signalling (USA) 1:200 Peroxidase 15 min. Tris/EDTA 
Cleaved Caspase-3 
(5A1E) 
Rabbit 
Monoclonal Cell Signalling (USA) 1:100 Fluorescence NO 
Cre Rabbit Polyclonal 
Dr. Christoph 
Kellendonk (NY, USA) 1:1500 Peroxidase 15 min. Tris/EDTA 
ErbB4 (C-18) Rabbit Polyclonal Santa Cruz (USA) 1:200 Fluorescence 30 min. Citrate 
Ki67 (#VP-K452) Mouse Monoclonal 
Vector Laboratories 
(USA) 1:100 Peroxidase 15 min. Citrate 
Ki67 (#VP-K452) Mouse Monoclonal 
Vector Laboratories 
(USA) 1:50 Fluorescence NO 
Milk proteins Rabbit Polyclonal 
Prof. Nancy Hynes 
(Basel, Switzerland) 1:5000 Fluorescence NO 
Miz1 (10E2) Mouse Monoclonal 
Prof. Martin Eilers 
(Würzburg, Germany) 1:10 Peroxidase 30 min. Tris/EDTA 
Myc (Y69) Rabbit Monoclonal Abcam (UK) 1:100 Peroxidase 30 min. Citrate 
PrlR (M170) Rabbit Polyclonal Santa Cruz (USA) 1:150 Fluorescence NO 
pStat5 (#71-6900) Rabbit Polyclonal Invitrogen (USA) 1:25 Peroxidase 20 min. Citrate 
 
Table 2.3A: List of primary antibodies used for immunohistochemistry. 
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Secondary antibodies 
 
Antibody Info Company/Provider Dilution Technique Reference 
Anti-Rabbit 
Ig/Biotinylated 
Goat 
Polyclonal Dako (Denmark) 1:500 Peroxidase E0432 
Anti-Mouse 
Ig/Biotinylated 
Rabbit 
Polyclonal Dako (Denmark) 1:500 Peroxidase E0464 
Anti-Rabbit 
Alexa Fluor 488 
Goat 
Polyclonal 
Molecular Probes 
(USA) 1:500 Fluorescence A-11008 
Anti-Mouse 
Alexa Fluor 647 
Goat 
Polyclonal 
Molecular Probes 
(USA) 1:500 Fluorescence A-21235 
Anti-Rabbit 
Alexa Fluor 546 
Goat 
Polyclonal 
Molecular Probes 
(USA) 1:500 Fluorescence A-11010 
 
Table 2.3B: List of secondary antibodies used for immunohistochemistry. 
 
 
2.2.5.5.2. Immunofluorescence 
 
Secondary antibodies tagged to a fluorophore (see Table 2.3B for details) were diluted using 
blocking substance (10% goat serum in PBS) and exposed to the tissue sections inside of a 
humidified chamber for 1 hour at room temperature. Then, samples were incubated with 0.7 
µg/ml Hoechst 33342 (14533; Sigma) for 5 minutes at room temperature for nuclei visualization. 
After 3 PBS washes (5 minutes each), covering slides to protect them from light, sections were 
transferred to H2Odd and washed for 5 minutes. Subsequently, slides were mounted with Mowiol 
and kept covered at 4° C till documentation with an Olympus BX61 fluorescence microscope 
(Olympus, Japan) assembled with an F-view digital camera (Olympus, Japan). 
 
2.2.5.6. TUNEL assay 
 
This method was first described by Gavrieli and colleagues (Gavrieli et al., 1992). Nuclear DNA 
fragmentation, a hallmark of the last phases of apoptosis, can be detected and quantified using the 
Terminal desoxynucleotidyl transferase-mediated dUTP Nick End Labeling (TUNEL) assay 
(DeadEnd Fluorometric TUNEL System, G3250; Promega, USA). Fluorescein-12-dUTP is 
incorporated at 3´ -OH ends and labeled DNA can be visualized and documented by fluorescence 
microscopy. Briefly and according to manufacturer´s instructions, slides were deparaffinized 
washing twice in xylene (Roth, Karlsruhe, Germany) and immersed in 100% ethanol (each step 
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for 5 minutes). Then, sections were rehydrated in decreasing concentrations of ethanol: 96%, 
80% and 70% for 3 minutes each. Samples were then washed in PBS for 5 minutes and fixed in 
4% formaldehyde in PBS for 15 minutes. Next, sections were incubated at room temperature for 
10 minutes with a 20 µg/ml Proteinase K solution, washed for 5 minutes in PBS and fixed again 
with 4% formaldehyde in PBS for 5 minutes. After this, slides were incubated with 100 µl of 
equilibration buffer for 5-10 minutes at room temperature. Tissue sections were labeled for 60 
minutes at 37° C, covering slides with plastic coverslips in a humidified chamber, using 50µl of 
TdT reaction mix per slide containing: 45µl of equilibration buffer, 5 µl of nucleotide mix and 1 
µl of rTdT enzyme (the 1 µl of rTdT enzyme was substituted with 1 µl of H2Od in negative 
controls). After removing plastic coverslips, reactions were stopped by immersing the slides in 2x 
SSC for 15 minutes. Finally, sections were washed twice in PBS (5 minutes each) and exposed to 
0.7 µg/ml Hoechst 33342 (14533; Sigma) for 5 minutes at room temperature. After 2 PBS washes 
(5 minutes each) and a H2Odd bath, slides were mounted with Mowiol.  
 
2.2.5.7. Sudan III lipid staining 
 
Sudan III lipid staining was performed on first pregnancy lactation day 6 cryosections following 
standard protocols. Briefly, sections were fixed in 4% PFA for 30 minutes at 4°C and 
subsequently washed with 50% Ethanol for 3 minutes. A 25-minute incubation with 0.3% Sudan 
III-solution (see Section 2.1.3.) in 70% ethanol followed. Then, sections were washed again with 
50% Ethanol and transferred to H2Od. Next, slides were counterstained with Mayer´s hemalum 
solution (Merck, Darmstadt, Germany) and washed in running tap water for 10 minutes. Finally, 
sections were transferred to H2Od and mounted with Mowiol.  
 
2.2.6. Ultrastructural analysis 
 
For transmission electron microscopy, tissue was fixed in a mixture of 2.5% glutaraldehyde, 
2.5% paraformaldehyde and 0.05% picric acid in 67 mM cacodylate buffer (pH 7.4) according to 
Ito und Karnovsky (Ito and Karnovsky, 1968). Postfixation was performed in 1% osmium 
tetroxide followed by an overnight incubation with 0.3% uranyl acetate dissolved in 50 mM 
maleate buffer (pH 5.0). Samples were embedded in Epon according to standard procedures. Thin 
sections were contrasted with lead citrate and examined with a Zeiss EM 109S electron 
microscope (Zeiss, Jena, Germany).  
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2.2.7. Morphometric analysis in lactating mammary glands 
 
2.2.7.1. Adipocyte percentage determination 
 
The percentage of fat (Fig. 3.18) was calculated by estimating the area occupied by adipocytes 
divided by the total mammary area in H&E stained sections using the wand tool from ImageJ 
1.43u software (NIH, USA). 10 pictures per animal were used for the analysis of first pregnancy 
(n=4 per genotype) and second pregnancy (n=3 per genotype) lactation day 6 sections of Ctr and 
Miz1∆POZ mammary glands.  
 
2.2.7.2. TUNEL assay quantification 
 
TUNEL positive cells, rare in both Ctr and Miz1∆POZ animals, were counted in 10 pictures per 
animal (20x magnification) on lactation day 1 and 6 samples of a first pregnancy (Fig. 3.20). 
ImageJ 1.43u software (NIH, USA) was used for both quantifications and at least 3 animals per 
genotype and time point were analysed. 
 
2.2.7.3. Percentage of Ki67 positive cells  
 
The percentage of Ki67 positive cells (Fig. 3.22A) on lactation day 6 of a first pregnancy was 
calculated by quantifying the number of Ki67 positive cells among all epithelial cells in 
representative 25x magnification immunohistochemical sections utilizing ImageJ 1.43u software 
(NIH, USA). More than 1000 cells per animal were scored in 3 animals per genotype. 
 
2.2.8. Statistics 
 
All comparisons between Ctr vs Miz1∆POZ animals or shscr vs shMiz1 HC11 cells were 
analysed by two-tailed Student´s t-tests. A two-way ANOVA with a Bonferroni's post-hoc test 
was used for the analysis of the percentage of cells containing lipid droplets over time in Fig. 
3.13. Also, a two-way ANOVA followed by Bonferroni's post-hoc test but for multiple pairwise 
comparisons was employed for pup weight analysis in Fig. 3.16. All statistical tests were 
performed using GraphPad Prism 5.03 (GraphPad Software, USA). P-values: NS (p>0.05); * (p= 
0.01-0.05); ** (p= 0.001-0.01); *** (p<0.001). Data are shown as mean ± s.d. 
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3. RESULTS 
 
3.1. Miz1/Myc expression in mammary gland development and HC11 
mammary cells. 
 
3.1.1. Miz1 expression during mammary gland development 
 
 
Figure 3.1: Miz1 expression during mammary gland development. Immunohistochemistry (A) and 
western blotting (B) showing Miz1 localization and expression levels in mammary glands from control 
animals (Wap-Cre+ Miz1+/+) at the indicated time points. Actin was used as a loading control in B. Scale 
bar in A: 50 µm. 
 
Miz1 expression during mammary gland development was assessed by immunohistochemistry 
and western blotting (Fig. 3.1) using Miz1 wildtype mice (Wap-Cre+ Miz1+/+). The first method 
revealed a nuclear staining in the virgin gland (45 dpp), during pregnancy (day 18.5) and 
involution (day 2). In lactation (day 6), also a cytoplasmic staining was visible in addition to the 
nuclear stain. Miz1 expression increased substantially during lactation as also seen by Western 
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blotting. The 10E2 antibody was used in Fig. 1B, but other commercially available Miz1 
antibodies were also utilized leading to comparable results (N17, H190 and B10; data not 
shown). Miz1 was only occasionally detected in virgin gland protein lysates, possibly due to the 
small fraction of ductal tissue compared to the more abundant fat pad. At pregnancy day 18.5, 
Miz1 was always undetectable albeit the glandular tissue had expanded until this time point. 
Miz1 expression increased in the transition from pregnancy to lactation as the protein could be 
detected at lactation day 1 and remained strongly expressed throughout lactation (lactation days 
1, 6 and 10 were analysed by western blotting; data not shown). After 48 hours of removal of the 
pups from the mother, commonly regarded as forced involution of the mammary gland, Miz1 
levels decreased considerably to the baseline levels observed in the virgin gland or during late 
pregnancy. 
 
3.1.2. Myc expression during mammary gland development 
 
Analogously to the study of the expression of Miz1 described above, immunohistochemistry 
against c-Myc was performed on sections from control mice spanning different stages of 
mammary gland development (Fig. 3.2).  Nuclear Myc expression was visible in virgin mammary 
ducts and in the forming alveoli during early pregnancy as described elsewhere by gene 
expression analysis (Blakely, 2005; Master et al., 2002) and by immunohistochemistry of 
pregnancy day 6.5 animals (Stoelzle et al., 2009). During late pregnancy, a clear nuclear Myc 
staining was visible in the lymph node but not in the surrounding mammary alveoli (see arrows in 
Fig. 3.2D). Myc expression was not detectable during lactation as described before (Klinakis et 
al., 2006) and was hardly discernible at involution day 2.  
Taken together, Miz1 and Myc are expressed in the ductal epithelium of the virgin mammary 
gland (Fig. 3.1A and 3.2A). Myc levels increase at the beginning of pregnancy when mammary 
epithelial cells proliferate heavily and the gland expands to fill the fat pad. Blakely et al. show 
data from an oligonucleotide array analysis in the mammary gland and describe high expression 
of Myc during early pregnancy (days 6.5 and 12.5). Our own immunohistochemical analysis 
supports this view (Fig. 3.2B and C). At the end of pregnancy (day 18.5), Myc levels decrease 
(Blakely, 2005) and were detectable only in the lymph node but not in the mammary epithelium  
(Fig. 3.2D). At the onset of lactation, Miz1 expression increases (Fig. 3.1 and data not shown) 
while Myc keeps at low levels throughout lactation (Blakely, 2005; Klinakis et al., 2006) as seen 
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in Fig. 3.2E. Once lactation is terminated, Miz1 levels decrease and both Miz1 and Myc are 
expressed at low levels during early mammary involution (Fig. 3.1 and 3.2F). 
 
 
 
Figure 3.2: Myc immunohistochemistry during mammary gland development. Paraffin-embedded  
inguinal mammary glands were stained with a Myc-specific antibody (see Material & Methods for 
details). Time points analysed were the following: virgin gland at 45 dpp (A; n=3), pregnancy day 10.5 
(B; n=2), 14.5 (C; n=2) and 18.5 (D; n=3), lactation day 6 (E; n=3) and involution day 2 (F; n=3). Scale 
bars: 50 µm and 10 µm in the inset. 
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3.1.3. Miz1 expression during HC11 cell mammary differentiation 
 
HC11 cells were used as an in vitro mammary cell culture model in the present thesis. HC11 cells 
are immortalized, non-transformed mammary epithelial cells obtained from the COMMA-1D cell 
line which in turn derives from mid-pregnant mammary tissue of BALB/c mice (Ball et al., 1988; 
Danielson et al., 1984). This cell line can functionally differentiate and produce milk proteins 
upon addition of a lactogenic hormone cocktail referred to as DIP (includes dexamethasone, 
insulin and prolactin). A schematic representation of the protocol followed for HC11 mammary 
cell differentiation is represented in Fig. 3.3A. Briefly, HC11 cells are seeded in a RPMI-based 
complete growth medium and allowed to remain confluent for 48 hours. Then, EGF-free and 
low-serum medium is added to the cells in order to induce competence for differentiation 
(Chammas et al., 1994; Hynes et al., 1990). After further 48 hours, the hormonal cocktail (DIP) is 
included in fresh EGF-free medium in order to differentiate the cells, which subsequently start 
producing milk proteins. ß-casein expression can be detected as soon as 3 hours after hormone 
stimulation (Ball et al., 1988). HC11 cells represent a valuable tool for the study of mammary 
cell proliferation and differentiation in vitro.  
In relation with the study of the expression of Miz1 and Myc in different developmental stages in 
vivo, a similar approach was used in HC11 cells across the above-mentioned differentiation 
protocol. Miz1 mRNA and protein levels increased when HC11 cells became confluent (Fig. 
3.3B and C), as expected for a transcription factor that activates cell cycle arrest genes like 
Cdkn2b, encoding p15Ink4, or Cdkn1a which translates into p21Cip1 (Seoane et al., 2001; Staller et 
al., 2001; Wu et al., 2003a). Miz1 levels increased even before EGF was withdrawn from the 
medium. Two different housekeeping genes were used for normalization of qPCR data (GAPDH 
and Hprt) as shown in Fig. 3.3B. Importantly, Miz1 levels did not increase after addition of the 
lactogenic hormone cocktail (Fig. 3.3B and C) but remained steady or slightly decreased and this 
was true for a period of 7 days after induction of differentiation (data not shown). This 
observation contrasts with the clear upregulation of Miz1 in vivo at the onset of lactation. The 
trigger of Miz1 expression in early lactation might therefore not be prolactin. Other possible 
candidate molecule which could be responsible for Miz1 upregulation in early lactation in vivo is 
the cyclic peptide oxytocin, which is released after pups are born and contracts mammary 
myoepithelial cells allowing milk ejection or let-down (Reversi et al., 2005). The actual 
mechanism engaged in Miz1 upregulation during lactation in vivo remains to be elucidated. 
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Figure 3.3: Miz1 expression during HC11 mammary cell growth and differentiation. (A) Schematic 
representation of the protocol for differentiation of HC11 cells. EGF: Epidermal growth factor. DIP: 
Differentiation media containing dexamethasone, insulin and prolactin (See Material & Methods for 
experimental details). (B) qPCR analysis of Miz1 gene expression normalized to GAPDH and Hprt in 
HC11 cells during proliferation and differentiation. (C) Western blot of Miz1 expression in HC11 cells 
using tubulin as a loading control. 
 
 
3.1.4. Myc expression during HC11 cell mammary differentiation 
 
In contrast to Miz1, Myc is downregulated when HC11 mammary cells become confluent as has 
been already reported (Grolli et al., 1997). Myc promotes proliferation, but when cells become 
contact-inhibited it is reasonable that Myc levels decrease and cells arrest. Our own data support 
this assumption as can be seen by qPCR and Western blotting analysis on Fig. 3.4.  Myc levels 
are high after 24 hours of HC11 seeding when cell proliferation is active and rapid. Myc mRNA 
and protein levels gradually decrease after this time point till Myc is hardly detectable by 
Western blotting. Myc expression decreases even before EGF is removed from the HC11 
Results 
 
 
 66 
medium. Finally, only after 72 hours of differentiation, mRNA levels seem to elevate while 
protein is still negligible. 
A similar analysis of Miz1 and Myc expression in HC11 cells shows that Myc levels are high in 
actively cycling cells and decrease when the cells arrest in their proliferation after removal of 
serum and growth factors from the medium (Si et al., 2010). In this publication, Miz1 levels are 
not altered in the two physiological states analysed.   
To sum up, Miz1 and Myc have an opposing regulation when HC11 cells become confluent 
(Miz1 increases its expression while Myc is downregulated), but their expression levels do not 
seem to be directly regulated by prolactin hormonal treatment or prolactin receptor downstream 
signalling. 
 
 
 
Figure 3.4: Myc expression during HC11 mammary cell growth and differentiation. (A) qPCR 
analysis of Myc gene expression normalized to GAPDH and Hprt in HC11 cells during proliferation and 
differentiation. (B) Western blot of Myc expression in HC11 cells using tubulin as a loading control. 
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3.2. MMTV-Cre mediated deletion of the Miz1 POZ domain in the virgin 
mammary gland and its effect on ductal morphogenesis and mammary 
stem/progenitor cells. 
 
3.2.1. Conditional knockout of the Miz1 POZ domain in the virgin mammary 
gland. 
 
Miz1 constitutive knockout mice are embryonic lethal at E7.5 due to massive apoptosis of 
ectodermal cells during gastrulation (Adhikary et al., 2003). In order to conditionally knockout 
Miz1 in the mammary gland, the Cre/loxP system was employed. Cre recombinase can excise a 
DNA segment by homologous recombination at a pair of 34 bp LoxP sequences which flank the 
desired genomic region to be deleted. The use of a cell specific promoter for Cre recombination 
allows the study of the function of a certain gene in a desired tissue during a particular 
developmental stage (Orban et al., 1992; Rossant and McMahon, 1999).  
In the case of the conditional deletion of Miz1, Dr. Werner Lutz engineered a plasmid in which 
the exons 3 and 4 of the Miz1 gene, which code for the POZ/BTB transactivation and 
tetramerization domain of the Miz1 protein, are flanked by LoxP sites (Fig. 3.5A). Afterwards, a 
transgenic mouse line was generated by Dr. Christian Kosan and Prof. Tarik Möröy (IRCM, 
Montreal, Canada). The knockout mice in which the POZ/BTB domain of Miz1 is excised will be 
referred to as Miz1∆POZ in this thesis.   
Miz1 gene deletion in the mammary gland was accomplished by using two distinct Cre strains 
which have different tissue specificity and temporal expression (Wagner et al., 1997) and were 
kindly provided by Prof. Lothar Hennighausen (NIDDK, Bethesda, USA). Wap (Whey acidic 
protein)-Cre is expressed specifically in mammary alveolar luminal cells during pregnancy and 
was useful for the study of the role of Miz1 in mammary differentiation and lactation. More 
details about this strain will be addressed in the Section 3.4 of the present thesis. The MMTV 
(Mouse mammary tumor virus) long terminal repeat (LTR)-Cre strain (Line A) was employed for 
the study of Miz1 function in the virgin mammary gland. Specifically, ductal morphogenesis and 
mammary stem/progenitor cell biology were investigated in Miz1∆POZ animals.  
MMTV-Cre, in the Line A mouse strain, is expressed already in the embryo and in the luminal 
and basal compartments of the adult mammary gland. It is also reported to be active in other 
tissues like oocytes, salivary gland or skin (Wagner et al., 2001). This line is not desirable for the 
study of mammary differentiation due to a lactation defect of the dams (Robinson and 
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Hennighausen, 2011; Yuan et al., 2011) but it is useful for mammary morphogenesis and stem 
cell research in the virgin gland due to the early Cre expression and its activity in mammary 
stem/progenitor cells of the newborn (Buono et al., 2006; Jiang et al., 2010).  
MMTV-Cre mediated deletion of the POZ/BTB domain of Miz1 is represented in Fig. 3.5B. Due 
to the mosaic expression of MMTV-Cre, the Miz1 recombinant band can be observed also in skin 
earclips. Cre and Miz1 genotyping of 4 knockout or Miz1∆POZ (MMTV-Cre + and Miz1lox/lox) 
and 4 wildtype/control (hereafter referred to as Ctr) animals (MMTV-Cre + and Miz1+/+) is 
shown in Fig. 3.5B. 
 
 
 
Figure 3.5: MMTV-Cre mediated Miz1 POZ domain recombination in the virgin mammary gland. 
(A) Schematic representation of the MMTV Cre-loxP system strategy used to conditionally knockout the 
exons 3 and 4 of the Miz1 gene, which code for the POZ/BTB transactivation and tetramerization domain 
of the Miz1 protein, in the virgin mammary gland. (B) Genotyping of Cre and Miz1 from earclips of 
knockout (n=4) or wildtype (n=4) mice. Fig. 3.5A was greatly inspired by Fig. 3.24 in Dr. Anneli 
Gebhardt´s thesis. 
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3.2.2. Mammary ductal morphogenesis in Ctr and Miz1∆POZ animals after 
MMTV-Cre mediated deletion. 
 
The mouse mammary gland develops from a rudimentary tree mainly postnatally. Pubertal 
mammary gland development is driven by club-shaped structures termed terminal end buds 
(TEBs). Cells of TEBs exhibit a high-rate proliferation and migration resulting in the formation 
of a ductal tree which fills the fat pad in the virgin adult mouse. This process is tightly controlled 
by estrogen and progesterone which support ductal outgrowth and branching morphogenesis, 
respectively (Hennighausen and Robinson, 2005; Macias and Hinck, 2012). 
In order to address the function of Miz1 in virgin mammary gland development, MMTV-Cre Ctr 
and Miz1∆POZ inguinal mammary glands were harvested, fixed and carmine alum-stained at 
different time points of pubertal growth. Miz1 deficient glands showed a slight developmental 
delay as observed in 30 days old mammary whole-mounts shown in Fig. 3.6. While TEBs already 
reached the lymph node in Ctr animals, the migration of the ductal tree and the formation of 
TEBs in Miz1∆POZ animals seemed to be impaired after one month of postnatal mammary 
development.  
 
 
Figure 3.6: Mammary whole-mounts of 30 days old Ctr and Miz1∆POZ animals. Representative 
stereomicroscopic pictures of carmine alum-stained 30 days old inguinal mammary glands from MMTV-
Cre Ctr (n=7) and Miz1∆POZ (n=3) dams. TEBs are indicated by arrows. 
 
After 45 days postpartum, the ductal tree of Miz1∆POZ animals reached a similar extent and size 
as in Ctr mice, except for one of the three knockout dams analysed which seemed to have a more 
severe developmental delay phenotype than its age-matched genetically identical counterparts 
(Fig. 3.7).  
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The reason for this obvious developmental deviation in Miz1∆POZ mice is currently unknown 
but could be related to the extent of Miz1 recombination due to a distinct Cre expression in the 
different animals. 
 
 
Figure 3.7: Mammary whole-mounts of 45 days old Ctr and Miz1∆POZ animals. Representative 
stereomicroscopic pictures of carmine alum-stained 45 days old inguinal mammary glands from MMTV-
Cre Ctr (n=6) and Miz1∆POZ (n=3) dams. 
 
After 65 days of virgin mammary gland development, no overt differences were observed 
between Ctr and Miz1∆POZ mice and the developmental delay phenotype is rescued (Fig. 3.8). 
The ductal tree fills the complete fat pad in both Ctr and Miz1∆POZ mice at this time point.  
 
Figure 3.8: Mammary whole-mounts of 65 days old Ctr and Miz1∆POZ animals. Representative 
stereomicroscopic pictures of carmine alum-stained 65 days old inguinal mammary glands from MMTV-
Cre Ctr (n=7) and Miz1∆POZ (n=3) dams. 
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Histological sections of 45 days old Ctr and Miz1∆POZ mammary glands were stained with 
hematoxylin and eosin (H&E) in order to examine carefully the ductal compartment. As seen in 
Fig. 3.9, the cellularity or amount of cells per duct is greatly decreased in Miz1∆POZ mice. This 
phenotype could be explained by the decreased proliferation observed in ducts from Miz1∆POZ 
mice, probably due to reduced levels of the EGF-like ligand amphiregulin (data not shown; 
collaboration with Hedyeh Kiaveh). However, the expression of luminal (E-cadherin and ß-
catenin) and basal (SMA and cytokeratin 14) markers was not seemingly different in Ctr and 
Miz1∆POZ 45 days old virgin mammary glands (data not shown; collaboration with Hedyeh 
Kiaveh). 
 
Figure 3.9: H&E staining of 45 days old mammary ducts. Representative pictures of hematoxylin and 
eosin-stained (H&E) and transversally cut mammary ducts of MMTV-Cre Ctr and Miz1∆POZ animals 
after 45 days of postpartum development are shown. Scale bar: 50 µm.  
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3.2.3. MMTV-Cre Miz1∆POZ animals accumulate mammary stem/progenitor 
cells 
 
The function of Miz1 in mammary stem/progenitor cells was investigated using Ctr and 
Miz1∆POZ MMTV-Cre virgin animals as a source of primary cells. The mammary gland serves 
as a convenient system for stem/progenitor cell research due to the possibility of transplantation 
of mammary tissue into a cleared fat pad (Deome et al., 1959) and to the ability of mammary 
stem cells to form undifferentiated cellular spheres, termed mammospheres, when cultured in 
serum-free methylcellulose-based medium (Dontu et al., 2003). The latter method derives from 
the use of neurospheres for the study of neural stem cells (Reynolds et al., 1992). Mammospheres 
are able to self-renew and differentiate in the absence of attachment to any substratum and the 
mammary stem/progenitor cells contained in a sphere are able to form colonies which express 
markers of all three lineages of the adult mammary gland (Dontu and Wicha, 2005a). It is 
possible to estimate the frequency of stem/progenitor cells in a particular cellular population by 
using this method, but mammospheres can only be cultivated for several passages in vitro and not 
indefinitely due to occurrence of cellular senescence (Dey et al., 2009a).   
Culture of primary mammary cells as mammospheres was employed in order to investigate if 
Miz1 has any impact on the frequency of mammary stem/progenitor cells in vivo. Two pairs of 
mammary glands (thoracic and inguinal) from virgin MMTV-Cre Ctr (n=5) and Miz1∆POZ 
(n=4) animals were subjected to chemical digestion by a mix of collagenase and hyaluronidase, 
and after several treatments, described in detail in Material & Methods, cells were counted and 
seeded into 24-well low-attachment plates which contained medium with 1% methylcellulose. 4 
technical replicates per animal were used in all passages.  
After two weeks encompassing the formation of primary spheres, these were disaggregated, cells 
were counted and 2000 cells per well were seeded. Another two weeks of culture yielded 
secondary mammospheres which were quantified. Results from these experiments are shown in 
Fig. 3.10A. The number of secondary mammospheres formed was significantly higher (about 3-
fold) when cells were isolated from Miz1∆POZ mammary glands. To test the hypothesis of 
accumulation of stem/progenitor cells in Miz1∆POZ animals, these secondary spheres were 
disaggregated, counted and 2000 cells per well were seeded. As shown in Fig. 3.10B, the number 
of tertiary spheres was again significantly higher when mammary cells derived from Miz1∆POZ 
mice. Although the tertiary sphere number was greatly reduced in comparison to the number of 
secondary spheres in both Ctr and Miz1∆POZ animals, possibly due to cellular senescence (Dey 
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et al., 2009a), the relative amounts were similar to the ones measured for secondary spheres: 
about 3-fold more mammospheres in Miz1∆POZ mice. Representative pictures of secondary 
mammospheres obtained are shown in Fig. 3.10C. Although the number of secondary and tertiary 
spheres formed is higher in cells derived from Miz1∆POZ mammary glands, the sizes of growing 
secondary spheres measured were not significantly different between Ctr and Miz1∆POZ animals 
as shown in Fig. 3.10D (mammosphere diameters were measured using ImageJ software). Taken 
together, a higher frequency of stem/progenitor cells was observed when primary cells from 
Miz1∆POZ animals were seeded for the formation of secondary and tertiary mammospheres, but 
no differences in sphere size were found between Ctr and Miz1∆POZ mice.  
 
 
 
Figure 3.10: Stem/progenitor cells accumulate in Miz1∆POZ mammary glands. (A and B) 
Representation of the number of secondary and tertiary mammospheres quantified two weeks after 
seeding 2000 cells per well in methylcellulose-based medium. Primary cells from 5 Ctr and 4 Miz1∆POZ 
MMTV-Cre virgin mice, using 4 technical replicates per animal, were scored. (C) Representative pictures 
of Ctr and Miz1∆POZ secondary mammospheres. (D) Diameters of growing secondary spheres from 3 Ctr 
and 2 Miz1∆POZ animals were measured using ImageJ software. Scale bar in C: 50 µm. 
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The expression of different stem cells markers was analysed by quantitative PCR (qPCR) in 
mammary glands of 45 days old Ctr and Miz1∆POZ animals. This approach resulted in the 
discovery of a highly active Hedgehog pathway in Miz1∆POZ mice (data not shown; 
collaboration with Hedyeh Kiaveh). Miz1 has been recently described as a positive regulator of 
the Hedgehog pathway in vitro (Lu et al., 2013a) but its impact on the regulation of this 
signalling cascade in vivo has not been addressed in this recent report. Further experiments are 
required to elucidate the reason for the accumulation of stem/progenitor cells in Miz1∆POZ 
mammary glands and to determine the role of Miz1 in the Hedgehog pathway in vivo. 
 
3.3. Role of the interaction of Miz1 and Myc in mammary stem/progenitor 
cell biology and adipocyte differentiation.  
 
The transcription factor c-Myc plays a major role in stem cell biology (Laurenti et al., 2009) and 
its properties in cellular reprogramming have been widely investigated using the induced 
pluripotent stem cell (iPS) technology (Folmes et al., 2013; Nakagawa et al., 2010; Takahashi 
and Yamanaka, 2006). Deletion of Myc from the mammary epithelium leads to impaired stem 
cell self-renewal and to a decreased population of luminal progenitors (Moumen et al., 2012; 
Stoelzle et al., 2009). Myc overexpression, using MMTV-c-Myc animals, is accompanied by an 
increased proportion of ductal cells in relation to lobular cells and an alteration of the stem cell 
niche (Chepko et al., 2005). 
After assessing the increased mammary stem/progenitor cell frequency in Miz1∆POZ animals 
described above, the next step was to test whether the phenotype observed was dependent on the 
interaction of Miz1 with Myc. Myc interacts with Miz1 through a region outside the helix-loop-
helix domain of Myc and a specific Myc mutant (MycV394D) can still transactivate gene 
expression via binding with Max, but cannot repress gene expression by association with Miz1 
(Herold et al., 2002). Subsequently, MycVD/VD knock-in animals were generated by Dr. Christian 
Kosan and Prof. Tarik Möröy (IRCM, Montreal, Canada). Thoracic and inguinal mammary 
glands from these mice (Myc+/+ as control and MycVD/VD) were digested and seeded for 
mammosphere formation using methylcellulose-based medium in analogy to the experiments 
performed with Miz1∆POZ animals. As represented in Fig. 3.11, the number and sizes of 
secondary (Fig. 3.11A and B) and tertiary (Fig. 3.11C and D) mammospheres originated from 
Myc+/+ and MycVD/VD mammary tissue were not significantly different after seeding 2000 cells 
per well in both passages.  
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Figure 3.11: Mammosphere number and size in Myc+/+ and MycVD/VD animals. (A) Example of 
genotyping of 6 Myc+/+ and 2 MycVD/VD animals. (B) Representative pictures of secondary mammospheres 
formed. Number (C and E) and size (D and F) of secondary and tertiary mammospheres, respectively, 
originated after seeding 2000 mammary cells per well from 4 Myc+/+ and 3 MycVD/VD mice. 4 technical 
replicates per animal were used. Scale bar in B: 100 µm. 
 
As can be seen in Fig. 3.11E, secondary mammospheres were not overtly different 
morphologically in Myc+/+ and MycVD/VD animals. Taken together, the abolishment of the 
interaction between Miz1 and Myc did not affect the frequency of stem/progenitor cells and the 
size of the spheres, using MycVD/VD knock-in animals as a model system. Thus, the increased 
numbers of stem/progenitor cells observed in Miz1∆POZ glands may occur by a Myc-
independent mechanism. 
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In order to investigate if the interaction between Miz1 and Myc has any effect on 3D culture 
morphogenesis, cells isolated from Myc+/+ and MycVD/VD mammary glands were seeded on Lab-
Tek chambers (Nunc, Thermo Scientific) coated with basement membrane extract (Cultrex, 
Trevigen) at a density of 12500 cells/ml. This extract is purified from Engelbreth-Holm-Swarm 
(EHS) sarcomas and includes laminin, collagen IV, entactin and heparin sulfate proteoglycan. 
Representative pictures of the culture, which spanned 21 days, are shown in Fig. 3.12. 
 
Figure 3.12: 3D culture of primary cells from Myc+/+ and MycVD/VD mammary glands. Representative 
pictures of the growth and differentiation of primary cells from Myc+/+ (n=4) and MycVD/VD (n=3) 
mammary glands cultured on a basement membrane matrix. Scale bar in B: 50 µm. 
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The protocol used has been described in the literature (Debnath et al., 2003) and details can be 
found in the Materials & Methods section. The primary cells seeded could have arisen from 
epithelium or from the stromal compartment of the virgin mammary gland as whole thoracic and 
inguinal glands were enzymatically digested in order to obtain single-cell suspensions. In the 
presence of the basement membrane matrix (Cultrex, Trevigen) a fraction of the mammary gland 
cells isolated, most possibly preadipocytes of stromal origin, differentiated and started producing 
large droplets after one week of culture. Adipocytes successfully grow on matrigel-based culture 
(Hazen et al., 1995) and, most interestingly, around 60% of stromal cells harvested from human 
adipose mammary tissue have been shown to differentiate into adipocytes in the presence of 
matrigel (O’Connor et al., 2003). As described in the latter article, other extracellular matrix 
substrata have less efficiency inducing de novo lipogenesis: 5% of the cells differentiated into 
adipocytes on fibronectin and 13-28% on tissue culture plastic and collagen I. 
To characterize the droplets formed by primary mammary cells in 3D culture, a Sudan Black 
staining was carried out confirming their lipidic nature (Fig. 3.13A). Lipid droplets were not 
visible in any cell from both genotypes in the first 4 days of culture. After one week, 47.06 ± 
24.77% of all Myc+/+ seeded cells had differentiated into lipid-droplet-producing adipocytes but 
only 9.47 ± 4.76% of MycVD/VD cells had done so at this time point (Fig. 3.13C). After 10 days of 
culture, the Myc+/+ cells producing lipid droplets expanded to 73.23 ± 13.20% of the total cells 
while the percentage of MycVD/VD which had undergone functional differentiation to produce 
lipids was of only 24.30 ± 4.78%. The culture continued till 21 days after seeding but the 
proportion of differentiated cells between Myc+/+ and MycVD/VD mammary primary cells was not 
markedly altered during the period ranging from 10-21 days of culture (Fig. 3.13C). 
The number of primary mammary gland cells seeded per well was the same from both genotypes 
and no lipid droplets were observed at the beginning (first four days) of the culture. Then, either 
the amount of preadipocytes originally present in MycVD/VD mammary tissue was low or 
MycVD/VD preadipocytes were not efficiently differentiating and producing lipid droplets in the 
absence of a functional Miz1/Myc complex. More experimental data would be required to 
ascertain which of these two possible explanations is more accurate. 
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Figure 3.13: Lipid staining and quantification of the percentage of Myc+/+ and MycVD/VD adipocytes. 
(A) Sudan Black staining demonstrated the lipidic nature of the droplets analysed. (B) MycVD/VD cell 
showing negativity after Sudan Black staining. (C) Quantification of the percentage of primary cells 
derived from Myc+/+ and MycVD/VD mammary glands which produced lipid droplets in the 21 days of 
culture. A two-way ANOVA with a Bonferroni's post-hoc test was used for statistical analysis. Scale bar 
in B: 50 µm. 
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3.4. Wap-Cre mediated deletion of the Miz1 POZ domain in the pregnant 
mammary gland causes a lactation defect by attenuated Stat5 expression 
and phosphorylation. 
 
3.4.1. Conditional knockout of the Miz1 POZ domain in the pregnant and 
lactating mammary gland. 
 
In analogy to the mouse model used for the deletion of the POZ domain of Miz1 in the virgin 
mammary gland, Miz1lox/lox mice (Gebhardt et al., 2007) were crossed to Whey acidic protein 
(Wap)-Cre animals (Wagner et al., 1997) in order to conditionally knockout the Miz1 POZ 
domain in luminal mammary epithelial cells during late pregnancy and lactation (Fig. 3.14). Prior 
to mating, both lines were backcrossed six generations to a 129S2/SvHsd background. 
 
 
 
Figure 3.14: Conditional deletion of the Miz1 POZ domain in luminal mammary epithelial cells 
during pregnancy and lactation. (A) Schematic representation of the Wap-Cre mediated recombination 
strategy used to delete the exons which code for the Miz1 POZ domain and the relative position of the 
primers to detect it (Gebhardt et al., 2007). (B) Time course of the appearance of the Miz1 recombinant 
band performed on genomic DNA isolated from mammary glands at the indicated time points. 
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Wap promoter expression is more restricted to mammary epithelium than MMTV. As described 
before, MMTV-Cre recombination is detectable also in the salivary gland, the Harderian gland, 
seminal vesicles and lymphoid cells, while Wap deletion is specific for luminal epithelial 
mammary cells with expression in other tissues being several orders of magnitude lower than in 
the mammary gland (Pittius et al., 1988; Wagner et al., 1997). Wap-Cre represents a suitable 
model for the study of mammary differentiation during pregnancy and lactation in vivo due to the 
specificity of the deletion and precise timing. As can be seen in Fig. 3.14B, the appearance of the 
Miz1 recombinant band after PCR amplification occurs during mid-pregnancy and is sustained 
throughout lactation as already reported for the Wap-Cre mouse line (Wagner et al., 1997).  
Immunohistochemistry against Cre (Stoelzle et al., 2009) was performed on mammary gland 
sections during pregnancy and lactation and its nuclear expression could be detected at the end of 
pregnancy (pregnancy day 18.5) and during lactation (lactation days 1 and 6; day 6 not shown) in 
the luminal mammary epithelium of the forming alveoli but not in the stroma (Fig. 3.15). Cre 
expression at day 14.5 of pregnancy was almost negligible by immunohistochemical analysis 
(Fig. 3.15A) although the Miz1 recombinant band was already visible at this time point after PCR 
amplification (Fig. 3.14B). Taken together, the Miz1 POZ domain was efficiently recombined in 
vivo using the Wap-Cre promoter in the luminal mammary epithelial compartment starting at 
mid-pregnancy and during lactation. 
Due to the fact that Cre expression could affect mammary differentiation as reported for the 
MMTV-Cre model (Robinson and Hennighausen, 2011; Yuan et al., 2011) only Wap-Cre 
positive animals (Wap+ Miz1+/+ or Ctr and Wap+ Miz1lox/lox or Miz1∆POZ) were employed to 
study the role of Miz1 during mammary differentiation in vivo.  
Wap-Cre females of both genotypes were mated at 65 dpp for 1st pregnancy/lactation analysis 
and 2 weeks after completion of the 1st lactation for the study of the 2nd pregnancy/lactation. For 
pregnancy samples, mating plugs were checked every day and mammary dissection was 
performed at the indicated time points. 
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Figure 3.15: Cre immunohistochemistry in pregnant and lactating Ctr mammary glands. (A) Cre 
expression was analysed via peroxidase immunostaining in paraffin-embedded sections of Ctr mammary 
glands at pregnancy days 10.5 (n=2), 14.5 (n=2) and 18.5 (n=3) and lactation days 1 (n=3) and 6 (n=4; 
data not shown). (B) Higher magnification pictures of the Cre staining at pregnancy day 18.5 and lactation 
day 1. Scale bars: 50 µm. 
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3.4.2. Miz1∆POZ females feature a lactation defect. 
 
Newborn pup weights (Palmer et al., 2006) were monitored for 24 days after being fostered by 
Ctr and Miz1∆POZ mothers. The number of pups per mother was set to six at birth and the 
offspring from six mothers per genotype were analysed (n=6). No significant difference was 
observed on day 3 postpartum (3 dpp), but at 6 dpp the weight of the pups nursed by Miz1∆POZ 
mothers was significantly reduced (p<0.01) and this difference increased until 24 dpp (p<0.001; 
Fig. 3.16A). The described variation in weight from the age-matched pups was sex-independent 
(Fig. 3.16B). In conclusion, Miz1∆POZ mothers featured a lactation defect and their pups were 
found significantly smaller than the ones fostered by Ctr dams between 6 and 24 days of age in 
the period of time analysed. 
 
  
 
Figure 3.16: Miz1∆POZ mothers feature a lactation defect. (A) Pup weights of the offspring nursed by 
Ctr (black, n=6) and Miz1∆POZ (blue, n=6) mothers during 24 days postpartum. A two-way ANOVA 
followed by a Bonferroni's post-hoc test for multiple pairwise comparisons was employed for pup weight 
analysis. (B) Size differences were gender-independent. A representative picture of 24 days old male and 
female mice fostered by either Ctr or Miz1∆POZ mothers is shown. 
 
Hematoxylin and eosin (H&E) stainings revealed a higher proportion of adipose tissue in sections 
from Miz1∆POZ mammary glands compared to Ctr animals at lactation day 6 (Fig. 3.17A). This 
phenotype was also observed after a second pregnancy (Fig. 3.17A) and was further proved by 
carmine alum-stained whole-mount mammary preparations. In these, Miz1∆POZ mammary 
glands exhibited less alveolar density in lactation day 1 as shown in Fig. 3.17B.    
In order to quantify the proportion of adipose tissue in lactation day 6 samples from Ctr and 
Miz1∆POZ mammary glands, a morphometric approach was used. The percentage of fat was 
calculated measuring the area occupied by adipocytes and the total area of mammary gland in 
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H&E stained mammary sections corresponding to first and second pregnancies. The wand tool of 
ImageJ 1.43u software was employed for this quantification (Fig. 3.18). As shown in Fig. 3.17C, 
the percentages of fat measured in lactation day 6 first pregnancy sections were in average 2.65% 
in Ctr and 14.39% in Miz1∆POZ mammary glands (n=4; p=0.021). After a second pregnancy, the 
adipocyte proportion at lactation day 6 was 3.71% in Ctr and 16.55% in Miz1∆POZ glands (n=3; 
p=0.041). 
 
 
Figure 3.17: Increased proportion of adipose tissue in early lactation Miz1∆POZ mammary glands. 
(A) Representative H&E stainings of lactation day 6 mammary glands from Ctr and Miz1∆POZ animals. 
The first two pregnancies are shown. (B) Carmine-alum stained mammary whole-mount preparations at 
lactation day 1. (C) Adipocyte percentage quantification in lactation day 6 sections from Ctr and 
Miz1∆POZ mammary glands. Scale bar in A: 500 µm. 
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Thus, the difference in the ratio of glandular to adipose tissue measured during early lactation 
was similar after the first and second pregnancies.  
 
 
 
Figure 3.18: Quantification of the proportion of adipose tissue at lactation day 6 using ImageJ 
software. 10 pictures per animal were used for the analysis of first pregnancy (n=4 per genotype) and 
second pregnancy (n=3 per genotype) lactation day 6 sections of Ctr and Miz1∆POZ mammary glands. 
The wand tool of ImageJ 1.43u software was employed to calculate the adipocyte area in relation to the 
total mammary gland area in each sample. Scale bar: 30 µm. 
 
 
No marked differences were observed in H&E sections from Ctr and Miz1∆POZ mammary 
glands at first pregnancy day 18.5 (Fig. 3.19A and B). This observation might be related to the 
expression of endogenous Miz1 which, as already mentioned in Section 3.1.1, was hardly 
detectable by Western Blotting at the end of pregnancy. 
The reduced alveologenesis phenotype only became apparent at lactation day 1 (Fig. 3.19C and 
D), obvious at lactation day 6 (Fig. 3.19E and F) and partially rescued by lactation day 10 (Fig. 
3.19G and H). Taken together, the data indicate that Miz1∆POZ glands suffered a delay in 
alveolar development during early lactation which caused the nursing defect in mutant dams. 
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Figure 3.19: Representative H&E sections of Ctr and Miz1∆POZ mammary glands at different 
stages of pregnancy and lactation. The following time points were analysed: (A, B) Pregnancy day 18.5 
(n=3). (C, D) Lactation day 1 (at least n=3). (E, F) Lactation day 6 (n=8). (G, H) Lactation day 10 (n=4). 
Scale bar in B: 300 µm.  
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3.4.3. Apoptosis during lactation in Ctr and Miz1∆POZ mammary glands. 
 
One possible explanation for the reduced alveologenesis in Miz1∆POZ animals could be the 
occurrence of mammary epithelial cell apoptosis in mutant glands. To test this hypothesis, 
terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assays (Gavrieli et al., 
1992) and cleaved caspase-3 immunohistochemistry were performed on lactation day 1 and 6 
samples of Ctr and Miz1∆POZ first pregnancy mammary gland sections. TUNEL positive cells 
were rare in both Ctr and Miz1∆POZ mammary sections as can be seen in Fig. 3.20A-D.  
 
 
 
Figure 3.20: Apoptosis during lactation in Ctr and Miz1∆POZ mammary glands. TUNEL assay 
pictures and quantifications performed on Ctr and Miz1∆POZ sections at lactation days 1 (A, B) and 6 (C, 
D). TUNEL positive cells were quantified in 20x magnification mammary pictures (10 per animal) and at 
least 3 animals per genotype and time point were analysed. (E) Immunohistochemistry against cleaved 
caspase-3 in lactation day 6. Scale bars: 50 µm. 
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TUNEL positive cells were quantified in 20x magnification mammary pictures (10 per animal) 
and at least 3 animals per genotype and time point were analysed. In lactation day 1, 0.63 ± 0.23 
TUNEL positive cells per 20x picture were scored in Ctr while 0.55 ± 0.17 were found in 
Miz1∆POZ sections (Fig. 3.20B; p=0.6059). In lactation day 6, 0.25 ± 0.19 positive cells per 20x 
picture were observed in Ctr, whereas 0.13 ± 0.06 were counted in mutant glands (Fig. 3.20D; 
p=0.3632). In conclusion, no significant differences in DNA fragmentation, characteristic of a 
late stage of apoptosis, were found in Ctr and Miz1∆POZ lactation days 1 and 6 sections. These 
observations were further confirmed by cleaved caspase-3 immunohistochemistry at lactation 
days 1 (data not shown) and 6 (Fig. 3.20E). As for the TUNEL assay, at least 3 animals per 
genotype and time point were used. Taken together, apoptosis was not different between Ctr and 
Miz1∆POZ animals during early lactation and thus this process cannot explain the reduced 
alveolar density observed in Miz1∆POZ mice. 
 
3.4.4. Reduced proliferation during lactation in Miz1∆POZ mammary glands. 
 
Proliferation of mammary cells from Ctr and Miz1∆POZ animals was assessed by Ki67 
immunohistochemistry in lactation day 6 histological sections after a first pregnancy. A reduction 
in the number of positive cells and a decreased staining intensity were observed in Miz1∆POZ 
samples as shown in several magnifications in Fig. 3.21. While Ki67 positive cells were detected 
in the lymph nodes of both Ctr and Miz1∆POZ mammary glands (Fig. 3.21B), alveolar cells from 
Miz1∆POZ mice had an obvious reduction in Ki67 staining positivity.  
The Ki67 labelling index was then calculated in Ctr and Miz1∆POZ sections at lactation day 6 by 
counting Ki67 positive cells among all epithelial cells in representative 25x pictures using ImageJ 
software. More than 1000 cells per animal were scored in 3 animals per genotype (n=3). As 
represented in Fig. 3.22A, 50.40 ± 3.63% of the cells analysed were positive for Ki67 in Ctr 
animals while only 14.26 ± 0.89% were found to express Ki67 in Miz1∆POZ sections 
(p<0.0001). The Ki67 mRNA (Mki67) was also reduced in Miz1∆POZ glands as analysed by 
qPCR, but this difference was statistically not significant (p=0.0575; Fig. 3.22A). In conclusion, 
a reduced proliferation was observed in Miz1∆POZ sections at lactation day 6 compared to Ctr 
mammary glands. 
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Figure 3.21: Decreased proliferation in Miz1∆POZ glands at lactation day 6. Ki67 immunostaining is 
shown in lower and higher magnification for Ctr and Miz1∆POZ glands at lactation day 6 (A and B). As 
can be seen in B (lower pictures), lymph nodes exhibit cells strongly stained for Ki67 in both Ctr and 
Miz1∆POZ animals. In contrast, alveolar mammary gland cells from Miz1∆POZ mice displayed a much 
lower number of Ki67 positive nuclei. At least n=3 animals per genotype were used. Scale bars: 50 µm 
and 10 µm in inset from B. 
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The Miz1/Myc complex is a critical repressor of the cell cycle arrest gene Cdkn1a (Seoane et al., 
2002; Wu et al., 2003a; Hönnemann et al., 2012), encoding p21cip1, but the expression of Cdkn1a 
(p=0.3823) and Myc (p=0.5281) was not significantly altered in Miz1∆POZ mammary glands at 
lactation day 6 as analysed by qPCR (Fig. 3.22B). Taken together, the delay in mammary gland 
alveolar development during early lactation was influenced by a reduced proliferation of 
Miz1∆POZ epithelial cells and this was not caused predominantly due to overexpression of 
p21cip1 or an attenuated expression of Myc. Another potential candidate molecule for explaining 
the reduced proliferation phenotype in Miz1∆POZ lactating mammary glands will be addressed in 
the Section 3.4.8.  
 
 
Figure 3.22: Quantification of Ki67 staining and proliferation-related gene expression in Ctr and 
Miz1∆POZ mammary glands at lactation day 6. (A) On the left side, the percentage of Ki67 positive 
cells in histological sections from lactation day 6 animals was quantified using ImageJ software 
(p<0.0001). More than 1000 cells per animal were scored in 3 animals per genotype (n=3). On the right 
side, qPCR data of Mki67 expression in lactation day 6 samples (p=0.0575). (B) qPCR relative expression 
of Cdkn1a and Myc in Ctr and Miz1∆POZ glands at lactation day 6 (n=3 for all qPCR data shown).  
 
 
3.4.5. Morphogenetic 3D culture of HC11 cells and consequences after Miz1 
knockdown: unaltered apoptosis, reduced proliferation and delayed acinar 
lumen formation. 
 
HC11 mammary cells (Ball et al., 1988) were used as an in vitro model to study Miz1 function on 
cellular proliferation and apoptosis trying to test if parallelisms exist with the in vivo deletion of 
the Miz1 POZ domain described above. In addition, the impact of Miz1 in 3D mammary acinar 
formation was investigated. Stably-transfected HC11 cells with expression vectors encoding for 
either a scrambled short hairpin RNA used as control (shscr) or a Miz1 specific short hairpin 
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RNA to knockdown Miz1 (shMiz1) were generated (Fig. 3.23B). These cells were then cultured 
in an acinar morphogenetic in vitro assay already described (Debnath et al., 2003; Hebner et al., 
2008; Xian, 2005) where Cultrex basement membrane extract (Trevigen) was used to coat 
sterilized coverslips. In these conditions and with medium containing 2% Cultrex, mammary 
cells proliferate and then form growth-arrested polarized acini. After 6-8 days of culture a lumen 
starts to be discernible in the center of these structures as a consequence of cellular apoptosis 
(Debnath et al., 2002) and autophagy (Avivar-Valderas et al., 2011; Debnath, 2008). 
 
 
 
Figure 3.23: Three-dimensional culture of shscr and shMiz1 HC11 cells. (A) Representative confocal 
microscopy pictures of acinar structures formed by shscr and shMiz1 HC11 cells. Nuclei were stained 
with Hoechst (blue), actin filaments with Phalloidin-TRITC (red) and apoptotic cells with cleaved 
caspase-3 (green). (B) Western blot showing the knock-down of Miz1 in shMiz1 HC11 cells.  
(C) Quantification of the number of nuclei per acinus in shscr and shMiz1 HC11 cells merging data from 
two independent experiments. Acinar cell proliferation and apoptosis were quantified by analysis of Ki67 
(E) and cleaved Caspase-3 (F) positivity (D; cleaved Caspase-3: green and Ki67: yellow). Stainings and 
quantifications were performed by David Fuhrmann. Scale bars: 25 µm. 
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Representative pictures of acinar structures formed 6, 8 and 10 days after the seeding of shscr and 
shMiz1 expressing HC11 cells are shown in Fig. 3.23A. In this figure, phalloidin (red) was used 
to stain actin filaments of the cytoskeleton and cleaved caspase-3 (green) fluorescent 
immunostaining was employed to assess apoptosis at the indicated time points (Fig. 3.23A). As 
in Miz1∆POZ mammary glands in vivo, quantification of the number of cleaved caspase-3 
positive cells per acinus revealed no significant differences in apoptosis between shscr and 
shMiz1 expressing HC11 cells (Fig. 3.23F). 
The number of nuclei per acinus was quantified at the time points mentioned above. After 6 days 
of seeding, no significant differences were observed between shscr and shMiz1 HC11 cells. In 
contrast, after 8 and 10 days of culture, the number of nuclei per acinus was lower in HC11 cells 
with decreased levels of Miz1 (Fig. 3.23C). Moreover, Ki67 (yellow) fluorescent staining (Fig. 
3.23D) and quantification of Ki67 positive cells per acinus (Fig. 3.23E) revealed a significantly 
diminished proliferation of shMiz1 HC11 cells at 6 days post-seeding (p=0.0007). Thus, a 
parallelism can be drawn with the in vivo situation where apoptosis is not altered and 
proliferation is decreased in the absence of a functional Miz1. In addition, the establishment of a 
lumen was delayed in shMiz1 HC11 cells (data not shown).  
 
3.4.6. Reduced differentiation during lactation in Miz1∆POZ mammary 
glands. 
 
Despite the fact that mammary alveolar cell density was similar between Ctr and Miz1∆POZ 
animals at lactation day 10 (Fig. 3.19G and H), the difference in pup weights was not rescued and 
even increased over time (Fig. 3.16A). In order to identify genes potentially regulated by Miz1 
which could explain the observed lactation defect phenotype and to assess the relative expression 
of milk protein genes, a genome-wide cDNA microarray was performed using samples from Ctr 
and Miz1∆POZ animals obtained at day 6 of lactation (n=4 for each genotype). 
The expression of distinct casein genes (Csn1s1, Csn1s2a, Csn1s2b, Csn2, Csn3) and the whey 
acidic protein gene (Wap) was up to 2.5fold downregulated in mutant animals (later represented 
in Fig. 3.32). These observations could be confirmed by qPCR which showed a twofold 
downregulation in Miz1∆POZ glands of the genes encoding for α-casein (p=0.0003), ß-casein 
(p=0.0006) and whey acidic protein (p=0.0058) as represented in Fig. 3.24A. Moreover, less ß 
casein protein was detected by western blotting in mammary gland tissue from Miz1∆POZ 
animals at lactation day 6 (Fig. 3.24B). A decreased amount of milk was observed in the alveoli 
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from mutant animals compared with control animals (Fig. 3.24C) on sections of lactation day 6 
mammary glands, stained with an antibody against mouse milk proteins (Merlo et al., 1994). 
Collectively, the data show that differentiation of mammary gland epithelial cells is diminished in 
Miz1∆POZ glands leading to a reduced synthesis and secretion of several milk proteins. 
 
Figure 3.24: Decreased differentiation in Miz1∆POZ glands at lactation day 6. (A) qPCR data of the 
expression of the genes which code for milk proteins α-casein, β-casein and Wap in samples taken from 
Ctr and Miz1∆POZ animals at lactation day 6. (B) ß-casein western blot at lactation day 6. Each lane 
represents an individual animal. (C) Milk proteins immunofluorescence in mammary tissue from Ctr and 
Miz1∆POZ mice at lactation day 6. Scale bar in C: 50 µm. 
 
 
3.4.7. Reduced differentiation in HC11 cells with low levels of Miz1. 
 
In order to investigate whether the reduced differentiation phenotype observed in Miz1∆POZ 
animals can also be recapitulated on a cellular basis in vitro, we again took advantage of the 
HC11 cell line. These immortalized mid-pregnant mammary gland cells can undergo a limited 
differentiation after hormonal treatment and stimulate the synthesis of different milk proteins 
(Ball et al., 1988). A schematic representation of the protocol followed for HC11 differentiation 
is shown in Fig. 3.25A and a description of it was already provided in Section 3.1.3. The 
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expression of the csn2 gene (Fig. 3.25C) and the amount of translated ß-casein protein (Fig. 
3.25D) detected 24, 48 and 72 hours after adding the hormonal cocktail DIP (containing 
dexamethasone, insulin and prolactin) were lower in HC11 cells with decreased levels of Miz1 
(shMiz1).  
 
Figure 3.25: Reduced expression of the differentiation marker ß-casein in HC11 cells with low levels 
of Miz1. (A) Protocol for the differentiation of HC11 mammary cells. Each rectangle represents one day.  
EGF: epidermal growth factor; DIP: differentiation media containing dexamethasone, insulin and 
prolactin. Time points indicated correlate to the ones in C and D. (B) HC11 cells were stably transfected 
with scrambled short hairpin RNA (shscr), a Miz1 shRNA (shMiz1) and a vector overexpressing Miz1 as 
a positive control (↑Miz1). Semi-quantitative PCR (C) and western blotting (D) revealed a decreased 
expression of ß-casein when Miz1 levels were low (shMiz1). 
 
In conclusion, decreasing the levels of Miz1 in HC11 cells in vitro led to a reduced expression of 
the differentiation marker ß-casein. Thus, the diminished expression of milk protein genes 
observed in Miz1∆POZ lactating dams in vivo could be cell autonomous and not due only to an 
increased proportion of adipose tissue in mutant glands. 
 
3.4.8. Deficient Stat5 signalling in Miz1∆POZ mammary glands. 
 
Signal Transducer and Activator of Transcription 5a and 5b (Stat5a/b) are essential for proper 
adult mammary gland proliferation, differentiation and survival (Furth et al., 2011; Hennighausen 
and Robinson, 2008). Mammary alveolar formation and lactogenesis are severely impaired in the 
absence of Stat5 signalling as seen in knockout in vivo mouse models (Liu et al., 1997; Teglund 
et al., 1998; Cui et al., 2004). 
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In order to investigate whether Stat5a/b levels were altered in Miz1∆POZ glands, qPCRs and 
Western blots were performed at lactation day 6 after a first pregnancy. The expression of the 
genes Stat5a (p=0.1671) and Stat5b (p=0.0607) was slightly but not significantly decreased in 
mutant glands. Using an antibody which recognizes both Stat5 isoforms, Western blotting 
showed an obvious reduction in the levels of Stat5a/b proteins in Miz1∆POZ glands (Fig. 3.26B). 
The mammary epithelial cell-specific cytokeratin-18 and α-tubulin, which has a very low 
expression in adipose tissue (Spiegelman and Farmer, 1982), were employed as loading control. 
In addition, immunohistochemistry against phosphorylated Stat5 (Tyr694) revealed a diminished 
number of positive nuclei and a decreased staining intensity in mutant mammary gland tissue at 
lactation day 6 (Fig. 3.26C). 
  
 
Figure 3.26: Deficient Stat5 signalling in Miz1∆POZ glands at lactation day 6. (A) The expression of 
the genes Stat5a and Stat5b was analysed by qPCR in Ctr and Miz1∆POZ mammary glands (n=3) at 
lactation day 6. (B) Western blotting of Stat5a/b protein at lactation day 6. Each lane represents an 
individual animal. α-Tubulin and cytokeratin-18 were used as loading controls. (C) pSTAT5 (Tyr694) 
protein was detected by immunohistochemistry in lactation day 6 sections of control and mutant glands 
(first pregnancy samples are shown). Scale bar in C: 50 µm. 
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A reduced phosphorylation of Stat5 in vivo was detected by immunostaining also after a second 
pregnancy (data not shown). In conclusion, a deficient Stat5 signalling, crucial for proper 
mammary cell proliferation and differentiation, led to reduced mammary alveolar density and a 
lactation defect in Miz1∆POZ mothers. 
 
3.4.9. Deficient Stat5 signalling in shMiz1 HC11 mammary cells. 
 
HC11 mammary cells were used again to test whether the deficient Stat5 signalling observed in 
Miz1∆POZ glands also occurred in vitro when Miz1 levels are knocked down. After addition of 
the lactogenic cocktail (DIP) in the already described HC11 differentiation protocol (Fig. 3.27A), 
Stat5 was phosphorylated and could be detected after 24 hours of the hormonal induction, as 
previously reported (Schmitt-Ney et al., 1992). The protein levels of Stat5a/b and pStat5a/b were 
analysed by western blotting at the moment of adding the hormones (time 0 hours) and 24, 48 
and 72 hours after the start of differentiation in control (shscr) and low Miz1 expressing (shMiz1) 
HC11 cells. Stat5a/b protein after Miz1 knockdown was not as obviously reduced as in vivo but 
the detected pStat5a/b was greatly decreased in shMiz1 HC11 cells at the different time points 
analysed after the induction of differentiation with the lactogenic hormonal cocktail (Fig. 3.27B). 
 
 
 
Figure 3.27: Deficient Stat5 signalling in differentiating shMiz1 HC11 cells. (A) HC11 differentiation 
protocol representing the time points analysed. Protein samples were obtained at the moment of adding the 
lactogenic hormone cocktail (time 0 hours) and 24, 48 and 72 hours after the induction of differentiation 
(+DIP). (B) The levels of Stat5a/b and pStat5a/b (Tyr 694/699) were detected by Western blotting in 
control (shscr) and low Miz1 (shMiz1) HC11 cells at the time points indicated. α-Tubulin was used as a 
loading control. 
 
Results 
 
 
 96 
To sum up, Stat5 phosphorylation is diminished in vivo and in vitro when a functional Miz1 is 
lacking and this observation correlates with the decreased proliferation and differentiation 
detected in Miz1∆POZ lactation day 6 mammary glands and shMiz1 HC11 cells. 
 
3.4.10. Gene expression analysis of Stat5 pathway regulators. 
 
The expression of different Janus kinase 2 (Jak2)/Stat5 pathway components was analysed by 
qPCR in Ctr and Miz1∆POZ mammary glands at lactation day 6. A number of studies 
demonstrate that the more upstream components of the Stat5 pathway, namely the prolactin 
receptor (Ormandy et al., 1997; Grimm et al., 2002) and Jak2 (Shillingford et al., 2002; Wagner 
et al., 2004), are indispensable for normal alveolar formation and mammary differentiation. Stat5 
phosphorylation through activation of the prolactin receptor is mediated by the Jak2 protein 
(Gallego et al., 2001; Hennighausen and Robinson, 2008). The expression of the prolactin 
receptor (Prlr) was found to be downregulated in Miz1∆POZ mammary tissue by microarray 
analysis performed with Ctr and Miz1∆POZ lactation day 6 mammary glands. qPCR analysis 
further revealed a statistically significant (p=0.0402) decrease in the levels of Prlr in mutant 
glands (Fig. 3.28A).  
 
 
Figure 3.28: Gene expression analysis of Stat5 pathway regulators. qPCR data of the expression of 
(A) Prlr, (B) Socs1-3, Cav1 and (C) Erbb4 in Ctr and Miz1∆POZ glands (n=3 per genotype) at lactation 
day 6 of a first pregnancy.  
 
Then, the expression of genes which negatively regulate the Jak2/Stat5 pathway was analysed via 
qPCR. Suppressor of cytokine signaling (Socs) genes are part of a negative feedback loop which 
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maintains the levels of activated Stat5 under strict control (Sutherland et al., 2007; Tam et al., 
2001), although the mechanism of action in the mammary gland of the distinct family members 
varies (Lindeman et al., 2001; Harris et al., 2006; Nicholson et al., 2000). The expression of 
Socs1 (p=0.2132) and Socs3 (p=0.4060) was not significantly different between Ctr and 
Miz1∆POZ animals, but the expression of Socs2, a direct target of Stat5 (Harris et al., 2006), was 
downregulated (p=0.0425) in mutant glands (Fig. 3.28B). This observation further pointed to a 
decreased Stat5 signalling in Miz1∆POZ animals.  
Cav1 (Caveolin-1), component of the caveolae in the plasma membrane, has also been shown to 
act as a negative regulator of the Jak2/Stat5 pathway by direct interaction with Jak2 (Park et al., 
2002). The expression of Cav1 was found not significantly different (p=0.1368) between Ctr and 
Miz1∆POZ mice at lactation day 6 by qPCR (Fig. 3.28B).  
Stat5 phosphorylation is not only affected by the prolactin receptor/Jak2 pathway but also by 
ErbB4 (Receptor tyrosine-protein kinase ErbB-4), which directly phosphorylates Stat5 and, after 
proteolytic cleavage, translocates activated Stat5 into the nucleus (Long et al., 2003; Williams et 
al., 2004). As shown in Fig. 3.28C, the expression of Erbb4 was found significantly decreased 
(p=0.0433) in lactation day 6 samples from Miz1∆POZ dams. 
Taken together, the data point to a downregulation of the prolactin (Prlr) and ErbB4 (Erbb4) 
receptors which correlates with decreased Stat5 phosphorylation and nuclear translocation, 
causing the documented decline in proliferation and differentiation observed in Miz1∆POZ 
mammary glands which finally led to a lactation defect.  
 
3.4.11. Lipid aggregation in Miz1∆POZ lactating mammary glands. 
 
In order to assess the lipid synthesis capabilities of Ctr and Miz1∆POZ mammary glands, a Sudan 
III lipid staining was performed using lactation day 6 cryosections. As can be seen in Fig. 3.29 at 
different magnifications, fat droplets coalesced forming very large aggregates in the lumina of 
Miz1∆POZ alveoli. These lipid accumulations were much smaller in time-matched Ctr glands. 
A similar lipid aggregation phenotype was observed in a recent publication (Le Guillou et al., 
2012a), where this defect is explained by impaired calcium transport. Calcium positively 
regulates the size of milk fat globules as previously reported (Valivullah et al., 1988).  
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Figure 3.29: Lipid aggregation in lactation day 6 Miz1∆POZ mammary glands. Sudan III staining was 
performed on cryosections from Ctr and Miz1∆POZ glands at lactation day 6 (n=4 per genotype). 
Different magnifications are shown. Scale bars: 500 µm in A, 100 µm in B and 50µm in C.   
 
Le Guillou et al. point to a deregulation of the expression of a number of genes which control 
calcium transport to explain the fat accumulation in the lumina of alveolar cells observed upon 
overexpression of miR-30b. Namely, Clca1 and Clca2 are upregulated and Camk2b and Ano4 are 
downregulated in animals which display lipid aggregation.  
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Interestingly, a similar gene expression pattern was observed in our microarray analysis (see Fig. 
3.32) of lactation day 6 samples after comparing Miz1∆POZ animals in relation to Ctr mammary 
glands (Clca1: 4.6-fold up; Clca2: 5.4-fold up; Camk2b: 3.8-fold down; Ano4: 1.6-fold down). 
This observation was further confirmed by qPCR as shown in Fig. 3.30. 
 
 
Figure 3.30: Expression data of genes which regulate calcium transport in lactation day 6 samples. 
qPCRs showing the relative expression of Clca1, Clca2, Camk2b and Ano4 in Ctr and Miz1∆POZ 
mammary gland samples at lactation day 6. Each bar represents an individual animal.  
 
Clca1 and Clca2 proteins are chloride channels activated by calcium which share great homology 
in their sequence but not in tissue pattern expression (Pauli et al., 2000; Leverkoehne et al., 2002; 
Loewen and Forsyth, 2005). As already described by Leverkoehne et al., Clca1 expression is 
very low or negligible during the different stages of mammary gland development while Clca2 is 
highly expressed in lactating and involuting mammary glands when compared to other murine 
tissues. This observation was further supported with our own qPCR data using lactation day 6 
samples (Clca1 expression was found much lower than the one from Clca2). The expression of 
both genes was greatly upregulated in mutant glands (Fig. 3.30).  
Calcium/calmodulin-dependent kinase type IIβ (coded by the gene Camk2b) is a serine/threonine 
kinase which is activated upon increase of the intracellular levels of calcium and has an important 
role in synaptic plasticity in the central (Yamauchi, 2005) and peripheral nervous systems 
(Waggener et al., 2013), although it is expressed ubiquitously. Anoctamin 4 (coded by Ano4) 
belongs to the family of anoctamins (10 different proteins) which are chloride channels that have 
been shown to be also transiently activated by an increase of the intracellular levels of calcium 
(Tian et al., 2012). Camk2b and Ano4 are both downregulated in mutant glands. Taken together, 
Results 
 
 
 100 
the deregulation of calcium transport or flux in Miz1∆POZ mammary glands could account for 
the accumulation of lipid observed in the lumina of mutant mammary glands as previously 
described for miR-30b overexpression (Le Guillou et al., 2012a). 
 
3.4.12. Confirmation and extension of the qPCR expression data by 
microarray analysis. 
 
As already mentioned in Sections 3.4.6 and 3.4.11, a mouse genome Agilent array was performed 
for the analysis of gene expression on 1st pregnancy lactation day 6 mammary glands (n=4 per 
genotype). Interestingly, the number of genes downregulated in Miz1∆POZ glands was much 
higher than the ones upregulated, when compared with Ctr mice. After setting the threshold for 
fold change (FC) of relative gene expression to ±2, a total of 98 genes were found upregulated 
and 167 were downregulated in Miz1∆POZ versus Ctr glands. If the threshold was arbitrarily set 
to 1.5, the list of upregulated genes comprised 478 genes and the one of those with 
downregulated expression included 1033 genes (see Venn diagrams in Fig. 3.31A). Thus, the 
data suggest that, at least in the mammary gland, Miz1 is more often an activator of gene 
transcription than a repressor, taking into account that it is well documented that this protein can 
carry out both functions (Herkert and Eilers, 2010; Möröy et al., 2011).  
A bioinformatic analysis, using David Bioinformatics software, revealed several functional 
groups formed by the regulated genes obtained after comparison of array data from Miz1∆POZ 
versus Ctr mammary glands. The four most significant Gene Ontology (GO) terms provided by 
the software are represented in Fig. 3.31B. The relative abundance of genes between each of 
these groups is related to the size of the portions of the diagram. Two of the functional groups 
which systematically appeared in the different analysis of upregulated genes were “Immune 
response” and “Response to stress”. Miz1 is generally regarded as a cell cycle regulator, so it was 
not surprising to find this functional group when subjecting the list of upregulated genes in 
Miz1∆POZ glands to bioinformatic analysis. The most abundant lists of downregulated genes in 
mutant animals were the following: “Cellular metabolic process” and “Anatomical structure 
development”. These very general functional groups probably include some genes which would 
normally be directly activated by Miz1 and are downregulated in Miz1∆POZ mice. 
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Figure 3.31: Bioinformatic analysis of the lactation day 6 microarray. (A) Number of regulated genes 
in Miz1∆POZ mammary glands using different Fold Change (FC) thresholds. Note the increased number 
of genes downregulated in Miz1∆POZ animals. (B) The 4 most significant Gene Ontology (GO) terms 
were obtained using lists of genes regulated FC>2 and the Functional Annotation tool on David 
Bioinformatics v6.7. Cell functions are represented by relative gene abundance between groups. 
 
 
In order to provide a general view or summary of the molecular data obtained in this section 
dealing with the lactation defect phenotype observed in Miz1∆POZ dams, the microarray 
expression values of genes involved in the different cellular functions already discussed are 
represented in Fig. 3.32. When distinct values of Fold Change (FC) from the microarray analysis 
were available these were averaged. This is the reason why only some bars have standard 
deviation. The expression data of most of the genes provided in Figure 3.32 were further 
validated by qPCR and both approaches led to fairly similar results. Stat5 target genes (Yamaji et 
al., 2012), of both classes A (Csn1s2a, Csn2, Csn1s1 or Csn3) and B (Wap and Csn1s2b), were 
found downregulated in Miz1∆POZ glands, providing further evidence of the decreased 
activation of the Jak2/Stat5 pathway observed in mutant dams. The expression of crucial 
receptors (Prlr and Erbb4) that modulate the phosphorylation of Stat5 was also downregulated in 
Miz1∆POZ mammary glands. When negative regulators of the Jak2/Stat5 pathway were 
scrutinized, as already described by qPCR, the expression of Socs1, Socs3 and Cav1 was found 
not significantly different in Miz1∆POZ animals. Only Socs2, a Stat5 target gene, was 
downregulated in mutant mammary glands. Regarding mammary cell proliferation, Mki67 was 
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downregulated in Miz1∆POZ glands, correlating with the immunohistochemistry and qPCR data 
already provided (see Figures 3.21 and 3.22).  
 
 
 
Figure 3.32: Summary of microarray data. Functional gene groups derived from the lactation day 6 
microarray after normalization and filtering of the data. The relative gene expression is shown comparing 
Miz1∆POZ versus Ctr mammary glands. Fold changes were averaged when different values for the same 
gene were available. See Material and Methods for experimental details related to the Agilent Microarray. 
 
Continuing with the analysis of the array data of lactation day 6 samples, Myc expression was not 
significantly different between genotypes and Cdkn1a was upregulated about twofold in 
Miz1∆POZ glands. In the case of Cdkn1a, the expression of this cell cycle arrest regulator in the 
mammary glands of Miz1∆POZ mice was found to be quite heterogeneous when validating the 
array data by qPCR. Some mutant animals had high mammary levels of Cdkn1a mRNA at 
lactation day 6 while others expressed amounts comparable to those detected in Ctr mice. Several 
qPCRs were performed with n=3, n=4 and n=6 animals per genotype but, as shown in Fig. 3.22B, 
the expression of Cdkn1a was not significantly different in Miz1∆POZ mammary glands, 
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independently of the number of biological replicates analysed. In regard to the calcium transport 
genes, which might regulate lipid aggregation, and also in consonance with the data shown in 
Fig. 3.30 by qPCR, the expression in the array of Clca1 and Clca2 was greatly upregulated, while 
Camk2b and Ano4 were both downregulated in mutant glands.  
As mentioned above, a number of immune response genes were greatly upregulated in lactating 
mutant glands. The Gene Ontology (GO) terms “Immune response” or “Response to stress” 
appeared very frequently in the different functional analysis performed with David 
Bioinformatics comparing mutants to controls (see Fig. 3.31B). Distinct mRNAs which are 
normally expressed in the acute phase of an inflammatory process were upregulated in mutant 
glands at lactation day 6: Saa1, Saa2, Saa3, Lbp and Orm2. In addition, mRNAs related to the 
activation of the complement system were also highly expressed in mutant glands: Cfb and C4b 
(Fig. 3.32). A possible explanation for the “immune response” gene signature observed in mutant 
dams will be provided in the Discussion section. Despite the expression of these genes, F4/80 
immunohistochemistry did not reveal an increased recruitment of macrophages to the mammary 
alveoli of Miz1∆POZ mice at lactation day 6 (data not shown). 
 
3.4.13. Miz1 regulates vesicular transport gene expression  
 
In order to gain insight into the mechanism underlying the observed lactation phenotype, data 
from Miz1 ChIP-Seq experiments using the MDA-MB231 mammary epithelial cell line (Cailleau 
et al., 1974) were analysed. The data were provided by Dr. Björn von Eyss (Prof. Martin Eilers 
lab, Biocenter, Würzburg, Germany). In these ChIP-Seq experiments, 830 promoters bound by 
Miz1 were identified in MDA-MB231 cells. To elucidate how Miz1 regulates these target genes 
during lactation, Dr. Elmar Wolf (Prof. Martin Eilers lab, Biocenter, Würzburg, Germany) 
created a gene set with the 100 most strongly Miz1-bound genes (sorting by ChIP-Seq tag 
number) and correlated this list with the gene expression data from our cDNA microarray 
experiments performed on day 6 of lactation. This Gene Set Enrichment Analysis (GSEA) 
showed that a majority of Miz1 direct target genes are down-regulated in Miz1∆POZ animals 
(data not shown). All down-regulated genes which had at least 200 binding tags in the ChIP-Seq 
experiment are represented in Table 3.1. Interestingly, 13 out of the 23 identified genes 
(represented in grey color in Table 3.1) encode for proteins related to vesicular transport 
processes. 
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Gene symbol Binding [tags] 
Regulation 
∆POZ/Ctr [log2FC] Process/function 
Gphn 1355 -0,64397 protein localization, 
 synaptic structure 
Exoc2/Sec5 1173 -0.78775 membrane Trafficking, translocation of 
GLUT4 to the plasma Membrane 
Mrps23 1158 -0,41446 structural ribosomal protein 
Vamp4 1105 -0.98223 SNARE interactions in vesicular 
transport 
Tbc1d14 1029 -0.40866 regulation of autophagic vacuole 
assembly 
Lrp12 977 -0.74450 endocytosis 
Heatr5a 949 -0,55225 unknown 
Vps28 899 -0.87396 endocytosis 
Wdr13 893 -0,42085 unknown 
Dctn6 873 -0.93368 dynein dependent vesicular transport 
Tpk1 863 -0.42197 thiamine metabolism 
Ambra1 841 -0.48620 regulation of autophagic vacuole 
assembly 
Pdcd5/ 
TFAR19 
795 -1.00497 apoptosis 
Vps13d 736 -0.23141 Golgi localisation 
Pikfyve 729 -0.48238 phosphatidylinositol metabolic process, 
endocytosis 
Snx18/ Snag1 724 -0.56591 endosomal transport 
Tbxas1 702 -0.66024 oxidation-reduction process, 
iron/heme metabolism 
Tcea1 645 -0.83292 regulation of DNA-dependent 
transcription 
Tmbim4 645 -0,49351 apoptosis 
Nrip1 445 -0,54765 mammary gland development, 
energy metabolism 
Spast 428 -0.47523 microtubule dependent vesicular 
transport 
Dync2h1 374 -0.56335 dynein dependent vesicular transport 
Inpp5A 351 -0.43089 phosphatidylinositol metabolic process, 
endocytosis 
 
 
Table 3.1: Miz1 targets in MDA-MB231 mammary cells which are down-regulated in lactating 
Miz1∆POZ mammary glands. ChIP-Seq data from MDA-MB231 cells were combined with microarray 
expression analysis data obtained from control and Miz1∆POZ mammary gland tissue at lactation day 6. 
Listed are genes which show a strong Miz1 binding (>200 binding tags) and a down-regulation in 
Miz1∆POZ animals. Genes which code for proteins related to vesicular transport processes are highlighted 
in grey. Table created in collaboration with Prof. Hans-Peter Elsässer (Institute of Cellular Biology, 
Marburg, Germany), Dr. Elmar Wolf and Dr. Björn von Eyss (both from Prof. Martin Eilers lab, 
Biocenter, Würzburg, Germany). 
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Quantitative PCR further validated the lactation microarray analysis data. The expression of 
several Miz1 targets in MDA-MB231 cells, which code for proteins involved in vesicular 
transport processes, was downregulated in Miz1∆POZ mice (Fig. 3.33A). Moreover, 
ultrastructural analysis of the secretory vacuoles (Fig. 3.33B) revealed a higher percentage of 
casein micelle containing vacuoles (p<0.0011) in Miz1∆POZ animals (Fig. 3.33C) when lactation 
day 10 samples were analysed. In addition, a higher, but statistically not significant (p=0.1127), 
mean number of micelles per vacuole was observed in Miz1∆POZ animals. The data suggests that 
the formation, transport or sorting of secretory vesicles could be altered in Miz1∆POZ mammary 
glands. This observation correlates with the reported direct binding of Miz1 to genes which 
regulate vesicular transport in MDA-MB231 mammary epithelial cells and the reduced 
expression of these in Miz1∆POZ lactating glands.  
 
 
Figure 3.33: Genes related to vesicular transport processes are bound by Miz1 and downregulated 
in Miz1∆POZ mammary glands. (A) Quantitative PCRs of several genes related to vesicular transport 
from Table 3.1. (B) Electron microscopy showing vesicles with (arrows) and without (asterisks) casein 
micelles in tissue from control and Miz1∆POZ animals. (C) Vacuole type quantification in mammary 
glands of control and Miz1∆POZ animals from lactation day 10 (n=4). Total number of vacuoles counted: 
Control, 309-379; Miz1∆POZ, 339-404. Scale bar in B: 1 µm. 
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More experiments addressing development, maturation and transport of different intracellular 
vesicles are required to obtain a consistent model about the function of Miz1 in lactating 
mammary gland cells.  
 
3.4.14. Decreased Prolactin receptor and ErbB4 expression in Miz1∆POZ 
lactating glands. 
 
The Prolactin receptor (Ormandy et al., 1997; Grimm et al., 2002) and ErbB4 (Long et al., 2003) 
are of outstanding importance for proper mammary proliferation and differentiation. They 
modulate the phosphorylation and activity of Stat5. ErbB4 acts like a chaperone, favoring the 
nuclear translocation of phosphorylated Stat5 into the cell nucleus (Williams et al., 2004). The 
ChIP-Seq experiment revealed that Miz1 did neither bind Prlr nor Erbb4 directly. However, by 
immunofluorescence, prolactin receptor was hardly detectable in the plasma membrane of the 
epithelial cells from Miz1∆POZ lactating mammary glands (Fig. 3.34A) and nuclear ErbB4 was 
also reduced in mutant dams (Fig. 3.34B). 
 
 
Figure 3.34: Protein expression and localization of the prolactin receptor (PrlR) and ErbB4. PrlR 
(A) and ErbB4 (B) immunofluorescence (red) from control and Miz1∆POZ mammary gland tissue at 
lactation day 6. Nuclei were stained with Hoechst (blue). Scale bars in A and B: 50 µm. 
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In conclusion, the deletion of the Miz1 POZ domain in luminal mammary cells had an impact on 
the expression of a number of genes which regulate distinct intracellular vesicular transport 
processes. The sorting into the membrane of important receptors for mammary proliferation and 
differentiation like the Prolactin receptor (PrlR) or ErbB4 could be impaired by deranged 
vesicular transport. Reduction of PrlR and ErbB4 expression and their diminished availability at 
the cell surface can explain the decreased amount of phosphorylated Stat5 in the nucleus of 
Miz1∆POZ mammary cells during lactation. Thus, the reduced levels of pStat5 cannot adequately 
activate the transcription of proliferation and differentiation genes in Miz1∆POZ glands leading 
to the lactation phenotype observed.  
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4. DISCUSSION  
 
4.1. Expression of Miz1 and Myc during postnatal mammary development 
 
The study of the expression and function of proteins important for human health in normal 
development provides valuable information for the design of therapeutical opportunities in the 
context of disease. Myc is one of the current most promising targets for a number of cancer types 
including triple-negative breast cancer (Dang, 2012) and Miz1 has been shown to play an 
important role in Myc-mediated tumorigenesis (Wiese et al., 2013). Precise knowledge about the 
expression of the Miz1/Myc complex during the different stages of mouse mammary gland 
development was lacking in the literature and is analysed in this thesis.  
A nuclear Miz1 and Myc staining was detected in the ducts of developing virgin mammary 
glands by immunohistochemistry (Fig. 3.1 and 3.2). As already reported, Myc expression 
substantially increases during early pregnancy (Master et al., 2002; Blakely, 2005; Stoelzle et al., 
2009) and these high levels correlate with the stimulation of cell division during this phase of 
enhanced proliferation (Fig. 3.2). At the end of pregnancy, the immunohistochemical staining of 
Myc was detected in lymph nodes (internal positive control), but not in mammary alveolar cells 
where Miz1 protein was also found at very low levels (Fig. 3.1 and 3.2). In contrast, Miz1 
expression in the murine mammary gland was clearly boosted with the onset of lactation. By 
Western blotting, Miz1 protein could not be detected at the end of pregnancy (day 18.5), but was 
evident during lactation from day 1 after parturition (Fig. 1B; days 1 and 10 of lactation were also 
analysed, data not shown). The physiological upregulation of the endogenous levels of Miz1 in 
this particular developmental stage points to its significance during pup nursing. The lactation 
defect observed in Wap-Cre Miz1∆POZ mice supports this notion. The reason for the 
upregulation of Miz1 during lactation is still not clear. Two hormones play important roles in the 
mammary gland after parturition: prolactin stimulates milk protein synthesis in the luminal 
compartment of mammary alveoli, while oxytocin contributes to the contraction of myoepithelial 
cells for efficient milk ejection (Neville et al., 2002). Addition of prolactin in the DIP lactogenic 
cocktail (containing also insulin and dexamethasone) to confluent HC11 mammary cells did not 
result in an upregulation of Miz1 as shown by qPCR and Western blotting (Fig. 3.3). This was 
tested till 7 days after DIP-mediated induction of HC11 mammary cell differentiation (data not 
shown). Thus, prolactin does not induce Miz1 expression in vitro although a possible in vivo 
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effect should not be excluded. The hormone oxytocin might also constitute the trigger for Miz1 
expression during lactation. Thus, oxytocin or prolactin could be directly administered in vivo to 
test whether Miz1 is induced in the mammary gland. Also, obtaining samples earlier than 24 
hours after parturition can provide more precise information about the exact time point of Miz1 
upregulation. Additional experiments are required to unequivocally identify the molecular events 
that lead to the increase of Miz1 expression at around parturition and that maintain these high 
protein levels in the mouse mammary gland throughout lactation. Miz1 was detected in the cell 
nucleus during most developmental phases analysed, although immunohistochemistry also 
demonstrated a cytoplasmic staining of Miz1 during lactation. Miz1 has been shown to be 
associated with microtubules in the cytoplasm (Ziegelbauer et al., 2001; Ziegelbauer et al., 2004) 
and cellular treatment with the microtubule depolymerization agent T113242 (Lu et al., 2012) 
results in the translocation of Miz1 from the cytoplasm to the cell nucleus (Ziegelbauer et al., 
2001). Also, Myc was reported to sequester Miz1, which lacks an intrinsic nuclear localization 
signal, into the cell nucleus upon Myc overexpression (Peukert et al., 1997). Although Miz1 
function in the cytoplasm remains obscure, some immunosuppressive functions of Miz1 in this 
cellular compartment were already described (Liu et al., 2009).  
Myc levels during lactation remain low although the function of this transcription factor has been 
shown indispensable for a proper translation of milk proteins and the conditional knockout of 
Myc in the pregnant mammary gland also leads to a lactation defect (Stoelzle et al., 2009). In 
vitro, Myc expression decreases as HC11 cells become confluent and the protein can hardly be 
detected during mammary differentiation after DIP addition to the medium (Fig. 3.4; Grolli et al., 
1997). As stated earlier, Miz1 can act as a transactivator or as a transrepressor in collaboration 
with other proteins (Möröy et al., 2011). The decreased levels of Myc during lactation could 
favor Miz1 function as an activator of transcription as less repressive Miz1/Myc complexes 
would be available. Microarray analysis of samples from lactating mammary glands corroborate 
this view as two thirds of significantly regulated genes have a decreased expression in Miz1∆POZ 
glands (Fig. 3.31). In addition, acetylated lysine 9 and trimethylated lysine 4 of histone H3 
(AcH3K9 and H3K4me3), marks of transcriptionally active chromatin, were found in 553 Miz1 
target genes out of the total 734 Miz1-bound genes as shown in human embryonic stem (ES) cells 
using ChIP-on-chip analysis (Varlakhanova et al., 2011). Miz1 also seems to act predominantly 
as a transactivator in the lactating mammary gland although its repressive function (e.g. in a 
Miz1/Myc complex) could have a great significance in other cell types or contexts, like cell cycle 
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arrest gene control and tumorigenesis (Hönnemann et al., 2012; Wiese et al., 2013). In ES cells, 
Miz1 and Myc are shown to share binding to 203 genes out of the 734 Miz1-bound genes 
(Varlakhanova et al., 2011). Thus, Myc-independent functions of Miz1 are obvious and have 
already been described in the immune system, the cerebellum (Kosan et al., 2010; Saba et al., 
2011; Wolf et al., 2013) and now, with this work, in the lactating mammary gland. 
ChIP-Seq data generated in Prof. Eilers´ lab point to the regulation by Miz1, through direct 
binding, of a number of genes important for vesicular transport, endocytosis, autophagy and 
lysosomal biogenesis (Wolf et al., 2013). The expression of many of these genes bound by Miz1 
in cells of a human mammary cell line was downregulated in mutant lactating glands, as observed 
by microarray analysis and validated by quantitative PCR (Fig. 3.32 and 3.33). An interesting 
question that derives from these data arises: would Miz1 bind to the same set of genes in a 
proliferating ductal cell in the virgin gland as in an alveolar cell actively producing milk proteins? 
Performing ChIP-Seq experiments with chromatin samples from these distinct developmental 
phases would provide a feasible answer. Miz1 could potentially have different affinity for 
binding to the variable DNA motifs described (Wolf et al., 2013), as Myc has been shown to have 
a varying affinity to different canonical and non-canonical E-boxes (Fernandez et al., 2003; Lin 
et al., 2012). Lower affinity sites would only be occupied when the expression of the protein is 
high, as in the case of Miz1 in the mammary gland during lactation. A similar analysis was 
performed studying the occupancy of Miz1 and Myc in Hox genes after inducing the 
differentiation of ES cells into embryoid bodies (EBs) (Varlakhanova et al., 2011). Comparable 
experiments would be of particular interest in the mammary gland. 
After lactation is completed and upon cessation of pup suckling, cell death and tissue remodeling 
shape the involuting mammary gland in a highly coordinated manner (Watson and Kreuzaler, 
2011b). Myc has been described as a mediator of accelerated apoptosis in SOCS3-deficient 
involuting mammary glands where high levels of pStat3 stimulate Myc expression (Sutherland et 
al., 2006). A sudden decrease of the expression of Miz1 in the mammary gland was detected 48 
hours after removal of the pups from the mother (Fig. 3.1). This suggests that Miz1 is possibly 
not required when apoptosis is triggered in the early steps of involution. The described function 
of Miz1 as an activator of the anti-apoptotic gene Bcl2 (Patel and McMahon, 2007) would be in 
agreement with this view. The analysis of Miz1 expression and apoptosis, comparing wildtype 
and Miz1∆POZ glands in more time points after the initiation of involution, would be required to 
more precisely assess the possible role of Miz1 in this remodeling phase.  
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4.2. Impact of Miz1 in the virgin gland and mammary stem cells 
 
As stated earlier, a nuclear Miz1 staining was detected in ductal cells of the pubertal mammary 
gland (Fig. 3.1). To study the function of Miz1 in the virgin gland, MMTV-Cre (Line A) 
mediated deletion of the POZ domain of this transcription factor in the luminal and basal 
compartments of the mouse mammary gland was accomplished (Fig. 3.5). Recombination under 
the MMTV promoter takes place already during embryonic development and occurs also in 
stem/progenitor cells (Buono et al., 2006; Jiang et al., 2010). Thus, despite some unspecific tissue 
recombination, MMTV-Cre animals are a good model to study stem cell function and mammary 
branching in the virgin gland (Wagner et al., 2001), but are not suitable for lactation research due 
to the fact that the integration of the transgene results in a reduced mammary alveologenesis as 
recently described (Robinson and Hennighausen, 2011; Yuan et al., 2011).  
The development of the ductal epithelial tree through the adipocyte-rich stroma or fat pad was 
analysed in Ctr and Miz1∆POZ animals by whole-mount preparations after carmine alum staining 
(Fig. 3.6-3.8). Although the mammary gland finally develops normally in mutant mice (Fig. 3.8), 
a developmental delay was observed in 30-day old Miz1∆POZ animals. At this time point, 
terminal end buds (TEBs) already reach the lymph node in control animals while the rudimentary 
epithelial tree remains close to the nipple and TEBs are not as obvious in Miz1∆POZ glands (Fig. 
3.6). By 45 dpp, ductal elongation is variable in knockouts allowing the hypothesis of a 
heterogeneous extent of Cre-mediated recombination of the exons which code for the POZ 
domain in different animals (see floxed and recombinant bands in the Miz1 genotyping gel of 
Fig. 3.5B). Two of the three knockout animals analysed had developed normally at 45 dpp, while 
the other had a clear delay in the migration of the TEBs, not observed in any of the 6 wildtype 
animals studied at this time point (Fig. 3.7 and data not shown). Finally, no obvious differences 
were observed in ductal elongation or branching morphogenesis in mammary glands from Ctr 
and Miz1∆POZ animals at 65 dpp (Fig. 3.8). 
TEBs progress through the fat pad by an incompletely understood mechanism which involves 
collective cell migration (Ewald et al., 2008), regulation of endocrine signals, extracellular matrix 
(ECM) remodeling, stromal-epithelial interactions and cell adhesion (Hinck and Silberstein, 
2005). In regard to this, Miz1 has recently been linked to cellular migration by positively 
regulating RhoA gene expression in a complex with the Myc/Max/p300/Skp2 proteins (Chan et 
al., 2010). These data are still controversial, considering the existing model of Myc-mediated 
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repression and the fact that Miz1 binding at the RhoA promoter could not be detected in several 
cell lines recently analysed by ChIP-Seq (Wiese et al., 2013). More experiments would be 
required to ascertain the possible role of Miz1 in cellular migration. Miz1 levels have been shown 
to be high in metastatic prostate cancer compared to primary prostate tumors (Chan et al., 2010). 
Metastatic cells disseminate to secondary organs in a complex mechanism which involves 
cellular migration (Bravo-Cordero et al., 2012) and it would be interesting to extend the 
mentioned analysis (Chan et al., 2010) to other tissues and rule out a more general positive 
correlation between Miz1 expression and metastasis.  
Also, E-cadherin was shown to be important for collective cell migration in epithelial sheets 
maintaining tight cell-cell adhesion contacts (Li et al., 2012). E-cadherin expression was found 
indistinguishable between control and Miz1∆POZ virgin ducts by immunofluorescence staining 
analysis (data not shown; collaboration with Hedyeh Kiaveh). As described earlier, ECM 
remodeling is important for a proper mammary ductal morphogenesis in the virgin mammary 
gland. Integrins are crucial trans-membrane receptors necessary for the adhesion between cells 
and the ECM and for maintaining cell-cell contacts (Raymond et al., 2012; Glukhova and Streuli, 
2013). Unexpectedly, MMTV-Cre mediated deletion of ß1 integrin does not impair mammary 
ductal morphogenesis in the virgin gland (White et al., 2004), but K5-Cre basal ablation does 
(Taddei et al., 2008). Despite the fact that the Miz1/Myc complex has been shown to regulate ß1 
integrin expression in keratinocytes by direct binding (Gebhardt, 2006), we could not detect 
obvious differences in ß1 integrin expression between control and Miz1∆POZ virgin ducts by 
immunohistochemistry (data not shown; collaboration with Hedyeh Kiaveh).  
In addition to E-cadherin, ductal cellular architecture was analysed by immunostaining of ß-
catenin (luminal marker) and cytokeratin-14 (basal marker) in control and mutant mammary 
ducts and no differences were observed between both genotypes (data not shown; collaboration 
with Hedyeh Kiaveh). Interestingly, 45 day-old knockout ducts displayed less cellularity 
compared to aged-matched controls and the continuity of the luminal cell epithelium was 
seriously disrupted in various Miz1∆POZ virgin ducts (Fig. 3.9). In line with these observations, 
decreased proliferation in mutant glands was observed by Ki67 immunohistochemistry (data not 
shown; collaboration with Hedyeh Kiaveh). Diminished Ki67 positivity was also observed in 
WAP-Cre Miz1∆POZ lactating mammary glands (Fig. 3.21) and in K14-Cre Miz1∆POZ 
papillomas in the skin (Hönnemann et al., 2012). Thus, the ability of cells to orderly proliferate in 
the absence of a functional Miz1 is compromised in different cellular contexts.  
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Further, qPCR data revealed a reduced expression of the EGF receptor ligand amphiregulin in 
Miz1∆POZ virgin glands (data not shown; collaboration with Hedyeh Kiaveh). Amphiregulin is 
one of the main drivers of estrogen and progesterone mediated pubertal ductal morphogenesis 
and proliferation, and it is highly expressed in invasive breast carcinomas (McBryan et al., 2008; 
Aupperlee et al., 2013). The binding of amphiregulin to the EGF receptor can occur after 
autocrine, paracrine or juxtacrine secretion of the ligand (Willmarth and Ethier, 2008). Although 
the expression of amphiregulin was clearly downregulated in Miz1∆POZ virgin glands compared 
to controls, the lack of a reliable antibody for immunohistochemistry and Western blotting 
hampered the yield of more conclusive results. In summary, the absence of the POZ domain of 
Miz1 in the virgin mammary gland led to a modest phenotype characterized by a delay in ductal 
morphogenesis in mutant glands, while Miz1∆POZ ducts displayed less cellularity correlating 
with a decreased Ki67 positivity. The expression of luminal and basal markers in virgin 
mammary ducts was not affected by Miz1 POZ domain deletion. The mechanism to explain the 
delay in mammary duct morphogenesis observed in Miz1∆POZ mammary glands remains to be 
elucidated. 
The mammary gland has emerged as a valuable organ for stem/progenitor cell studies due to the 
development of in vivo (e.g. transplantation of mammary cells or tissue into the cleared fat pad of 
immunocompromised mice or lineage tracing experiments) and in vitro (e.g. mammosphere 
culture) techniques, which allow the determination of the mammary stem cell frequency in a 
cellular population and the enrichment of stem/progenitor cells in culture (Deome et al., 1959; 
Dontu and Wicha, 2005b; Van Keymeulen et al., 2011b). Currently, Myc is recognized as a 
crucial cellular pluripotency regulator (Kim et al., 2010; Smith et al., 2011; Chappell and Dalton, 
2013) and is indispensable for the maintenance of the mammary stem cell compartment (Stoelzle 
et al., 2009; Moumen et al., 2012; Moumen et al., 2013). On the other hand, the role of Miz1 on 
stem cell function alone or in association with Myc is still incompletely understood. Of note, the 
stem cell compartment in the hair follicle bulge region of the skin is not altered by Miz1 POZ 
domain deletion under the K14-Cre promoter as shown by BrdU labeling and 
immunofluorescence of the skin stem cell markers cytokeratin 15 and CD34 (Hönnemann et al., 
2012). Also, overexpression of Myc in neural progenitor cells (NPCs) leads to an increased 
neurosphere formation and neural stem/progenitor cell accumulation while forced expression of 
the MycVD/VD mutant, unable to bind to Miz1, is unable to stimulate self-renewal as efficiently as 
wildtype Myc (Kerosuo et al., 2008). Inspired by this neural stem cell culture approach 
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(Reynolds et al., 1992), mammosphere experiments allow the estimation of the frequency of 
mammary stem/progenitor cells in a complex cellular population and its propagation through 
serial passaging by cultivation in serum-free semisolid medium (Dontu et al., 2003; Dey et al., 
2009b). As described in this thesis, Miz1∆POZ mice accumulate mammary stem/progenitor cells 
after secondary and tertiary mammosphere culture (Fig. 3.10) through a Myc-independent 
mechanism (Fig. 3.11). Members of the hedgehog pathway (Ptch1, Ptch2, Smo, Gli1, Gli2 and 
Bmi1) have been shown to be highly upregulated in mammospheres compared to differentiated 
mammary cells and exogenous addition of Shh to mammary cells increases mammosphere 
formation in culture (Liu, 2006). However, mammary development is not altered in the absence 
of Shh in vivo (Gallego et al., 2002; Michno et al., 2003), although redundancy in the function of 
the different Hedgehog ligands (Shh, Dhh and Ihh) could explain the lack of phenotype in Shh 
mutants (García-Zaragoza et al., 2012). Work from our laboratory revealed a high expression of 
sonic hedgehog (Shh) by qPCR and Western blotting and a decreased amount of primary cilia in 
mutant virgin glands after staining acetylated tubulin (Hedyeh Kiaveh; data not shown). Miz1 has 
recently been shown to positively regulate the hedgehog pathway in vitro interacting with Smo 
and Gli2 by POZ domain-independent and dependent binding, respectively (Lu et al., 2013b). In 
this publication, Miz1 is shown to be recruited with Smo into the primary cilia, a process that 
would be possible in Miz1∆POZ mice, as Miz1 interacts through its C-terminus with Smo. In 
addition, ablation of the Myc binding domain of Miz1 (amino acids 641-715) has no effect on Gli 
activation (Lu et al., 2013b) suggesting that the interaction with Myc is not required for Miz1 
regulation of the hedgehog pathway. This last point would be in agreement with our own 
observations on mammosphere formation in Myc and MycVD/VD mice (Fig. 3.11). Also, binding 
of Miz1 to Gli2 would facilitate the accumulation of Gli2 at the tips of primary cilia and 
ciliogenesis seems to be not affected by Miz1 knockdown in vitro (Lu et al., 2013b). In vivo, Gli2 
expression in the virgin mammary gland is only stromal while during pregnancy and lactation it 
is both epithelial and stromal (Lewis et al., 2001). Miz1 expression in the virgin gland was weak 
in the stroma and strong in the epithelial compartment (Fig. 3.1), so that the interaction between 
Miz1 and Gli2 might be rare in the in vivo situation and would need to be formally demonstrated. 
Although Shh is significantly upregulated in Miz1∆POZ glands, downstream components of the 
Hedgehog pathway (Ptch1, Bmi1, Gli1 and Gli2; data not shown) are not statistically altered in 
mutant glands, leading to the hypothesis of an increased Shh ligand secretion in mutant glands to 
compensate for the reduced amount of primary cilia, essential for hedgehog signalling (Goetz et 
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al., 2009), in Miz1∆POZ glands. The high levels of Shh observed in Miz1∆POZ glands could 
explain the accumulation of stem/progenitor cells seen in the mammosphere assays already 
described (Fig. 3.10) but more experiments are necessary to find the possible mechanistical 
difference between Miz1 regulation of the hedgehog pathway in vivo and in vitro. A likely 
function of Miz1 in dynein and kinesin-mediated vesicular transport along microtubules in the 
cytoplasm (Franker and Hoogenraad, 2013) has not been investigated so far, despite the fact that 
Miz1 is associated to microtubules (Ziegelbauer et al., 2001). Vesicular transport is required for 
the transfer of proteins from the cytosol and Golgi apparatus to the primary cilia, which depends 
on a functional polarized trafficking (Hsiao et al., 2012). Considering that Miz1 has been recently 
described as an activator of genes related to vesicular transport by direct binding to their 
promoters (Wolf et al., 2013), it would be interesting to investigate in more depth the requirement 
of Miz1 for a proper ciliogenesis and its impact on the Hedgehog signalling pathway.  
Unequivocal mammary stem cell markers that would allow their prospective isolation are 
currently not known, although a considerable stem cell enrichment is already possible in virtue of 
the Lin−CD24+CD29hCD49fh cell surface FACS sorting profile (Shackleton et al., 2006; Stingl et 
al., 2006; Santos et al., 2013). The two current models of mammary cell hierarchy favor either the 
existence of a multipotent progenitor that gives rise to luminal (ductal and alveolar cells) and 
basal (myoepithelial cells) progeny or a model in which two lineage-restricted populations of 
stem cells repopulate either the luminal or basal mammary compartments but not both (Visvader 
and Smith, 2011; Joshi and Khokha, 2012). Both hypothetic possibilities were supported recently 
by two research groups which agree on the fact that the behavior of mammary stem cells differs 
in transplantation experiments when compared to the physiological situation (Van Keymeulen et 
al., 2011b; van Amerongen et al., 2012). Although cells with the most repopulating or self-
renewal potential in transplantation experiments express basal markers and reside in the basal 
mammary compartment (Makarem et al., 2013), recent data challenge these ideas pointing to the 
existence of separated populations of luminal and basal stem cells that contribute exclusively to 
their own compartment (Van Keymeulen et al., 2011b). Other lineage tracing experiments 
revealed that expression of Wnt signalling-associated protein Axin2 in the embryo marks the 
prospective luminal compartment while Axin2 positive cells in the prepubescent mammary gland 
finally contribute to the basal compartment (van Amerongen et al., 2012). Also, transplanted 
mouse basal mammary cells are both multipotent and lineage-restricted in primary recipients 
(Nguyen et al., 2014). In this publication, a novel clonal analysis via barcoding (Schmidt et al., 
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2009) revealed that primary luminal clones occasionally transformed into bilineage ones in 
transplanted secondary mice. Luminal mammary cells seem to have lower repopulating abilities 
but display multilineage differentiation potential (Shehata et al., 2012). Even more recent data 
point to the existence of bipotent stem cells and long-lived progenitors based on a new 3D high 
resolution imaging method combined with inducible lineage tracing (Rios et al., 2014). The 
plasticity of mammary cells in their commitment in response to environmental cues is astonishing 
as progenitor cells from other tissues are able to reprogram into the mammary cell fate upon 
transplantation into the fat pad (Booth et al., 2008; Boulanger et al., 2012; Bruno et al., 2014). 
Although our understanding of mammary stem cells has increased substantially in the last years, 
more research will be required to unequivocally delineate the hierarchical cellular organization of 
the mammary gland.  
As described in Section 3.3, the disruption of the interaction between Miz1 and Myc in vivo, by 
culturing Myc+/+ and MycVD/VD knock-in primary cells, neither affected the mammary 
stem/progenitor cell frequency nor the mammosphere sizes observed (Fig. 3.11). Thus, the 
accumulation of stem/progenitor cells observed in MMTV-Cre Miz1∆POZ primary cells cultured 
as mammospheres could be Myc-independent as described in other systems (Kosan et al., 2010; 
Saba et al., 2011; Wolf et al., 2013). Unexpectedly, the culture of Myc+/+ and MycVD/VD knock-in 
primary cells in basement membrane extract (Cultrex) reveals an interesting phenotype 
concerning lipid droplet formation. As seen in Figs. 3.12 and 3.13, primary mammary cells 
produce lipid droplets in culture stimulated by the lack of serum in the medium (Deslex et al., 
1987; Cabodevilla et al., 2013) and by the proadipogenic properties of Matrigel-like basement 
membranes (O’Connor et al., 2003; Lewis et al., 2012). While approximately 75% of all Myc+/+ 
primary cells cultured on Cultrex basement membrane differentiated into lipid droplet-forming 
cells after 10 days of culture, only around 25% of MycVD/VD knock-in primary cells contained 
lipid droplets at this time point (Fig. 3.13C). Several possibilities could account for the observed 
phenotype. As whole mammary glands were disaggregated and digested, a different proportion of 
preadipocytes might have been already present in the glands of the distinct mice before starting 
the culture. Another more likely explanation could be that the formation of a functional 
Miz1/Myc complex is required for proper adipocyte differentiation, which is enhanced by culture 
in serum-free and basement membrane-containing media. In relation to this, after induction of 
differentiation using a lactogenic hormone cocktail, HC11 mammary cells overexpressing Myc 
produced normal levels of ß-casein while forced expression of the MycVD/VD mutant led to a 
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disrupted differentiation and hardly discernible ß-casein expression by semiquantitative PCR 
(data not shown). It would be interesting to assess the function of the Miz1/Myc complex in 
cellular differentiation also in other tissues examining the relative levels of both proteins before 
and during the differentiation process (as in Figs. 3.3 and 3.4), while simultaneously testing their 
DNA binding status in these different developmental stages by ChIP-Seq or ChIP-on-chip. Myc 
has been shown to be downregulated in many contexts at the onset of differentiation, including 
the mammary gland (Grolli et al., 1997 and Fig. 3.4), and to inhibit functional differentiation 
when overexpressed (Eilers and Eisenman, 2008). In spite of this fact, Myc can also promote 
functional differentiation in epithelial tissues like the skin (Gandarillas and Watt, 1997), 
sebaceous glands (Cottle et al., 2013) or the mammary gland (Schoenenberger et al., 1988b; 
Blakely, 2005). Thus, cellular context and Myc levels play an important role in the differentiation 
process (Watt et al., 2008). The function of Miz1 during mammary gland differentiation is 
discussed in detail in the section below. 
 
4.3. Miz1 in the lactating mammary gland  
 
Deletion of the Miz1 POZ domain in mammary gland epithelial cells during gestation (Fig. 3.14) 
rendered a functionally mutated Miz1 protein which causes a lactogenic defect in the first and 
second pregnancies (Figs. 3.16 and 3.17). Wap-Cre mediated gene deletion is generally regarded 
as a highly specific and temporally regulated mouse model, which allows the study of mammary 
differentiation and lactation in vivo (Wagner et al., 1997). Cre expression is limited to the luminal 
alveolar compartment of the mammary gland and starts after the second week of pregnancy 
(Wagner et al., 1997; Stoelzle et al., 2009 and Fig. 3.15). The lactation defect observed in 
Miz1∆POZ dams was characterized by a diminished proliferation and differentiation of the 
glandular cells which caused a delayed development of the mammary gland during lactation and 
resulted in malnutrition of the pups. The reduced proliferation and differentiation detected in 
lactating mutant glands was also recapitulated in vitro using mid-pregnant immortalized HC11 
mammary cells with normal and low levels of Miz1 cultivated to form three-dimensional acini 
(Fig. 3.23) or induced to functionally differentiate by addition to the medium of a lactogenic 
cocktail containing prolactin (Fig. 3.25). As referred to earlier, Miz1 expression in the normal 
mammary gland is low at late pregnancy (P18.5) but dramatically increases during the transition 
from pregnancy to lactation (L1), where it remains high until day 2 of involution (Fig. 3.1). In 
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line with this notion, phenotypical differences of the mammary gland between control and 
Miz1∆POZ animals, like a transient reduction of the glandular tissue (Figs. 3.17 and 3.18), a 
decrease of milk protein expression (Fig. 3.24) and an extracellular coalescence of lipid droplets 
(Fig. 3.29), become visible not before lactation, although the Cre recombinase under the control 
of the Wap promoter was expressed already at day 14.5 of pregnancy (Fig. 3.14; Wagner et al., 
1997; Stoelzle et al., 2009). The sudden increase and decrease of Miz1 protein levels at the 
beginning and end of lactation, respectively, supports the data provided showing that Miz1 has an 
important function in maintaining the lactation state of the mammary gland. Although 
standardized pup weights from control and Miz1∆POZ dams (n=6) were not altered at day 3 of 
lactation, they become statistically significant from day 6 on (Fig. 3.16). Miz1∆POZ glands 
finally catched up with controls in alveolar development (Fig. 3.19) but pup weights were not 
rescued in the 24-day period analysed and differences even increased throughout time (Fig. 3.16). 
This observation allowed us to think that although alveoli finally fill up mutant fat pads at 
lactation day 10, Miz1 is required for a proper mammary differentiation in a cell autonomous 
manner and this supposition was confirmed after inducing differentiaton in HC11 mammary cells 
with normal and low levels of Miz1 (Figs. 3.24 and 3.25). TUNEL assays and cleaved caspase-3 
immunohistochemistry revealed that apoptosis is not playing a role in the phenotype observed in 
mutant glands (Fig. 3.20) and this observation could be recapitulated in vitro (Fig. 3.23F). These 
results are in line with Miz1∆POZ ablation in the skin where apoptosis is indistinguishable 
between control and mutant animals (Hönnemann et al., 2012).  
Miz1 was originally found as a Myc binding protein (Peukert et al., 1997) and it was shown that 
the binding of Myc/Max complexes to Miz1 at the initiation region of a promoter represses gene 
expression (Seoane et al., 2001; Staller et al., 2001). This has been well documented for Cdkn1a 
and Cdkn2b, encoding the cyclin dependent kinase inhibitors p21cip1 and p15ink4b, respectively. In 
skin, it was shown that a functional mutation of Miz1 in keratinocytes of the basal epidermal cell 
layer reveals an increase of p21cip1 as a result of the lack of Miz1/Myc repressing complexes. 
This leads to a reduced proliferation, a maintained or even increased differentiation and an 
alleviated development and growth of induced skin papillomas, all of which can be rescued on a 
p21cip1 null background (Hönnemann et al., 2012). However, neither Cdkn1a nor Cdkn2b were 
present under the 830 genes bound by Miz1 in a ChIP-Seq analysis performed in the mammary 
gland epithelial cell line MDA-MB231 (Dr. Björn von Eyss; data not shown), indicating that 
Miz1 does not regulate these genes in this cell type. This is in agreement with the observation 
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that the expression of Cdkn1a was not significantly altered in the mammary gland from 
Miz1∆POZ animals compared to controls (Fig. 3.22B), making it unlikely that the reduced 
proliferation observed is primarily caused by upregulated p21cip1. In addition, analysis of p21cip1 
expression during lactation (L6) by immunohistochemistry did not reveal any obvious differences 
between both genotypes (data not shown). The Myc protein was found expressed at very low 
levels during lactation by immunohistochemistry (Fig. 3.2), as previously described for mRNA 
by microarray analysis (Blakely, 2005). However, when the Myc gene was deleted during mid to 
late pregnancy in a conditional mouse model using Wap-Cre, a lactation defect phenotype was 
also observed (Stoelzle et al., 2009). Phenotypically, the authors describe a delayed proliferation 
and differentiation, impaired translation of milk proteins and a reduction of mammary gland 
precursor cells. Whether some of these observations are linked to the absence of Myc/Miz1 
repressive complexes remains to be elucidated. However, a significant upregulation of p21cip1, as 
observed in Miz1∆POZ skin (Hönnemann et al., 2012) and Myc-deficient mammary gland 
(Stoelzle et al., 2009), was not observed in the Miz1∆POZ mammary gland, suggesting that a 
relief of Cdkn1a repression by Myc/Miz1 is not the main reason for the reduction in proliferation. 
Moreover, keratinocyte differentiation was enhanced in Miz1∆POZ skin in a p21cip1 dependent 
manner (Hönnemann et al., 2012) while differentiation of Miz1∆POZ luminal mammary gland 
cells was decreased (Fig. 3.24). 
The expression of milk protein genes was lower in lactating mammary glands from mutant mice 
(Fig. 3.24 and 3.32) and in HC11 cells induced to differentiate after stable knockdown of Miz1 
(Fig. 3.25). The alveoli of lactating wildtype animals were often filled with milk proteins and this 
situation was rare in mutant glands (see red fluorescence in Fig. 3.24C). In turn, lumina from 
Miz1∆POZ mammary glands were filled with large lipid aggregates as seen after Sudan III lipid 
staining from lactation day 6 cryosections (Fig. 3.29). These data imply that milk from knockout 
dams has a low protein and high lipid content. The reduced protein content would affect the 
proper growth of the pups after suckling and the high lipid composition might complicate milk 
ejection due to increased milk viscosity (Stinnakre et al., 1994). The reason for the milk fat 
aggregate accumulation in the lumina of knockout glands is still not clear but could be explained 
by an altered calcium transport which has been shown to positively regulate lipid aggregation 
(Valivullah et al., 1988). Information about the regulation of calcium transport and its impact in 
milk fat aggregation is scarce in the literature but several genes have been shown to influence the 
process. For instance, overexpression of miR-30b during lactation results in a reduced number of 
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lipid droplets which, in turn, are characterized by a larger area than those in control animals (Le 
Guillou et al., 2012b). From the genes which are described to regulate calcium flux in this 
publication, two are upregulated (Clca1 and Clca2) and two downregulated (Camk2b and Ano4) 
after miR-30b overexpression, and these are regulated in a similar fashion in Miz1∆POZ 
mammary glands (Figs. 3.30 and 3.32). In line with the lipid droplet aggregation described, a 
high viscosity of milk in mutant glands could lead to inefficient clearing and subsequent milk 
stasis in Miz1∆POZ lumina. Microarray analysis of lactation day 6 samples provided evidence of 
an increased amount of mRNAs characteristic of an inflammatory response in mutant glands, 
which comprised acute phase response or complement activation genes (Fig. 3.32). Milk stasis 
has been shown to induce the expression of acute phase response genes like Saa3 (Molenaar et 
al., 2009). However, no immune cells are apparent in Miz1∆POZ glands after HE staining or 
immunohistochemical analysis of the macrophage-specific antigen F4/80 (data not shown). An 
alternative explanation of the stimulation of an immune response genetic program in knockout 
animals would be related to the already described function of Miz1 as a negative regulator of 
inflammation by selectively suppressing TNF-α-induced Jnk1 activation (Liu et al., 2009; Do-
Umehara et al., 2013). More experimental data would be required to test the cited possibilities. 
The signal transducer and activator of transcription (Stat) 5, especially Stat5a, establishes a 
central signalling node for proliferation and differentiation of the luminal mammary gland 
epithelium, as well as for alveologenesis during pregnancy and lactation (Hennighausen and 
Robinson, 2008). When Stat5 was conditionally deleted in late pregnancy using Wap-Cre, a 
similar reduction in mammary gland tissue was observed as in our animal model (Cui et al., 
2004). More sophisticated experiments revealed that the extent of glandular tissue that develops 
in late pregnancy and lactation depends on the Stat5 concentration in the luminal cells (Yamaji et 
al., 2012). In parallel to the morphological phenotype, genes encoding milk proteins or proteins 
involved in the regulation of luminal cell proliferation and differentiation were gradually down-
regulated with different Stat5 dosages (Yamaji et al., 2012). In line with these observations is the 
mammary gland specific knockout of SnoN or Ski novel protein (Jahchan et al., 2012). Deletion 
of SnoN, which stabilizes the Stat5 protein, reduces Stat5 concentrations in luminal mammary 
epithelial cells and induces a lactogenic defect resembling the phenotype seen in Stat5 knockouts 
or in the Miz1∆POZ mammary gland. Miz1∆POZ animals also exhibit a reduced amount of Stat5 
compared to control tissue when analysed by Western blots. Since the mammary gland epithelial 
cytokeratin-18 and tubulin, which is expressed at very low levels in adipose tissue (Spiegelman 
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and Farmer, 1982), were used as loading controls, the difference of Stat5 concentrations cannot 
be attributed to a different ratio between adipose and glandular tissue (Fig. 3.26). Whether the 
subtle decrease of Stat5a/b gene expression is sufficient to explain the reduced Stat5 protein in 
mutant glands, or if the deletion of the Miz1 POZ domain inhibits Stat5 translation or promotes 
Stat5 degradation, remains to be elucidated. Miz1 could favor stabilization of Stat5 as reported 
for SnoN (Jahchan et al., 2012) and further experiments would be required to test this hypothesis. 
As expected, due to the lower concentration of Stat5 in mutant glands, immunohistochemistry 
also revealed a clear decrease in phosphorylated Stat5 (Fig. 3.26). Taken together, the reduced 
proliferation and differentiation in the mammary gland of Miz1∆POZ animals during lactation is 
the consequence of a lower concentration of activated Stat5. 
Stat5 is phosphorylated by a variety of cytokine receptors depending on the cell type (Furth et al., 
2011). Cytokine receptors recruit Jak2 resulting in the phosphorylation of Stat5 (Levy and 
Darnell, 2002). The Jak2/Stat5 pathway is altered in lymphocytes when a functional Miz1 is 
absent, mainly by the upregulation of the Suppressor of cytokine signalling 1 (SOCS1) in 
response to interleukin-7 stimulation (Kosan et al., 2010). As already described, SOCS proteins 
negatively affect Stat5 phosphorylation keeping the Jak2/Stat5 pathway under strict control in a 
negative feedback loop (Sutherland et al., 2007). In the mammary gland both, Socs1 and Socs2, 
are target genes of activated Stat5 (Hennighausen and Robinson, 2008), but we observed only a 
lower Socs2 expression in Miz1∆POZ animals, while Socs1 was not altered and, in particular, not 
upregulated like in mutant B-cells (Kosan et al., 2010). Interestingly, Socs1 does not occur in the 
Miz1 binding list from ChIP-Seq data in MDA-MB231 cells (Dr. Björn von Eyss; data not 
shown), indicating that this is not a Miz1 target gene in mammary gland cells, in contrast to B-
cells, where Socs1 expression is directly regulated by Miz1 (Kosan et al., 2010). Caveolin-1 
prevents the access of Jak2 to the prolactin receptor and, as described, its expression is not 
increased in mutant glands (Figs. 3.28 and 3.32). In conclusion, neither the three Socs genes 
(Socs1, Socs2 and Socs3) nor Caveolin-1 (Cav1) are upregulated in Miz1∆POZ mammary glands 
(Figs. 3.28 and 3.32) making it unlikely that the decreased activation of Stat5 in knockouts is 
directly derived from high levels of these negative regulators of the Jak2/Stat5 pathway.  
In mammary gland cells, the Jak2/Stat5 pathway is activated by the prolactin receptor (Gallego et 
al., 2001). The expression of this receptor is significantly downregulated in Miz1∆POZ animals, 
providing a possible explanation for the reduced pStat5 (Fig. 3.28). In line with this notion is the 
observation that heterozygous knockout of the prolactin receptor in the mouse mammary gland 
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leads to a similar phenotype as seen in the Miz1∆POZ animals (Harris, 2006). The knockout 
phenotype was rescued on a Socs2 null background indicating that half dosage of the prolactin 
receptor is sufficient when the Jak2 inhibitor SOCS2 is absent. However, although Socs2 was 
downregulated in the mammary gland of Miz1∆POZ mice (Fig. 3.28), Stat5 was less 
phosphorylated suggesting that either the amount of Stat5 itself was low or the concentration of 
the prolactin receptor was not in favor of a more efficient Stat5 phosphorylation. In addition, it 
has been shown that ErbB4 also phosphorylates Stat5 in a Jak2-independent manner in the 
mammary gland epithelium (Long et al., 2003) and promotes the nuclear translocation of pStat5 
(Williams et al., 2004). Of note, the mRNA of this protein is also decreased in Miz1∆POZ 
animals providing an additional explanation for the observed decrease of pStat5 (Fig. 3.28). Data 
obtained using ChIP-Seq technology suggested that Prlr and Erbb4 are not directly regulated by 
Miz1 (Dr. Björn von Eyss; data not shown). In contrast, about 50% of genes bound by Miz1 in 
ChIP-Seq analysis (with more than 200 binding tags) and found downregulated in the mammary 
gland from Miz1∆POZ animals by microarray analysis are related to vesicular transport processes 
indicating that Miz1 influences multiple functions related to secretion or intracellular protein 
targeting including the transport of plasma membrane proteins to their final destination (Table 
3.1). The expression of different Miz1-bound genes in ChIP-Seq experiments which were 
downregulated in mutant glands was validated by qPCR. Genes important for vesicular transport 
(Vamp4 and Spast) including those related to membrane protein trafficking (Exoc2 and Vps13d), 
endocytosis (Lrp12, Vps28 and Pikfyve) or autophagic vacuole assembly (Ambra1) were 
significantly downregulated in mutant glands (Fig. 3.33). These data are in agreement with a 
recently published report about Miz1 function in the cerebellum (Wolf et al., 2013). In addition, 
vesicular transport was found altered in Miz1∆POZ animals after careful examination of casein 
micelle formation in lactating mammary gland samples using electron microscopy (Fig. 3.33B 
and C). It would be interesting to study Miz1 impact on vesicle formation and sorting of 
membrane receptors using time-lapse microscopy to elucidate whether the prolactin receptor and 
ErbB4 are correctly sorted to the plasma membrane and which steps of the transport are more 
influenced by Miz1 transcriptional activity (Rodriguez-Boulan et al., 2005; Chenouard et al., 
2014). The altered vesicular transport hypothesis is compatible with the observation that in 
Miz1∆POZ animals 1) the composition of the secretory vesicles is altered (Fig. 3.33), 2) ErbB4 
concentration in the nucleus is reduced (Fig. 3.34) after proteolytic cleavage of the membrane 
receptor (Williams et al., 2004) and 3) the prolactin receptor is not properly located in the plasma 
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membrane (Fig. 3.34). Signalling by the PrlR depends not only on a correct localization at the 
plasma membrane (Swaminathan et al., 2008), but is also modified by internalization via clathrin 
dependent or independent endocytosis (Piazza et al., 2009), another branch of vesicular transport. 
Interestingly, it has been shown that transcriptional expression of Prlr is enhanced by prolactin-
induced prolactin receptor signalling (Liby et al., 2003; Gutzman et al., 2004), suggesting a link 
between the observed reduction in the expression of Prlr to an impaired vesicular transport.  
In vivo studies during the last years revealed that Miz1 has pleiotropic functions in different 
tissues like skin (Gebhardt et al., 2007; Hönnemann et al., 2012), B- and T-cells (Kosan et al., 
2010; Möröy et al., 2011) or cerebellum (Wolf et al., 2013). Interestingly, the absence of 
functional Miz1 led to attenuated tumorigenesis in mouse skin (Hönnemann et al., 2012) and in a 
murine lymphoma model (Riggelen et al., 2010b), either by upregulation of Cdkn1a expression 
or by induction of senescence via an autocrine TGFβ signalling loop, respectively. Together with 
the fact that Miz1 is a central player in mediating the repressive function of the proto-oncogene 
Myc in cancer (Wiese et al., 2013), relevant roles of Miz1 in different kinds of tumors, also in the 
mammary gland, are likely. Several mouse models of breast cancer are available and some of 
them allow the study of metastasis (Hennighausen, 1999; Fantozzi and Christofori, 2006; Taneja 
et al., 2009). In the course of this thesis, MMTV-Cre (Line A) Miz1lox/lox mice were mated to 
MMTV-Polyomavirus Middle T Antigen (MMTV-PyMT) animals but no Miz1 knockouts 
(MMTV-PyMT+ and Miz1lox/lox) were obtained after several rounds of mating (data not shown). 
Miz1+/+ and Miz1lox/+ mice expressing PyMT developed mammary tumors at around 3-4 months 
of age as previously described for the MMTV-PyMT mouse strain (Lin et al., 2003). The reason 
for a possible embryonic lethality of mice lacking the POZ domain of Miz1 and simultaneously 
expressing MMTV-PyMT is currently not known. Other mouse models could be used to study 
the influence of Miz1 in mammary tumorigenesis as in other tissues (Riggelen et al., 2010b; 
Hönnemann et al., 2012; Wiese et al., 2013) and to test whether Miz1 has an effect in metastasis 
in vivo as already suggested (Chan et al., 2010).  
This is the first report about the physiological function of Miz1 in the mammary gland and 
documents its importance for an adequate mammary cell proliferation and differentiation during 
lactation. Miz1 levels increase in the transition from pregnancy to lactation and remain elevated 
until involution is triggered by cessation of pup suckling. We propose a tentative model (Fig. 4.1) 
where the lack of functional Miz1 causes a downregulation of a gene set involved in vesicular 
transport, limiting a proper localization, degradation and recycling of plasma membrane proteins. 
Discussion 
 
 
 124 
This disrupts the Jak2/Stat5 pathway due to impaired signalling via prolactin receptor and ErbB4, 
reflected by an alleviated expression of Stat5 target genes like Csn1s1, Csn1s2a, Csn1s2b, Csn2, 
Csn3, Wap or Socs2 as well as Prlr and Erbb4. This deficiency in Stat5 activation leads to a 
decrease in mammary proliferation and differentiation which cause the lactation phenotype 
observed in Miz1∆POZ animals. 
 
 
 
 
Figure 4.1: Hypothetical model for the function of Miz1 in the lactating mouse mammary gland. 
Miz1 binds to many genes which are important for vesicular transport and these are downregulated in 
Miz1∆POZ glands. Impaired sorting of these vesicles could be the cause of the observed reduction in the 
exposure of the prolactin receptor and ErbB4 to the plasma membrane leading to a decreased amount of 
activated Stat5 in mutant glands. In consequence, the reduced levels of phosphorylated Stat5 dimers 
(represented by smaller symbol size) cannot adequately activate the transcription genes important for  
proliferation and differentiation in Miz1∆POZ glands leading to the described lactation defect (Modified 
according to Williams et al., 2004 and Hennighausen and Robinson, 2008). 
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5. APPENDICES 
 
5.1. Summary 
 
5.1.1. Zusammenfassung  
 
Die Analyse von Proteinen, die für die embryonale Entwicklung sowie für Erkrankungen relevant 
sind, stellen wertvolle Informationen für die Entwicklung neuer therapeutischer Konzepte zur 
Verfügung. Das Protooncogen Myc ist zum Beispiel ein vielversprechendes Zielprotein in einer 
Reihe von unterschiedlichen Tumoren einschließlich des sogenannten „triple negativen“ 
Brustdrüsenkarzinoms. In der vorliegenden Arbeit wurde zum ersten Mal die Funktion des 
Transkriptionsfaktors Miz1 in der Brustdrüse der Maus untersucht. Hierzu wurde ein 
konditionelles Miz1 knockout Mausmodell verwendet. Bei diesem Modell wird die POZ Domäne 
deletiert. Diese ist essentiell für die Ausbildung von Tetrameren, die dann stabil an das 
Chromatin binden können. Die Deletion wurde mit zwei unterschiedlichen Cre-Stämmen 
durchgeführt. Ein MMTV-Cre Stamm wurde verwand, um die POZ Domäne in nulliparen 
Mäusen zu deletieren, wobei die postnatale Morphogenese der Drüse, sowie  die 
Brustdrüsenstammzellen untersucht wurden. Ein Wap-Cre Stamm wurde eingesetzt, um die 
Alveologenese und die Brustdrüsendifferenzierung während der Schwangerschaft und der 
anschließenden Laktation zu analysieren.  
Die Deletion der POZ Domäne mit MMTV-Cre erfolgt bereits im embryonalen Gewebe und 
führte zu einer Verzögerung der postnatalen Ausbildung und Verzweigung des Drüsenganges und 
einem zellärmeren Gangepithel. Weiterhin wurde eine von Myc unabhängige Anreicherung von 
Stamm- bzw. Vorläuferzellen in Miz1∆POZ Tieren beobachtet. Unterschiede in der Expression 
von luminalen und myoepithelialen Markern traten nicht auf. Die Verzögerung der postnatalen 
Gangentwicklung war in zwei Monate alten Tieren nicht mehr zu beobachten. 
Mit Hilfe der Immunhistochemie und mit Western Blots konnte gezeigt werden, dass die 
Expression von endogenem Miz1 in normalen Tieren während der Laktation stark erhöht ist, 
während am Ende der Schwangerschaft nur wenig Miz1 nachgewiesen werden konnte. Die Miz1 
Expression wird also während bzw. kurz nach der Geburt sprunghaft erhöht. Wird die Involution 
eingeleitet, fällt die Miz1 Expression innerhalb von 48 Stunden auf Werte zurück, wie sie vor der 
Laktation beobachtet wurden. Die Deletion der POZ Domäne während der Schwangerschaft mit 
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Hilfe von Wap-Cre erzeugte einen Laktationsdefekt während der ersten und der zweiten 
Schwangerschaft. Drüsen mit mutiertem Miz1 zeigte eine reduzierte Alveologenese, sowie eine 
verminderte Proliferation und Differenzierung. Dies konnte in der HC11 Zelllinie, die aus einer 
Maus-Brustdrüse isoliert wurde, verifiziert werden. HC11 Zellen mit geringer Miz1 Expression 
proliferieren langsamer und expremieren weniger β-Casein, wenn sie mit einem „laktogenen 
Hormoncocktail“, der u.a. Prolactin enthält, behandelt werden. Dabei zeigt sich weder in vivo 
noch in vitro eine Änderung der Apoptoserate , wenn die Miz1 POZ Domäne deletiert oder Miz1 
ausgeschaltet wird. Brustdrüsen mit mutiertem Miz1 haben geringere Mengen an  Stat5, was zu 
einer Reduktion der Expression entsprechender Zielgene wie α-Casein, β-Casein or whey acidic 
protein (Wap) führt. Negative Regulatoren des Jak2/Stat5 Signalwegs wie Socs (Socs1, Socs2, 
Socs3) oder Caveolin-1 (Cav1) waren in ihrer Expression nicht verändert. Im Gegensatz dazu 
wurde eine Verringerung des Prolactinrezeptors und von ErbB4 beobachtet. Beide Proteine sind 
wichtig für die Phosphorylierung von Stat5. Allerdings konnte mit Hilfe von CHIP-Seq 
Experimenten eine direkte Bindung von Miz1 an die Gene dieser beiden Proteine nicht gezeigt 
werden. Jedoch bindet Miz1 an verschiedene Gene, die für die Regulation des vesikulären 
Transportes, der Endozytose und der Autophagie entscheidend sind. Ein Modell, in dem die 
Störung des vesikulären Transportes der beiden Rezeptorproteine im Mittelpunkt steht, wird 
vorgeschlagen.  
 
5.1.2. Summary 
 
The study of the expression and function of proteins important for human health in normal 
development provides valuable information for the design of therapeutical opportunities in the 
context of disease. Myc is one of the current most promising targets for a number of cancer types 
including triple-negative breast cancer and Miz1 has been shown to play an important role in 
Myc-mediated tumorigenesis. In the present work, the function of the Myc-binding protein Miz1 
in the mammary gland is investigated for the first time using two different lines of transgenic 
mice expressing Cre-recombinase to conditionally knockout the POZ domain of Miz1 in the 
murine mammary gland. Deletion of this evolutionary-conserved region impedes multimerization 
and stable association of Miz1 with chromatin. MMTV-Cre mediated deletion was used to 
investigate Miz1 function in the virgin gland, considering branching morphogenesis and 
mammary stem/progenitor biology. Ablation under the Wap-Cre promoter provided information 
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about alveologenesis and mammary differentiation.  The mammary gland is a very suitable organ 
for stem cell and developmental studies as rounds of proliferation, differentiation and apoptosis 
occur after each pregnancy.  
POZ domain deletion using MMTV-Cre (Line A), already active in the embryo, led to a delayed 
ductal tree formation, less cellularity in knockout ducts and a Myc-independent accumulation of 
stem/progenitor cells in virgin mammary glands of Miz1∆POZ animals. No differences in the 
expression of luminal and myoepithelial markers were observed between control and Miz1∆POZ 
virgin mice. In addition, the delay in the development of the mammary ductal tree in knockout 
mice is rescued at around two months of age.  
Endogenous Miz1 expression in the mammary gland of control animals was found to be highly 
boosted during lactation by immunohistochemistry and Western blotting. Very low Miz1 levels 
were detected at the end of pregnancy, which increased after parturition and diminished upon 
cessation of pup suckling at around 48 hours of forced involution. Miz1 POZ domain ablation in 
luminal alveolar mammary cells during pregnancy using the WAP-Cre transgenic line resulted in 
a lactation defect in mutant dams during the first two pregnancies analysed. Mutant lactating 
glands display a reduced alveologenesis as a result of a diminished mammary cell proliferation 
and differentiation. These data were also confirmed in vitro using the HC11 murine mammary 
cell line after retroviral infection for stable knockdown of Miz1. HC11 cells with low levels of 
Miz1 show a reduced proliferation and a decreased expression of ß-casein after inducing 
differentiation by addition of a lactogenic hormone cocktail containing prolactin. Apoptosis is 
unaffected after either Miz1 POZ domain ablation in vivo or stable knockdown of Miz1 in vitro. 
Mutant glands display lower levels of activated Stat5 which lead to a reduced expression of its 
transcriptional targets, mainly genes which code for milk proteins like α-casein, β-casein or whey 
acidic protein (WAP). Gene expression of negative regulators of the Jak2/Stat5 pathway like 
Socs (Socs1, Socs2 and Socs3) or Caveolin-1 (Cav1) is not upregulated in Miz1∆POZ lactating 
glands. In contrast, the expression of receptors important for a proper phosphorylation of Stat5, 
like the prolactin receptor or ErbB4, is decreased in lactating mutant glands. ChIP-Seq 
experiments revealed that genes encoding the prolactin receptor and ErbB4 are not direct targets 
of Miz1. Rather, Miz1 binds to genes which regulate vesicular transport and thus alters processes 
like endocytosis and autophagy in mammary gland cells. A model in which the vesicular 
transport of these receptors in mutant glands could be disrupted is proposed.  
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In conclusion, this work shows for the first time that Miz1 is important for mammary 
stem/progenitor cell regulation in the virgin gland and for a proper proliferation and 
differentiation in the lactating mammary gland.  
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5.2. List of abbreviations 
 
AEC   3-amino-9-ethylcarbazole 
ANOVA  Analysis of variance 
APS   Ammonium Persulfate 
BCA   Bicinchoninic acid assay 
bFGF   Basic fibroblast growth factor 
BME   Basement membrane extract 
CD   Cluster of differentiation 
cDNA   Complementary DNA 
ChIP-Seq  Chromatin immunoprecipitation-sequencing 
Cre   Cre recombinase 
Ct   Threshold cycle  
Ctr   Control 
Cy   Cyanine 
dd   Double-distilled 
DEPC   Diethylpyrocarbonate 
DIP   Dexamethasone-insulin-prolactin  
DMEM  Dulbecco's modified eagle's medium 
dNTPs   Deoxynucleotide triphosphates 
EDTA   Ethylenediaminetetraacetic acid 
EGF   Epidermal growth factor 
EMT   Epithelial to mesenchymal transition 
FACS   Fluorescence activated cell sorting 
FBS   Fetal bovine serum 
FITC   Fluorescein isothiocyanate 
GAPDH  Glyceraldehyde 3-phosphate dehydrogenase 
GFP   Green fluorescent protein 
GSEA   Gene Set Enrichment Analysis 
HBS   Hepes buffered saline 
HEPES  Hydroxyethyl piperazineethanesulfonic acid 
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HRP   Horseradish peroxidase 
H&E   Hematoxylin and eosin 
Ig   Immunoglobulin 
iPSC    Induced pluripotent stem cell  
K5   Cytokeratin 5 
K14   Cytokeratin 14 
MEBM  Mammary epithelial basal medium 
MMTV  Mouse mammary tumor virus 
M-MuLV  Moloney murine leukemia virus 
NMR   Nuclear magnetic resonance 
NOD/SCID  Nonobese diabetic/severe combined immunodeficiency 
OD   Optical density 
PCR   Polymerase chain reaction 
PFA   Paraformaldehyde 
PVDF   Polyvinylidene fluoride 
RIPA   Radioimmunoprecipitation assay buffer 
RPMI   Roswell Park Memorial Institute 
RQI   RNA quality indicator 
rTdT   Terminal Deoxynucleotidyl Transferase 
SD   Standard deviation 
SDS   Sodium dodecyl sulfate 
SMA   Smooth muscle actin 
TBE   Tris borate EDTA 
TDLUs  Terminal ductal lobular units 
TEBs   Terminal end buds 
TEMED  Tetramethylethylenediamine 
TGFβ   Transforming growth factor beta 
TNFα   Tumor necrosis factor alpha 
TRITC   Tetramethylrhodamine isothiocyanate 
UV   Ultraviolet 
WAP   Whey acidic protein 
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